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ABSTRACT 
The physiological roles of highly unsaturated fatty acids (HUFA), mainly arachidonic 
acid (AA, 20:4ω6) and docosahexaenoic acid (DHA, 22:6ω3), are not completely understood.  In 
order to study specific functions for AA and DHA, a delta-6 desaturase knockout (D6D-/-) 
mouse was created.  D6D is a key enzyme in synthesizing HUFA from the precursor dietary 
essential fatty acids, linoleic acid (LA, 18:2ω6) or α-linolenic acid (ALA, 18:3ω3).  By 
disrupting D6D expression, LA and ALA provided in the diet will not be metabolized to HUFA.  
Phenotype of the D6D-/- mouse is therefore specific to lack of AA and/or DHA and consists of 
ulcerative dermatitis, male infertility, gastrointestinal ulcers, and hepatic lipidosis.  New insight 
on specific AA and DHA roles was established through dietary prevention of HUFA deficiency 
phenotype.   
The absence of a D6D isozyme had to be assessed before further characterizing HUFA 
roles with the D6D-/- mouse model.  The presence of a D6D isozyme would interfere with the 
creation of HUFA deficiency.  The primary D6D isozyme candidate was Fads3 gene due to its 
increased gene expression in D6D-/- liver and homology to the Fads2 gene that encodes for 
D6D.  Cloning and transfection of Fads3 into cultured HEK293 cells confirmed lack of D6D 
activity (Chapter 3).   
The order of appearance of D6D-/- phenotype due to HUFA deficiency had yet to be 
determined.  A D6D-/- time course study (Chapter 4) characterized the mouse at different ages 
in order to follow sequence of HUFA deficiency pathology.  The amount of HUFA in D6D-/- at 
weaning was comparable to control mouse indicating the presence of HUFA stores that most 
likely result from HUFA passed on from the mother.  Subsequent HUFA depletion with age 
correlated with severity of D6D-/- phenotype.  Male infertility, gastrointestinal erosions, and 
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hepatic lipidosis are the first observed HUFA deficiency phenotype to appear at 6 weeks of age, 
followed by impaired antibody response at 9 weeks, and ulcerative dermatitis by 21 weeks of 
age. 
HUFA supplementation studies helped determine specific roles for AA and DHA in 
preventing HUFA deficiency phenotype.   Hepatic lipidosis was prevented by either AA or DHA 
(Chapter 5).  AA essentiality was specific to skin and gastrointestinal function since DHA 
supplementation was unsuccessful in preventing ulcerative dermatitis or gastrointestinal ulcers 
(Chapter 6).  DHA essentiality was specific to male reproduction as indicated by full restoration 
of spermatogenesis, sperm counts, and sperm motility (Chapter 7).  The role of DHA in 
spermatogenesis is related to acrosome biogenesis, a process which relies on vesicle fusion 
(Chapter 8).  The immune system (Chapter 9) was further characterized following up on 
splenomegaly and thymic atrophy observations of the first characterization of the D6D-/-.  
HUFA deficiency results in decreased antibody response indicating essentiality for HUFA in 
immune function.  
In summary, these studies showed for the first time a specific requirement for AA in skin, 
and of DHA in male reproduction.  The mechanism behind DHA requirement in male fertility 
has been linked to acrosome biogenesis.  Future research done with the D6D-/- mouse model will 
help develop hypothesis on other potential mechanisms behind the essentiality of AA and DHA.  
Understanding how HUFA maintain tissue homeostasis will help in the development of 
treatments for diseases that result from an altered essential fatty acid metabolism.  
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CHAPTER 1 
INTRODUCTION 
In the 1930’s, dietary essential fatty acids (EFA) were discovered after rats fed a fat-
free diet developed pathology reversed by supplementation of the polyunsaturated fatty acids 
linoleic acid (LA; 18:2 ω6) and α-linolenic acid (ALA 18:3 ω3) (1).  Depletion of these dietary 
EFA results in the classic deficiency symptoms of dermatitis, stunted growth, and reproductive 
problems.  Between the 1940’s and 1970’s, the importance of EFA was further demonstrated in 
humans with infants on fat-free formula and adults on fat-free total parenteral nutrition which 
also developed the classic EFA deficiency symptoms (2).  Dermatitis and growth retardation 
have been attributed solely to LA and ALA deficiency; however the functional importance may 
not fall entirely on these EFA since they are metabolized to the respective highly unsaturated 
fatty acids (HUFA),  arachidonic acid (AA; 20:4 ω6) and docosahexaenoic acid (DHA; 22:6 ω3) 
which also participate in physiological processes.  It is well established that AA is a precursor to 
eicosanoids (3), such as prostaglandins and leukotrienes, which act as signaling molecules in a 
variety of tissues, modulating cell behavior in processes related to inflammation, reproduction, 
bone metabolism, and immune function.  DHA is present in large amounts in brain, retina, and 
testis and is a HUFA attributed a membrane structural role, providing fluidity to cellular 
membranes for cell signaling (4).    
Despite our current knowledge of AA and DHA, the physiological roles of HUFA are 
still not completely elucidated.  Attributing specific physiological roles to each HUFA and 
elucidating the mechanism behind their function requires an in vivo experimental model of 
HUFA deficiency.  A major limitation in the traditional approach of creating HUFA deficiency is 
the concurrent depletion of the dietary EFA precursors, LA and ALA.  The deficiency symptoms 
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in this case would not be specific to AA and DHA.  Studying AA functions is compromised by 
stunted growth due to LA deficiency complicating research done on other physiological 
processes such as reproduction.  DHA deficiency studies result in compensatory synthesis of a 
structurally similar ω6 HUFA, docosapentaenoic acid (DPA; 22:5 ω6) (5), which may mask 
physiological functions of DHA.   
To overcome this obstacle, the delta-6-desaturase knockout (D6D-/-) mouse was created 
(6,7).  D6D is a key enzyme in synthesizing HUFA from the dietary precursor EFA.  By 
disrupting D6D expression, LA and ALA provided in the diet will not be metabolized to HUFA 
resulting in a state of deficiency specific to the lack of AA and/or DHA.  Advantages of using 
the D6D-/- mouse to elucidate specific AA and DHA functions are therefore: a) the physiological 
role of AA can be studied without concurrent LA deficiency symptoms of growth retardation and 
disruption of  skin water barrier (1); b) DHA functions can be determined without the 
compensatory synthesis of the D6D product, docosapentaenoic acid (DPA, 22:5 ω6). 
New insight into the role of HUFA was achieved with an initial characterization of the 
D6D-/- mouse (6,7).  Despite the presence of LA and ALA, pathology persisted including male 
infertility, liver lipidosis, gastrointestinal ulcers, and ulcerative dermatitis (6).  Determining 
specific roles for AA and DHA in each of these physiological processes require further 
characterization of the D6D-/- mouse.  The requirement of HUFA in male reproduction, for 
example, has been inferred due to the high amounts of AA and DHA in testis, however, the 
mechanism of HUFA function for male fertility has not been determined.  The D6D-/- 
demonstrated that HUFA deficiency resulted in disruption of spermatogenesis (6,7).  Further 
characterizing the disrupted stage of spermatogenesis in D6D-/- will help elucidate the 
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mechanism by which HUFA participate in sperm formation and could have implications in 
treating male infertility. 
The general objective of this research is to further characterize the D6D-/- mouse in order 
to elucidate specific physiological functions of AA and DHA and their underlying mechanisms.  
In order to achieve this objective, the research is divided into three parts: a) establishing a time 
course of D6D-/- pathology, b) determining specific HUFA physiological functions through 
dietary prevention of D6D-/- pathology, c) and elucidating the mechanism behind HUFA 
requirement for male fertility.   
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 CHAPTER 2  
REVIEW OF LITERATURE 
Classification of fatty acids 
Fatty acid functionality is determined by the physical and chemical properties that result 
from its chemical structure.  The structure of fatty acids consists of a hydrocarbon chain with a 
carboxyl and methyl end (Figure 2.1).  This chain varies in length and in the number of double 
bonds within their chemical structure.  Depending on the presence or absence of double bonds 
within the chemical structure, fatty acids can be classified into two major categories: saturated or 
unsaturated fatty acids. 
Saturated fatty acids do not have double bonds and are major components of cellular 
membranes.  They participate in energy production through beta-oxidation or in energy storage 
as components of triglycerides in adipose.  Palmitic acid (16:0) and stearic acid (18:0) are the 
most common saturated fatty acids (Figure 2.1) and can be synthesized in the liver from acetyl 
coenzyme-A (Figure 2.3). 
Unsaturated fatty acids have one or more double bonds within their structure and can be 
further classified into monounsaturated or polyunsaturated (Figure 2.1).  Monounsaturated fatty 
acids (MUFA) have one double bond.  Oleic acid (18:1n9) is the most common MUFA and, like 
saturated fatty acids, is an important building block of cellular membranes.  Oleic acid is 
synthesized from stearic acid after the addition of a double bond by a desaturase enzyme known 
as stearoyl-CoA desaturase (SCD-1) (Figure 2.3).   
Polyunsaturated fatty acids (PUFA) have two or more double bonds and also increase 
fluidity of cellular membranes in addition to being involved in eicosanoid signaling and gene 
regulation.  PUFA can be identified with an omega nomenclature based on the position of the 
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double bond in reference to the methyl end of the hydrocarbon chain.  For example, omega-3 
fatty acids have a double bond positioned three carbons from the methyl end, while omega-6 
fatty acids have a double bond six carbons from the methyl end.  The omega-6 and omega-3 
PUFA are termed essential fatty acids (EFA) due to their requirement in the diet.  Specifically, 
omega-6 linoleic acid (LA; 18:2n6) and omega-3 α-linolenic acid (ALA; 18:3n3), cannot be 
synthesized by humans due to the lack of a desaturase that would insert a double bond at either 
carbon 3 or 6 from the methyl end of the structure. LA and ALA can be consumed in the diet 
from plant oil sources such as corn or canola, respectively.  In order to obtain the full benefit of 
LA and ALA, once consumed, these PUFA are metabolized into highly unsaturated fatty acids 
(HUFA), which are physiologically essential fatty acids of at least 20 carbons in length and a 
minimum of four double bonds.  PUFA metabolism to HUFA requires desaturase and elongase 
enzymes (Figure 2.3).  Delta-5 (D5D) and delta-6 desaturases (D6D) are the desaturases in 
PUFA metabolism that insert double bonds at a specific position within the fatty acid structure.  
The role of elongases is chain elongation through addition of carbons.  The main HUFA 
produced from LA is omega-6 arachidonic acid (AA; 20:4n6) while from ALA we obtain the 
omega-3 docosahexaenoic acid (DHA; 22:6n3).  AA and DHA can be considered as 
physiologically essential fatty acids (Figure 2.2). 
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 Figure 2.1 Chemical structure of saturated, monounsaturated (MUFA), and 
polyunsaturated fatty acids (PUFA). 
 
 
 
Figure 2.2 Chemical structure of highly unsaturated fatty acids (HUFA). 
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 Figure 2.3 Synthesis of monounsaturated (MUFA) oleic acid (left) and of highly 
unsaturated fatty acids (HUFA) arachidonic acid (AA) and docosahexaenoic acid (DHA).  
 
Discovery of essential fatty acids and their functions  
The discovery of essential fatty acids (EFA) dates from 1929 when recently weaned rats 
fed a fat free diet developed dermatitis and growth retardation; fatty livers and testicular 
degeneration were also observed (1).  Neither saturated fatty acids nor MUFA alone were 
successful in treating these deficiency symptoms (2).  Fat sources containing PUFA omega-6 LA 
were able to restore skin function and growth. Omega-3 ALA treatments showed improvements 
in fat deficiency symptoms but did not completely cure them (3). These studies demonstrated for 
the first time the dietary requirement of PUFA for proper physiological function of skin, liver, 
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and reproductive organs.  The specific PUFA for proper function of each tissue was yet to be 
determined. 
A fat free diet study with mice further supported the essentiality of PUFA by reversal of 
EFA deficiency symptoms through corn oil supplementation containing 60% linoleic acid (4).  
The mouse EFA deficiency symptoms included dry skin, dermatitis, infertility, and fatty liver, 
similar pathology to that seen in fat deficient rats.  Within this study, another group of mice 
began the fat-free diet at mature age with a starting body weight of 20 grams. In these mice, 
observable EFA deficiency symptoms did not occur until 8 months on the fat-free diet.  The 
delay in appearance of EFA deficiency symptoms in mature mice was explained by higher PUFA 
storage levels in adipose since the EFA deficient diet was initiated at adult age.   When a skin 
injury was induced in these mature mice, wound healing was impaired compared to controls, 
suggesting a chronic condition of EFA deficiency in which insufficient PUFA stores resulted in 
delayed tissue repair.     
In the 1950s, essentiality of EFA in humans was first studied in infants fed milk of 
different fat composition and LA levels (5).  Infants fed low fat milk presented dry skin and 
diarrhea after a month.  Biochemical evidence of EFA deficiency defined as a ratio of omega-9 
mead acid (20:3n9) to omega-6 AA of more than 0.2 was present in the lipid profile of these 
infants.  In absence of EFA, the liver synthesizes mead acid (20:3n9) in place of AA (20:4n6) 
(Figure 2.4).  Incorporating LA to the low fat milk corrected serum lipid profiles increasing AA 
and decreasing mead acid while deficiency symptoms were reversed by two weeks.  AA 
supplementation also corrected skin problems although required up to five weeks to be 
successful.  Saturated fatty acid supplementation did not correct the skin dryness nor did it 
modify the unsaturated serum lipid profiles.  
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In the 1970’s, the essentiality of PUFA became more apparent with several cases of EFA 
deficiency due to fat-free total parenteral nutrition (TPN) or intravenous feeding.  A 77-year-old 
female became EFA deficient after receiving fat free TPN due to a resection of the small bowel 
(6); the patient developed dermatitis within a month.  Fat-free TPN given to infants of less than 6 
months of age presented an EFA deficient serum lipid profile with a decrease of AA and an 
increase in mead acid; one infant fed fat-free TPN for 4.5 months presented dermatitis and a very 
high mead acid to AA ratio of 18; serum profiles were reversed with LA supplementation (7).  
When on fat-free TPN, newborns were shown to become EFA deficient by the first week of life 
as reflected by lipid plasma measurements (8).  In 1975, three cases of adult EFA deficiency 
were documented due to fat free TPN; patients developed dermatitis as early as 46 days; LA 
treatment corrected skin abnormalities (9).  Up to this point, all cases of EFA deficiency were 
treated with success using omega-6 LA.  In 1982, LA was incorporated to TPN lipid emulsions 
with either sunflower or safflower oil.  However, the use of safflower oil based TPN resulted in 
the first human case of omega-3 deficiency.  The deficiency was explained due to lack of omega-
3 ALA in safflower oil.   A 6-year-old girl on safflower oil TPN presented abnormalities in her 
nervous system and vision.  Her serum lipid profiles suggested omega-3 deficiency with only 
34% of control values.  The switch to sunflower oil lipid emulsions, which contains omega-3 
ALA, corrected the deficiency symptoms (10,11).  Omega-3 deficiency reflected in plasma 
levels was also reported in elderly patients fed by gastric tube (12). 
LA is a major component of fat emulsions for TPN since soybean oil is currently used a 
fat source to prevent EFA deficiency.  TPN made with fish oil, which is high in HUFA, has also 
been effective in preventing EFA deficiency.  The fish oil based emulsion known as Omegavens 
(Fresenius Kabi, Bad Homburg, Germany) was developed as an alternative to the soybean oil 
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preparation.  In 2005, a TPN patient allergic to soybean oil developed EFA deficiency due to fat-
free TPN and was successfully treated with the fish oil emulsion despite concerns of low LA 
levels in Omegavens (13).  Omegavens is being considered a potential alternative to avoid long 
term TPN associated liver diseases which are thought to be attributed to the high LA content in 
soybean oil based TPN (14).  The safety and efficacy of TPN with a fish oil based emulsion were 
tested on 18 infant patients with cholestasis which were previously on soybean oil TPN (15); the 
patients did not develop essential fatty acid deficiency and reversal of cholestasis was achieved.  
Several cases have shown that fish oil, used as a sole fat source in TPN, can successfully prevent 
EFA deficiency (16), demonstrating the essentiality of HUFA and not just LA.     
The essentiality of HUFA, AA and DHA, was shown in a human case of impaired HUFA 
synthesis which resulted in corneal ulcerations, impaired growth, and skin abnormalities (17).  
Impaired HUFA synthesis in this patient was demonstrated by culturing her skin fibroblasts and 
evaluating conversion of 14C-labeled omega-6 LA to AA, and from 14C-labeled omega-3 ALA to 
DHA. Both omega-6 and omega-3 pathways in the patient’s skin fibroblasts were disrupted due 
to delta-6 desaturase (D6D) deficiency as determined by low levels of D6D mRNA and a 
decrease in HUFA production (17).  D6D is the rate limiting enzyme in HUFA synthesis and this 
case demonstrates that disrupted D6D activity impairs physiological function of tissues despite 
presence of LA and ALA. This reiterates the importance of HUFA in maintaining tissue 
function.  
The role of AA is well established as being a precursor to eicosanoids which are lipid 
signaling mediators produced by cells to regulate functions related to inflammation and 
homeostasis of tissues.  In 1964, eicosanoids known as prostaglandins were first identified as AA 
metabolites (18).  Later on, thromboxanes and leukotrienes were also confirmed to be AA 
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metabolites (19).  AA is cleaved from membrane phospholipids by phopholipase and is then 
metabolized by prostaglandin H2 synthase, also known as cyclooxygenase, into an intermediate 
prostaglandin (PG) H2.  PGH2 is further metabolized into various PG and thromboxanes (20).  
The type of eicosanoid produced depends on the cell type and tissue.  The functions of each 
eicosanoid depend on the prostanoid receptor to which it binds.  These functions have been 
characterized through the use of knockout mice for each prostanoid receptor (21).  Pain and 
inflammation are physiological processes in which PGI2 and PGE2 are involved (22).  PGD2 
and E2 participate in immune responses such as allergy and chemotaxis of lymphocytes.  PGF2α 
induces uterus contractions.  Bone remodeling is stimulated by PGE2 secreted from osteocytes.  
Arachidonic acid is therefore involved in the physiological processes of many tissues through the 
production of its metabolites.   
   Docosahexaenoic acid is a major fatty acid in phospholipids of brain and retina, and is 
considered to have a membrane structural role which allows proper function of these tissues.  
Studies of omega-3 deficiency created by removing the DHA precursor ALA from the diet, has 
given insight into the possible role of this HUFA in retina and brain.  In retina, DHA is in high 
concentration within the rod photoreceptors of the retina and is important for vision.  Visual 
acuity was reduced by half in rhesus monkeys fed an ALA deficient diet for 8 weeks; DHA was 
almost depleted at 9% of control plasma phospholipids (23).  A specific physiological role for 
ALA for vision has not been established, other than being the precursor for DHA.  Due to DHA 
accumulation in retina, it is this HUFA and not its precursor which is considered physiologically 
essential for vision.  A possible function for DHA in vision is as modulator of retinoid trafficking 
in the visual cycle of the retina; DHA was shown to interact with the bovine interphotoreceptor 
retinoid binding protein favoring delivery of 11-cis-retinal to photoreceptor cells for rhodopsin 
 12
restoration (24).    The electroretinogram, which evaluates retinal function, is delayed in third 
generation omega-3 deficient rodents, further demonstrating the importance of omega-3 PUFA 
for vision (25).  These results were explained by inefficient G protein signaling for rhodopsin 
activation using DHA deficient rodent rod outer segments (26).   In relation to brain, omega-3 
deficiency rodent studies with up to 87% decrease in omega-3 brain fatty acids show impaired 
learning and cognitive performance, including spatial learning in a water maze (27), olfactory 
based learning (28), and a reference memory test with the Barnes circular maze (29).   
It is likely that in order to obtain the full benefits of dietary PUFA, LA and ALA must be 
metabolized to their respective HUFA, AA and DHA. The mechanisms behind AA and DHA 
functions, as well as their roles in other tissues, have yet to be entirely explained.  Many studies 
of EFA deficiency suggest certain roles for AA and DHA, however, concurrent depletion of the 
HUFA precursors, LA and ALA, makes it difficult to assign specific roles for each HUFA.  An 
approach to study HUFA functions would be creating specific HUFA deficiency without 
depleting precursor dietary essential fatty acids.  This would require disrupting PUFA 
metabolism and HUFA synthesis.      
 
Delta-6 desaturase and HUFA synthesis 
Research on PUFA metabolism began in the 1950’s and 60’s with individual 
measurements of plasma and tissue fatty acids from animals fed LA or ALA.  LA was proven to 
be the precursor to AA while ALA was shown to be precursor to a different set of HUFA of 
pentaenoic and hexaenoic nature (30), establishing the existence of two separate PUFA 
metabolic pathways for omega-6 and omega-3 fatty acids.  The LA metabolic pathway was 
further elucidated by feeding rats 14C-labeled LA and isolating its metabolites, which included 
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AA (31).  The use of gas chromatography allowed distinguishing fatty acids by length and 
number of double bonds. This technique drove the progress of understanding PUFA metabolism 
with studies of rats fed different levels of LA and ALA indicating competition between omega-3 
and omega-6 metabolic pathways for production of HUFA.  Increasing the dose of omega-6 LA 
without changing the omega-3 ALA dose increased omega-6 metabolite levels, such as AA, 
while suppressing omega-3 fatty acid synthesis from ALA (32).  A similar study was done 
feeding different levels of ALA at constant LA resulting in an increase in omega-3 fats in tissues, 
while suppressing HUFA synthesis derived from LA (33).  In vitro desaturation of LA and ALA 
using rat liver microsomes also showed competition between PUFA substrates indicating higher 
affinity towards omega-3 ALA for desaturation (34).  The competition between metabolic routes 
suggested that the omega-6 and omega-3 pathways share the same enzymes for HUFA synthesis.  
Based on the fatty acid products analyzed by gas chromatography and derived from LA and 
ALA, it was clear that the enzymes involved in HUFA synthesis would need to elongate and 
desaturate the fatty acid structure.   
In the omega-6 pathway (Figure 2.4), the sequence of events starting from LA (18:2n6) 
to AA (20:4n6) consist of desaturation by D6D at carbon 6 of LA (18:2n6) to make 18:3n6, 
followed by an elongation resulting in 20:3n6, and a second desaturation by D5D at carbon 5 to 
make AA (20:4n6).  Tissue culture studies suggested that D6D and D5D are two separate 
desaturase systems by using transformed cell lines lacking D6D activity, unable to make AA 
from LA , but successful when incubated with the omega-6 intermediate dihomo-gamma 
linolenic acid (DGLA; 20:3n6) (35).  This indicated that a separate enzyme D5D was involved in 
conversion of the omega-6 intermediate DGLA (20:3n6) to AA (20:4n6).   The cloning and 
expression of the D6D and D5D genes confirmed the role of these enzymes within HUFA 
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synthesis (36,37); D6D being specific to LA (18:2n6) and ALA (18:3n3), the first step in HUFA 
synthesis, while D5D acts upon 20:3n6 and 20:4n3, precursors to AA and eicosapentaenoic acid 
(EPA) respectively.    
In the omega-3 pathway (Figure 2.4), HUFA synthesis of DHA (22:6n3) begins with 
ALA (18:3n3) desaturation by D6D to make 18:4n3, which is elongated to 20:4n3.  D5D 
desaturation results in EPA (20:5n3).  Two subsequent elongation steps make 24:5n3.  D6D 
desaturation then forms 24:6n3 which is beta-oxidized in peroxisomes to form the HUFA 22:6n3 
or DHA (38). In cases of omega-3 deficiency, AA or 20:4n6 can be further desaturated by D6D 
to form DPAn6 (22:5n6) (Figure 2.4).   
Figure 2.4 Synthesis of highly unsaturated fatty acids.  In omega-3 deficiency, docosapentaenoic 
acid (DPA) is synthesized.  In essential fatty acid deficiency*, mead acid is synthesized from 
omega-9 oleic acid. 
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In summary, the D6D enzyme is critical for HUFA synthesis as the rate limiting enzyme 
involved in the first and last desaturation steps of the metabolic pathways for synthesis of 
HUFA: AA, DHA and DPAn6.  D6D is described as a front-end desaturase with two membrane 
spanning domains and an amino-terminal cytochrome b5 binding domain (36,39).  This enzyme 
is located in the membrane of endoplasmic reticulum and its expression occurs in most tissues 
including liver, adrenal gland, brain, testis, skin, heart, and lung.   
D6D is an enzyme of interest in developing a strategy to further study the physiological 
roles of HUFA.  A traditional experimental design to study the physiological roles of EFA is to 
deplete a whole group of PUFA from the diet making it difficult to attribute deficiency 
symptoms to a certain fatty acid.  Specific functions of AA, for example, could not be studied 
because its depletion would also require the elimination of its precursor LA, which can readily be 
converted in mammals to AA with the D6D enzyme.    The best approach to study HUFA 
functions is by creating specific HUFA deficiencies without depleting dietary essential fatty acid 
precursors, LA and ALA.  Based on our knowledge of HUFA synthesis, this can be achieved by 
disrupting the rate limiting enzyme D6D with the creation of a D6D-/-mouse.  A D6D-/- mouse 
could be fed LA and ALA but would not synthesize HUFA due to absence of D6D expression.  
Any deficiency symptoms and pathology that occurs in this -/- would be attributed specifically to 
the lack of HUFA (Figure 2.5). 
 
Studying HUFA functions with the D6D -/- mouse model  
The Fads2 gene is found on mouse chromosome 19, has 12 exons and encodes for the 
444 amino acid peptide of D6D. There is 87% homology between the mouse and human D6D 
aminoacid sequences (36).  Fads2 forms a gene cluster with two other desaturase genes, Fads1 
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and Fads3 (39).  The Fads1 encodes for the D5D enzyme, while the role of the Fads3 protein 
product has not been known. A D6D-/- mouse was created by targeted disruption of the Fad2 
gene (40,41).  Fads2/D6D expression was disrupted by using a targeting vector consisting of a 
1.9 kb neomycin resistant gene that replaced a 1.3kb region of the Fads2 promoter region and 
exon1.  This vector was delivered by electroporation to 129S6/SvEvTac mouse embryonic stem 
cells. These stem cells were then added to multi-cellular C57BL/6J mouse blastocysts which are 
implanted to pseudo-pregnant C57BL/6J surrogate females. Offspring with an agouti coat 
(chimeras) were bred with C57BL/6J wild type females to generate heterozygous offspring with 
the mutant gene. 
The initial characterization of the D6D -/- mixed strain (129S6/SvEvTac and C57BL/6J) 
mice consisted in providing a diet with sufficient dietary LA and ALA but depleted of HUFA for 
a period of 4 months at which point phenotype specific to HUFA deficiency was characterized 
(41).  D6D-/- mice presented skin and gastrointestinal tract ulceration, male infertility, altered 
immune system, and hepatic lipidosis (41).  The D6D-/- established essentiality for HUFA in 
skin, reproduction, gastrointestinal tract, and liver which previously could only be inferred due to 
inability to create specific HUFA deficiency. 
 
Hepatic lipidosis due to HUFA deficiency 
Fatty liver is common in EFA deficiency (42), however it was not clear whether the 
dietary essential PUFA, LA and ALA, are required in maintaining liver lipid homeostasis, or if 
this role corresponds to their respective HUFA products, AA and DHA.  Liver triglyceride (TG) 
accumulation occurs in the D6D-/- mouse (41), despite presence of LA and ALA, indicating the 
requirement for HUFA and not the precursors LA and ALA in modulating TG levels in liver.    
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Hepatic lipidosis can occur due to increased lipogenesis.  Gene expression of lipogenic 
genes is reduced with PUFA treatments which include HUFA or their EFA precursors, LA and 
ALA.  Since LA and ALA can be metabolized into HUFA it is not clear which group of fatty 
acids are responsible for downregulation of lipogenic genes.    Stearoyl-CoA desaturase (SCD-1) 
involved in synthesis of MUFA is suppressed by LA and ALA treatments, as well as by their 
corresponding HUFA products, AA and EPA, in rat primary hepatocytes (43).  Rats fed 
menhaden fish oil, rich in omega-3 PUFA, showed suppressed lipogenesis with reduced 
expression of fatty acid synthase (FAS), when compared to rats fed saturated tripalmitin (44).  
Hepatic steatosis can be reversed with PUFA supplementation through downregulation of 
lipogenic genes, FAS and SCD-1, as shown in ob/ob mice (45).  Specifically, omega-3 fatty acid 
supplementation reduces liver lipid droplet size in mice fed high fat diets (46) and with essential 
fatty acid deficiency (47).  Fish oil-based TPN, rich in omega-3 DHA, also effectively prevented 
hepatic steatosis in humans (16).  The D6D-/- hepatic lipidosis suggests a specific role for HUFA 
in regulating lipogenesis which cannot be replaced by their precursors LA and ALA. 
In addition to the decreased expression of lipogenic genes, increased fatty acid oxidation 
would also favor prevention of hepatic lipidosis.  PUFA bind and activate transcription factor 
PPARα (48), which upregulate genes of fatty acid oxidation (49).  Activation of PPARα can also 
lead to an increased secretion of apo-B100, an essential component of VLDL (50), the TG rich 
lipoprotein secreted from liver.   
In D6D-/- mice, HUFA deficiency results in altered lipid homeostasis in liver despite 
presence of LA and ALA.  The specific role of HUFA in lipid homeostasis is yet to be 
elucidated.  Due to the role of PUFA in regulating gene expression of lipid metabolism, HUFA 
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may be required in modulating lipogenesis, fatty acid oxidation, or lipid secretion, in order to 
prevent lipid accumulation in liver. 
 
AA essentiality for skin physiology 
EFA deficiency studies attributed skin pathology to lack of LA, but not to HUFA 
deficiency.  LA supplementation can prevent the common essential fatty acid deficiency 
symptoms of excessive skin water loss and dermatitis (3).  The explanation behind the skin 
disorders due to an essential fatty acid deficient diet is related to an inefficient epidermal water 
barrier (51).  The skin water barrier results from the structure and composition of the upper most 
layer of the skin known as the stratum corneum.  The stratum corneum consists of layers of 
corneocytes and intercellular lipids forming a barrier to moisture.  The lipids in the stratum 
corneum are comprised of ceramides, free fatty acids, and cholesterol.  Ceramides are the lipid 
class responsible for providing proper skin water barrier.  LA is an essential component of skin 
acyl-ceramides involved in proper formation of the lamellar layers of the permeability barrier.  In 
EFA deficiency, oleic acid unsuccessfully substitutes LA in skin ceramides resulting in a 
defective hydrophobic lipid matrix.  This was demonstrated in EFA deficient rodents where 
epidermal water loss was prevented only after linoleate or arachidonate supplementation, but not 
by oleate supplementation (52).  The effectiveness of AA supplementation in preventing skin 
water loss was explained by retroconversion to LA which was shown in vivo by tracking 
metabolism of radiolabeled (U-14C) AA in EFA deficient rats; isolated epidermal ceramides 
formed [14C]-labeled LA (53).   
HUFA deficiency in D6D-/- results in scratching behavior which leads to ulcerative 
dermatitis around neck and ears (41).  Ulcerative dermatitis in D6D -/- was unexpected due to 
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presence of LA.  This indicates HUFA is essential for a skin physiological function.  The 
mechanism behind the skin physiological role of HUFA is not entirely clear.   
The role of AA in skin is likely to be as precursor to signaling molecules such as 
prostaglandins (PG) and monohydroxy fatty acids.  Monohydroxy fatty acids have a central role 
in differentiation and inflammatory processes in the skin (54).  AA may be acted upon by 15-
lipooxygenase (15-LOX) forming the monohydroxy fatty acid, 15-hydroxyeicosatetraenoic acid 
(15-HETE).  15-HETE has been shown to have anti-inflammatory properties, improving 
psoriasis vulgaris (55) by reducing skin leukotriene B4 formation.  The monohydroxy fatty acid 
derived from LA, 13- hydroxyoctadecaenoic acid (13-HODE), has antiproliferative properties in 
skin by modulating protein kinase C (56).  The omega-3 DHA is not normally present in skin and 
DHA topical application on skin of guinea pigs results in epidermal hyperprofileration due to 
increase in protein kinase C activity (57).  Skin hyperproliferation can be reversed by LA-
derived 13-HODE topical treatments (58); treatment with AA-derived 15-HETE was not 
reported.  The main skin PG synthesized from AA in human and mouse skin are PGE2 and 
PGD2 (59).  These prostaglandins exert their function based on the prostanoid receptor to which 
they bind.  PGE2 has four types of receptors: EP1 through EP4, while PGD2 has DP1 and DP2.  
PGD2 is of particular interest in studying D6D-/- skin pathology due to its antipuritic effect and 
potential involvement in skin repair.  PGD2 through its DP1 receptor was shown to decrease 
scratching behavior in the Nc/Nga mouse model of acrodermatitis (60).  Similar to the D6D-/-, 
Nc/Nga mice present excessive scratching behavior that leads to skin ulceration.  Topically 
applied AA and PGD2 to Nc/Nga mice reduced scratching behavior allowing skin recovery from 
a lesion (61).  Silencing of the cyclooxygenase-1 gene in skin by RNA interference resulted in 
increased scratching behavior of the Nc/Nga mice, further demonstrating the importance of AA-
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derived PG in skin physiology (62).  The D6D-/- mouse model confirmed AA essentiality for 
skin function, with partially restored PGD2 and prevention of dermatitis through AA 
supplementation (41) .   
PUFA are activators of PPAR, therefore, another possible mechanism of AA in 
contributing to proper skin structure formation may be as a ligand to transcription factor PPARγ.  
PPARγ activation favors keratinocyte differentiation and lamellar body biogenesis which are 
important processes for stratum corneum or skin barrier development (63).  Keratinocytes 
differentiate to corneocytes which are the main cell type in the stratum corneum.  Lamellar 
bodies are formed within keratinocytes and are then secreted providing lipids and enzymes 
required for lamellar layer formation characteristic of the skin barrier (64).  Free fatty acids 
cleaved from phospholipids present in lamellar lipid bodies are important for barrier homeostasis 
(65) as demonstrated by interference with free fatty acid release through topical application of 
phospholipase A2 inhibitors on mouse skin.  This leads to a perturbed structure of the skin 
barrier and epidermal hyperplasia (65).  Lamellar bodies which deliver these fatty acids are 
vesicles derived from Golgi and their proper secretion and formation relies on a SNARE 
complex (66).  HUFA have been shown to be required for SNARE complex formation (67) 
suggesting another possible role for AA in skin function for proper lamellar granule formation, 
which is essential in delivering components for skin barrier function. 
 
Role of HUFA in gastrointestinal physiology  
Intestinal ulceration was reported in the initial characterization of the D6D-/- (41).  
Protection and repair of the GI tract is mediated by inflammatory mediators which include PG, 
making AA a major player as a precursor.  A reduction in PG production due to lack of AA is a 
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potential mechanism behind the intestinal pathology in the D6D-/-.  The importance of PG for 
intestinal protection has been well established through the use of non-steroidal anti-inflammatory 
drugs which block PG synthesis and disrupt the mucosal layer of the intestine leading to lesions 
and ulcerations of the GI (68).  PG influence several factors related to protection of the intestinal 
epithelium.  PGE2 through its EP3 and EP4 receptor, for example, stimulates mucosal 
bicarbonate secretion for protection against acidic conditions (69).  Mucin secretion is also 
modulated by PGE2 providing a protective barrier for the mucosal layer (70).  PG regulation of 
intestinal blood flow to the mucosa protects the epithelium by diluting toxins (71).  Production of 
PG mainly occurs in the subepithelial tissue or lamina propria (72), which is the site of lymphoid 
tissue and immune cells, and therefore may have an immunomodulatory function. 
The role of DHA in intestine is considered anti-inflammatory through modulation of 
cytokine responses of the intestinal immune system.  The use of fish oil or omega-3 
supplementation has been an area of focus for treating GI inflammatory disorders such as 
Crohn’s disease and colitis (73,74).  Overproduction of inflammatory cytokines is considered to 
be a factor in inflammatory intestinal disorders.  Fish oil decreases inflammatory cytokine 
production in patients with Crohn’s disease (75) and reduces small intestine inflammation in 
SAMP1/Yit mice by inhibiting inflammatory cell recruitment to the mucosa (76).  Permeability 
defects after exposure to inflammatory cytokines were corrected by DHA in vitro through 
restoration of tight junction and intestinal epithelial barrier functionality (77).  DHA 
downregulates gene expression of inflammatory cytokines by inhibiting activation of 
transcription factor NFkB (78,79), which is involved in gene expression of IL1β, IL6, and TNFα.    
Therefore, studies of omega-3 PUFA functions in intestine have focused on the treatment of 
inflammatory disorders but their essentiality for intestinal function has not been evaluated.  The 
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D6D-/- mouse model allows the study of a possible DHA functional role in maintaining 
intestinal homeostasis in absence of AA.   
 
Modulation of the immune system by HUFA 
The immune system can be divided into two functional systems: innate and adaptive.  
The innate immune system is the first line of defense with macrophage and neutrophils involved 
in destroying pathogens through phagocytosis or release of toxic substances.  The adaptive 
immune system consists of lymphocytes, mainly T and B-cells, developing a highly specific 
acquired defense against a foreign protein or antigen through the production of antibodies.  
HUFA are present in immune cells and the fatty acid composition of macrophage, granulocytes, 
and lymphocytes can be modified according to the fatty acid composition of the diet.  These fatty 
acid modifications impact immune cell function.   
One of the earliest studies to demonstrate the impact of PUFA supplementation on 
immune function consisted of experimental allergic encephalomyelitis in guinea pigs showing 
diminished clinical signs and reduced lymphocyte proliferation in vitro with LA supplementation 
(80); LA is metabolized to AA, so the effect may not be specific to LA.  Several studies indicate 
reduced lymphocyte proliferation with in vitro or in vivo supplementation of HUFA in rodents 
(81,82).  Cultured lymphocytes from rat showed highest inhibition of lymphocyte proliferation 
when treated with HUFA, AA or EPA (81); HUFA inhibitory activity of lymphocyte 
proliferation was reversed with saturated palmitate or myristate treatments.  Rodents 
supplemented with omega-3 DHA rich-menhaden fish oil or with omega-6 gamma linolenic rich-
evening primrose oil, showed decreased lymph node-derived lymphocyte proliferation when 
compared to mice fed saturated rich hydrogenated coconut oil (82); fish oil fed rats specifically 
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showed decreased expression of IL-2 receptor on spleen and thymic lymphocytes (82).  Human 
peripheral blood lymphocytes also showed decreased proliferation in vitro with HUFA 
treatments when compared to saturated fatty acid and MUFA treatments (83-85).  A mechanism 
by which HUFA inhibit lymphocyte proliferation can be through modification of membrane lipid 
raft composition.  Lipid rafts are sites for protein activation and cell signaling required for 
immunological synapse of the T-cell receptor and antigen presenting cells (86).  Increased 
membrane fluidity in lipid rafts due to HUFA presence displaces signaling proteins, interfering 
with T-cell signaling and activation, required for differentiation and proliferation.  A HUFA 
EPA-treated Jurkat T-cell line and peripheral blood T lymphocytes showed displacement from 
lipid raft of a protein known as LAT or link to activation of T-cells; phosphorylation of LAT was 
blocked with HUFA treatment when compared to saturated fatty acid treated cells (87,88).  
Therefore, lipid rafts are sites in which HUFA may induce their immunosuppressive effects.   
Inflammatory cytokine production is decreased with EPA and DHA supplementation as 
demonstrated in lymphocytes (85)(89), macrophages (90), and peripheral blood mononuclear 
cells (91).  A decrease in inflammatory cytokines would also contribute to immune function 
modulation by HUFA.  In addition to immunosuppressive properties, HUFA are involved in 
resolving inflammation as precursors to lipid mediators of inflammation.  Molecules such as 
DHA-derived resolvins and AA-derived lipoxins allow an appropriate inflammatory and 
resolution process to restore tissue homeostasis after injury.  This resolution process may be 
compromised with HUFA deficiency.  The kinetics of the inflammatory process and its 
resolution has been characterized in a mouse peritonitis model using zymosan as the inducer 
(92).  An inflammatory process initiates with recruitment of neutrophils for host defense against 
invading microorganisms.  This initial phase is characterized by pro-inflammatory signals such 
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as cytokines and prostaglandins.  AA-derived leukotriene B4 production is involved in 
neutrophil recruitment and peaks at 4 hours of zymosan injection.  Maximum neutrophil 
infiltration occurs at 12 hours coinciding with DHA conversion to resolving mediators, such as 
resolvins and maresins, occuring between 12 and 20 hours (92).  This period is known as the 
resolution phase consisting of neutrophil clearance.  Halting recruitment of inflammatory cells as 
well as clearance of neutrophils from the inflammatory site is critical for the return to tissue 
homeostasis after injury or infection.  Neutrophils and monocytes from humans receiving 
omega-3 HUFA supplementation show decreased chemotaxis suggesting a role for HUFA in 
modulating immune cell recruitment (93).  Neutrophil apoptosis and machrophage phagocytosis 
of apoptotic cells contribute to inflammatory cell clearance.  The docosanoid resolvins derived 
from DHA play a role in resolution of inflammation (94).  DHA-derived maresins stop 
neutrophil infiltration and induce phagocytosis of apoptotic neutrophil in culture, while AA-
derived PGE2 and D2 do not enhance this phagocytosis (95).  In addition to phagocytosis of 
apoptotic neutrophils, DHA derived lipid mediators may contribute to resolution by modulating 
signaling pathways required for neutrophil apoptosis.  NFkB is a transcription factor which plays 
an important role in regulating granulocyte apoptosis (96).  Inhibition of NFkB favors neutrophil 
apoptosis.  DHA deficiency may result in lack of NFkB inhibition resulting in impaired 
apoptosis which would delay resolution. 
In a state of EFA deficiency, adaptive immunity evaluated in mice showed a low 
response to antigen which could be restored with LA-rich corn oil supplementation (97).  EFA 
deficiency in mice also results in impaired T-cell function as indicated by low delayed type 
hypersensitivity, while mice fed corn oil or fish oil had greater hypersensitivity (98).  Neutrophil 
functional response was also shown to be impaired in EFA deficient rats (99) and humans (100).  
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Essential fatty acid (EFA) deficiency leads to impaired immune function, but this may be 
secondary to growth retardation characteristic of LA deficiency (2).    
Evaluation of the essentiality of HUFA for immune function can be achieved with the 
D6D-/- mouse which does not present growth retardation. The D6D-/- mouse presents spleen 
pathology consisting of myeloid hyperplasia (41) suggesting an altered immune system.   
Peritoneal macrophage of HUFA deficient D6D-/- mice presented increased cholesterol 
biosynthesis and decreased paraoxynase-2 expression, a protein with antioxidant activity (101).  
AA supplementation of D6D-/- decreased macrophage cholesterol biosynthesis and increased 
paraoxynase-2 expression suggesting specific role of AA in macrophage function and prevention 
of atherogenesis (101).  This study demonstrates requirement of HUFA in maintaining adequate 
immune cell function.  Further characterization of D6D-/- is required to elucidate other HUFA 
roles within macrophage and the immune system. 
 
Role of HUFA in male fertility 
The requirement of fats for male fertility was demonstrated in the 1930’s (1) with rats fed 
a fat free diet with testicular degeneration; matings of these mice with females on chow diet had 
an extremely low breeding success rate.  Rats receiving a diet deficient in LA and ALA for 15 
weeks had low epididymal sperm concentration (102), however, this may be secondary to growth 
retardation characteristic of LA deficiency (2). The fact that D6D is highly expressed in mouse 
testis (103) indicates that this tissue is actively synthesizing HUFA.  Rat testis has a dramatic 
increase of DPAn6, a HUFA derived from AA, during the sexual maturation stage of the animals 
(104).   The HUFA, DHA, is more abundant than DPAn6 in the fatty acid composition of human 
sperm (105).  These HUFA are in high levels within membrane phospholipids of mature 
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spermatozoa (106).  The importance of HUFA in fertility is further implied with the observation 
of lower DHA phospholipid and fatty acids levels in sperm of infertile men when compared to 
healthy individuals (107).  The HUFA deficiency state of the D6D-/- results in disrupted sperm 
formation indicating a requirement for these fatty acids in fertility and spermatogenesis (40, 41). 
Spermatogenesis occurs within the epithelium of serminiferous tubules contained in the 
testis.  Within these polarized tubules, there is a basal and apical side.  The basal side contains 
germ cells known as spermatogonia which go through different cell stages making their way 
towards the apical or luminal side of the tubule, until formation of spermatozoa. These stages are 
characterized by cell types that include primary spermatocytes, secondary spermatocytes, round 
spermatids, and spermatozoa.  In the first stage, spermatogonia go through mitosis to form 
primary spermatocytes.  These cells then go through meiosis forming haploid secondary 
spermatocytes with half the genetic material of the spermatogonia.  A second meiosis results in 
round spermatids.  Round spermatids then go through spermiogenesis, a series of structural 
changes which include head elongation and tail formation that result in spermatozoa.  The 
spermatozoa are then released into the lumen reaching the epididymis where maturation 
continues.  The epididymis, in its cauda region, plays a role in storage of spermatozoa.   
The Sertoli cell is essential for spermatogenesis by constantly interacting with germ cells 
from all stages, providing support and nutrition.  Several studies demonstrate an active role for 
the Sertoli cell in HUFA synthesis suggesting it to be a source of AA and DHA for germ cells 
throughout spermatogenesis.   Primary culture studies of isolated rat Sertoli cells demonstrate 
synthesis of AA from 14C-labeled LA (108).  The Sertoli cell is the primary location of 22 carbon 
HUFA synthesis as shown in rat testes injected with 14C-labeled AA (109).  Higher DPA 
production was achieved in Sertoli cells versus germ cells.  Isolated human germ cell fractions 
 27
produced almost no DHA and DPA when incubated with 14C-labeled substrates, further 
demonstrating a role for Sertoli cells in HUFA synthesis (110).  Gene expression of D5D and 
D6D are limited to Sertoli cells isolated from rat testis (111).   The Sertoli cell therefore is the 
site of HUFA production; however, the fact that germ cells are richer in HUFA despite their lack 
of HUFA synthesis suggests lipid transport from the Sertoli cell.  High HUFA content and active 
synthesis in testis, as well as fatty acid composition of sperm has been well established, but the 
exact role of HUFA in spermatogenesis has not been elucidated.   
The role of AA in male fertility is most likely as a precursor to DPAn6 and to 
eicosanoids.  Eicosanoids can be synthesized by isolated sperm cells incubated with AA (112). 
Research of the role of eicosanoids in male fertility has been focused on their impact on mature 
sperm physiology but not on spermatogenesis.  PG are required for sperm motility as 
demonstrated by inhibition of PG synthesis in rats (113) and mice (114). PG of the E series is 
shown to enhance calcium influx into cytoplasm of mature sperm which is essential for the 
acrosome reaction in fertilization (115).  In addition to sperm motility and acrosome reaction, PG 
have an impact on steroid synthesis (116).   
AA and DHA are precursors to further elongated PUFA known as very long chain 
polyunsaturated fatty acids (VLCPUFA), such as 28:4n6 (AA derived) and 30:5n6 (DPA 
derived), which are incorporated into membrane sphingolipids.  Sphingomyelins and ceramides 
in the head of mammalian spermatozoa contain VLCPUFA as acyl groups and are suggested to 
participate in sperm capacitation (117).   
HUFA analysis of cell types throughout the different stages of spermatogenesis may 
provide information on the potential functional role of HUFA.  In mice, an increase of DPA from 
2% to 20% and of DHA from 4 to 14% of total fatty acids was observed from the preleptotene 
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spermatocyte stage to the condensed spermatid stage with an eventual HUFA decrease in mature 
sperm to 8-9% (118).  In mature sperm, DHA is abundant in tail and due to its high unsaturation 
is considered to provide motility (119).  Phospholipid DHA can also be found in sperm head 
(120), suggesting a DHA functional role other than membrane fluidity that has yet to be 
determined. 
The D6D male -/- infertility results from disrupted spermiogenesis (40,41), the last stage 
of spermatogenesis in which round spermatids are elongated to form spermatozoa.  The 
spermiogenesis stage is therefore of particular interest to study HUFA functions.   
Spermiogenesis consists of 16 steps in which essential components for proper sperm function are 
acquired (121).  Acrosome is formed during the first steps of spermiogenesis as a cap-like 
structure on the nucleus of the spermatid.  The acrosome is a vesicle that contains enzymes, such 
as acrosin, needed for the acrosomal reaction during fertilization.  Acrosome biogenesis occurs 
prior to the steps of nuclear elongation and flagellum formation, essential morphological changes 
for sperm motility.  Globozoospermia is the formation of round headed shaped sperm and is 
associated with lack of acrosome formation (122).  The globozoospermia mouse models such as 
PICK1-/-(123), Hrb-/- (124) and Golgi-associated PDZ- and coiled-coil motif-containing protein 
(GOPC) -/- (125) are acrosome-deficient and all present globozoospermia.  The Hrb protein is 
required for fusion of Golgi-derived proacrosomal vesicles during acrosome biogenesis, while 
GOPC participates in vesicle trafficking from Golgi to acrosome (123). A potential role of 
HUFA in fertility could be in acrosome biogenesis for fusion of pro-acrosomal granules derived 
from Golgi.   
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Role of HUFA in vesicle fusion 
Vesicle fusion is required for several biological processes including exocytosis, release of 
neurotransmitters, neurite outgrowth, and membrane repair.  The soluble NSF-attachment 
receptor (SNARE) complex is a four helical structure that drives the union of opposing 
membranes and is an important component of the vesicle fusion process (126).  This SNARE 
complex consists of proteins such as, syntaxin and synaptobrevin, which are on opposing 
membranes and interact to achieve vesicle fusion.  Syntaxin exists in an inactive and closed 
conformation with its N-terminal folded back over a SNARE motif and requires activation into 
an open conformation for SNARE assembly (127).  In brain, AA activates syntaxin (128) 
allowing SNARE complex formation consisting of syntaxin-3, SNAP25, and synaptobrevin 
interactions (129).  Neuroendocrine cells showed increased neurite outgrowth, a process that 
requires SNARE complex, when treated with AA; DHA was shown to efficiently substitute for 
AA for SNARE assembly in vitro as well as in a neurite outgrowth assay of cultured PC12 
neuroendocrine cells (129).  In retina, rhodopsin delivery by Golgi-derived vesicles requires 
SNARE components which are regulated by DHA (130).  Similar to brain and retina, testis are 
rich in HUFA and also have SNARE components.  Syntaxin, synaptobrevin, and SNAP have 
been identified in spermiogenesis during acrosome biogenesis in mouse (131), however the role 
of HUFA in regulating SNARE components in male fertility has not been demonstrated.  
SNARE complex formation is most likely required for fusion of proacrosomal vesicles during 
acrosome formation.  The mechanism behind proacrosomal vesicle fusion may parallel that seen 
in neuroendocrine cells and retina, where HUFA activate syntaxin to favor SNARE assembly.   
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SUMMARY 
The study of HUFA and their physiological roles has been limited due to the traditional 
approach of creating HUFA deficiency by depletion of LA (18:2n6) and/or ALA (18:3n3), 
precursors to HUFA: AA (20:4n6) and DHA (22:6n3).  New insight into the role of HUFA is 
established with the D6D-/- mouse model.  Male infertility, GI ulcers, liver lipid homeostasis, 
and dermatitis occur with AA and DHA deficiency despite presence of their corresponding EFA 
precursors LA and ALA.  The functionality of skin, GI, liver, and testis relies on HUFA and not 
just the dietary EFA.  Specific HUFA roles within these tissues have been discovered.  In skin, 
LA was considered the functional PUFA by maintaining skin barrier function, however 
ulcerative dermatitis in the D6D-/- mouse model and its prevention with AA supplementation 
demonstrated essentiality for AA in skin as well.  In male fertility, DHA and not AA fully 
restored D6D-/- spermatogenesis indicating a specific function for DHA in sperm formation.   
Further research is required to fully elucidate the mechanism behind the essentiality of 
HUFA in tissues.  The role of HUFA may be as precursor to signaling molecules such as 
eicosanoids; as structural components of membranes; as regulators of gene expression; or as 
activators of vesicle fusion machinery.  Understanding HUFA physiological roles could have 
implications in developing treatments for diseases where HUFA metabolism may be altered. 
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CHAPTER 3 
Fads3 IS NOT A DELTA-6-DESATURASE ISOZYME                                                      
FOR LINOLEIC ACID 
ABSTRACT 
Delta-6 desaturase (D6D) is a key enzyme for the synthesis of highly unsaturated fatty 
acids (HUFA).  D6D gene expression and activity was measured in D6D knockout (-/-) liver to 
verify that the gene was knocked out.  Gene expression of D6D was absent; however, 
desaturation activity remained as indicated by the conversion of 14C-labeled 18:2 n-6 to 18:3.  A 
possible explanation for this conversion is the presence of a D6D isozyme.  Fads3 is a gene that 
holds close sequence homology to the D6D gene but the function of its gene product is not 
known.  Fads3 may code for a D6D isozyme since this gene is upregulated in D6D -/- liver.  The 
hypothesis was tested by transfecting the Fads3 gene into 293-HEK cells incubated with a D6D 
substrate, 18:2 n-6. Fads3 was efficiently expressed by cells as confirmed by real time PCR, 
however, D6D activity was not observed as indicated by the absence of 18:3 fatty acid in culture.  
Another potential role for Fads3 is as a delta-8 desaturase (D8D) which would allow HUFA 
synthesis of 20:4 n-6 in absence of D6D.  20:2 n-6 fatty acid treatments of Fads3 transfected 
cells did not result in D8D activity.  In conclusion, Fads3 is not a D6D isozyme, at least for the 
desaturation step of 18:2 n-6 to 18:3, and it does not have D8D activity. 
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INTRODUCTION 
The Fads3 gene can be found on the same chromosome as desaturases involved in highly 
unsaturated fatty acid (HUFA) synthesis, forming a gene cluster with delta-5 (D5D) and delta-6 
desaturase (D6D) in humans (1).  Fads3 shares conserved structural domains with D5D and D6D 
which include an N-terminal cytochrome b5-like domain and a C-terminal fatty acid desaturase 
domain, therefore, Fads3 may potentially encode for a desaturase. The putative human Fads3 
gene product consists of 445 aminoacids and presents high sequence homology to D6D, sharing 
62% identity (2).  The function of the protein encoded by Fads3 however is not known.   
Initial characterization of the D6D-/- suggested the presence of a D6D isozyme.  Despite 
absence of D6D gene expression in D6D-/- liver, desaturation activity remained at 20% of +/+ 
levels as determined  by incubating liver microsomes with 14C-labeled linoleic acid and 
quantifying desaturation products (3).  The formation of a supposed D6D product prompted to 
check liver gene expression for potential D6D isozymes such as Fads3 and Fads6, which present 
homology to D6D.  Only Fads3 showed upregulation in liver D6D-/- (3) suggesting possible 
compensation for lack of HUFA synthesis.  Fads3 was therefore considered a strong D6D 
isozyme candidate. 
In order to study the role of HUFA with the D6D-/- mouse, it is imperative to confirm 
lack of a D6D isozyme and disrupted HUFA synthesis.  The objective of this study is to 
determine if mouse Fads3 is a D6D isozyme by measuring D6D activity in Fads3 transfected 
HEK293cells incubated with linoleic acid, a D6D substrate.  The potential role of Fads3 as a 
D8D enzyme was also evaluated. 
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METHODS 
Mouse Fads3 cloning 
a) Plasmid extraction from pFLCI Fads3 clone 
E. coli DH10B cells, transformed with ampicillin-resistant plasmid containing the Fads3 
gene (RIKEN clone A730007D17), were grown overnight at 37 ºC on agar plates with 
ampicillin.  The next day, a single colony was picked from the plate in order to inoculate a starter 
culture of 5ml LB medium.  After a 12 hour incubation period at 37 ºC in a shaker (300rpm), 
plasmids were extracted (QIAGEN Miniprep).  Enzyme digestion followed with restriction 
enzyme Sfi.  The digestion products were run on an agarose gel by electrophoresis and the band 
corresponding to the Fads3 insert was cut out and extracted (QIAquick gel extraction kit).  
b) Addition of restriction sites to FADS3 insert by PCR 
In order to clone the Fads3 insert into the mammalian expression vector, compatible 
restriction sites were required.  Restriction sites for Xho and BamH1 were chosen since the 
Fads3 sequence does not contain either Xho1 or BamH1 site according to Biology Workbench 
3.2.   The BamHI and Xho sites were added to the 5’ and 3’ end of the Fads3 cDNA insert by 
PCR.  Primer designed to add a Bamh1 restriction site to Fads3 was: Forward- 5’- 
GGATCCATGGGCGGTGTCGGGGAGCCCGGAGGGG-3’; primer to add Xho restriction site 
on other end of Fads3 was: Reverse-5’-CTCGAGGTGTCTGGGTTGCTTTTTATATAAAAAT.  
The underlined regions represent the restriction site region.  These sites allow using the 
corresponding enzymes to digest the Fads3 cDNA from the plasmid and proper insertion into the 
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mammalian expression vector.  PCR was run in order to obtain a Fads3 with the newly added 
restriction sites. 
c) Cloning Fads3 into pGEM-T vector and sequence confirmation 
The PCR product of Fads3 was run on an agarose gel by electrophoresis to confirm 
Fads3 insert size (1.2kb).  This PCR product was then extracted from the gel and ligated to a 
pGEM T-vector.  Ligation to the pGEM-T vector is an intermediate step that facilitates 
subsequent ligation to a mammalian vector. 
Competent E. coli cells were transformed with the pGEM T-vector containing the Fads3 
insert with the desired Xho and BamH1 restriction sites.  These cells were spread on agar plates 
and incubated overnight at 37 ºC.  Colonies were chosen from the plate and used in a PCR 
reaction that would amplify the Fads3 insert.  The PCR product was run on an agarose gel, the 
band corresponding to Fads3 was then extracted from the gel, digested using Xho and BamH1 
enzymes, and sequenced using BigDye3.1.  Sequencing was done at the University of Illinois 
Core Sequencing Facility using an ABI 3730XL capillary sequencer.  Once a colony containing 
the correct sequence for Fads3 was found, it was used to start a culture for a large scale 
extraction of the plasmid (QIAGEN Maxi plasmid kit).  
d) Cloning Fads3 into pcDNA3.1 mammalian vector 
The plasmid was extracted from the culture and digested using Xho and BamH1 
restriction enzymes.  The resulting Fads3 insert was run on a gel, extracted, and ligated to the 
mammalian vector pcDNA3.1 using a T4 DNA ligase (Promega).  Competent cells were 
transformed with this plasmid and grown on an agar plate.  Colonies were chosen for a PCR 
insert check.  Once a correct sequence was confirmed using BigDye3.1, the colony was used to 
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start a culture for a large scale extraction of the plasmid (QIAGEN Maxi plasmid kit).  The 
Fads3 insert in the pcDNA3.1 mammalian vector was then used for transfection into HEK-293 
cells.  
Quantification of the Fads3 mRNA level by real-time PCR 
In a separate experiment, RNA was extracted from Fads3 transfected cells using Trizol.  
cDNA was prepared using random primers and Superscript III reverse transcriptase. Fads3 and 
D6D gene expression were measured by  Real-time quantitative PCR, using SYBR Green 
fluorescent dye (Applied Biosystems) with mouse Fads3 primers, forward 5’-
AACCCCTGTTGATTGGAGAGCTA -3’, reverse 5’- GCTCGGAAGTCCTCGATCAG -3’; 
human D6D primers, forward 5’-CTGCCAACTGGTGGAATCATC -3’, reverse 5’-
ACAAACACGTGCAGCATGTTC-3’. 
D6D and D8D activity of FADS3 transfected HEK-293 cells 
HEK-293 cells were distributed to 60mm cell culture dishes from a 1.5 x 106 cells/ml 
suspension.  1.5 x 106 cells were added to each plate with a final volume of 3 ml complete 
medium (DMEM 10% FBS) and incubated overnight at 37 ºC.   The plasmids were transfected in 
duplicate.  Plasmids used were pcDNA3.1, empty vector used as a negative control; pD6D or 
pD5D, as a positive desaturase control; pFads3.  
Transfection into HEK-293 cells was achieved using Lipofectamine 2000 (Invitrogen).  
Plasmid (8ug) and lipofectamine were mixed at a 1 to 5 ratio in serum free medium.  Different 
ratios were tested and the 1 to 5 ratio gave the highest expression of transfected plasmid.  
Transfection mix was added to plated cells and incubated for 5 hours at 37 ºC.  Media was then 
replaced with complete media (10% FBS) and cells were incubated overnight.   
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Transfected cells were treated with either 18:2 n-6 or 20:2n6 bound to BSA at a final 
concentration of 150μM.  A set of Fads3 transfected cells treated with BSA alone were used as a 
negative control.  Cells were incubated for 24 hours.  Total lipids were extracted from treated 
cells using the Folch method (4).  In order to obtain quantifiable fatty acids, extractions from 
duplicates were pooled.  Fatty acid methyl esters were prepared with 3M methanolic-HCl and 
analyzed by HP5890 gas chromatography (Agilent Technologies, Wilmington, DE) using a 30 m 
× 0.25 mm Omegawax capillary column (Supelco).  Program used was 175 ºC for 5 minutes, 
followed by a 5 ºC increase per minute until a final temperature of 195 ºC for 50 minutes. 
RESULTS 
Fads3 cloning 
Like in human, mouse Fads3, D6D, D5D form a gene cluster in the 19th mouse 
chromosome.  An alignment comparison of mouse Fads3 and D6D/Fads2 resulted in 73% 
identity.  The mouse Fads3 presents the same conserved structural domains of D5D and D6D, 
which consist of a cytochrome b5-like domain and a membrane FADS like domain. The putative 
mouse Fads3 protein results in 449 amino acids, similar in length to the 445 amino acids of 
human Fads3.  Fads3 cloning into the mammalian vector was successful as confirmed by 
sequencing. 
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Blast alignment comparison of mouse Fads3 and D6D results in 73% identity 
GENE ID: 56473 Fads2 | fatty acid desaturase 2 [Mus musculus] 
gb|AF126798.1|AF126798 Mus musculus delta-6 fatty acid desaturase mRNA, complete cds 
Length=1508 
 Score =  411 bits (222),  Expect = 2e-110 
 Identities = 984/1337 (73%), Gaps = 111/1337 (8%) 
 Strand=Plus/Plus 
 
Query  257   CCCATCTTCCGCTGGGAGCAGA-TCCGCCAGCATGACCTAC-CAGGCGACAAGTGGCTGG  314 
             |||| |||||| |||||| ||| || |  ||||  |||| | ||  ||||  |||||| | 
Sbjct  129   CCCACCTTCCGTTGGGAGGAGATTCAG-AAGCACAACCTGCGCA-CCGACCGGTGGCTCG  186 
 
Query  315   TCATCGAGCGC-CGTGTCTACGACATCAGCC-GCTGGGCACAGCGGCACCCAGGGGG-TA  371 
             ||||||| |||  | |||||| || | | ||   ||| | ||||||||||| |||||  | 
Sbjct  187   TCATCGACCGCAAG-GTCTACAACGTTA-CCAAATGGTCCCAGCGGCACCCGGGGGGCCA  244 
 
Query  372   GCCGCCTCATCGGCCACCA--CGGTGCGGAGGACGCCACGGATGCCTTCCACGCCTTCCA  429 
              |||  ||||||| ||| |  ||| |  || || || |||||||||||||  |||||||| 
Sbjct  245   -CCGTGTCATCGGACACTATTCGG-G-AGAAGATGCTACGGATGCCTTCCGTGCCTTCCA  301 
 
Query  430   CCAAGATCTCCATTTTGTGCGCAAGTTCCTGAAACCCCTGTTGATTGGAGAGCTAGCCCC  489 
              |  || ||  | || ||| |||||||| |||| |||||| ||||||| ||||| ||||| 
Sbjct  302   TCTGGACCTGGACTTCGTGGGCAAGTTCTTGAAGCCCCTGCTGATTGGTGAGCTGGCCCC  361 
 
Query  490   AGAGGAACCCAGCCAGGATGGAGCTCAGAATGC-C-CAGCTGATCGAGGACTTCCGAGCC  547 
             |||||| ||||||| |||  | |  || || || | ||| | | |||||||||| | ||| 
Sbjct  362   AGAGGAGCCCAGCCTGGACCGTG-GCA-AAAGCTCTCAGATCACCGAGGACTTCAGGGCC  419 
 
Query  548   TTG-CGCCAGGCAGCTGAAGACATGAAGCTGTTTGAAGCTGATACCA-CT-TTCTT-TGC  603 
              ||  |  || | ||||| |||||||| || ||  || |  | |||| || ||||| |   
Sbjct  420   CTGAAG-AAGACTGCTGAGGACATGAACCTCTTCAAAAC-CA-ACCACCTGTTCTTCT-T  475 
 
Query  604   ACTCCTGCTGGGCCACATCCT-GGCTATGG--AGTTGTTGGCCTGGCTT-ATCATCTACC  659 
              ||||| |||  ||||||| | | | ||||  ||   || |||||| || ||| ||| |  
Sbjct  476   TCTCCTCCTGTCCCACATCATCGTC-ATGGAAAG-CCTT-GCCTGG-TTCATCCTCT-CG  530 
 
Query  660   T-CTTGGGCCCTGGCTGGGTGTCCAGTATCCT--T-GCTGCC-CTGATCCTGGCCATCTC  714 
             | ||| ||| |||||||| | |||  || |||  |  | |||  || |||| || | ||| 
Sbjct  531   TACTTCGGCACTGGCTGGAT-TCC--TACCCTCGTCACAGCCTTTG-TCCTCGCTACCTC  586 
 
Query  715   TCAGGCCCAGTGCTGG-TGTCTGCAACATGATCTA-GGTCATGC-TTCCATCT-TCACTA  770 
             |||||||||  ||||| || ||||||||||| ||| || ||  | |||  ||| | |  | 
Sbjct  587   TCAGGCCCA-AGCTGGATGGCTGCAACATGA-CTATGGCCA-CCTTTCTGTCTAT-AAGA  642 
 
Query  771   AGTCCAGGTGGAACCATGTGGCCCAGC-AGTTCGTGATGGGGCAGTTGAAAGGCT-TTTC  828 
             | ||||  |||||||| || | ||| | |||| || || || || || ||||| |   || 
Sbjct  643   AATCCATATGGAACCACGTTGTCCA-CAAGTTTGTCATTGGCCACTT-AAAGGGTGCCTC  700 
 
Query  829   CGCCCACTGGTGGAATTTCCGCCACTTCCAGCACCATGCCAAACCCAACATCTTCCACAA  888 
              ||| ||||||||||   ||| || ||||| ||||||||||| ||||||||||||||||| 
Sbjct  701   AGCCAACTGGTGGAACCACCGACATTTCCAACACCATGCCAAGCCCAACATCTTCCACAA  760 
 
Query  889   AGACCCAGATGT-GACTGTC-GCACCTGTCTTCCTCCTGGGGGAGT--CA-TCTGTGGAG  943 
              ||||| ||  |  |  | | |||  ||| ||  |||| || ||||  ||  |  | ||| 
Sbjct  761   GGACCCGGACATAAAGAGCCTGCA--TGTGTTTGTCCTTGGCGAGTGGCAGCCCCTTGAG  818 
 
Query  944   TATGGCAAGAAGAAAC-GCAGATACCTGCCCTACAACCACCAGCATCTATACTTCTTCCT  1002 
             |||||||||||||| | | | |||||||||||||||||||||||||  |||||||||||| 
Sbjct  819   TATGGCAAGAAGAAGCTG-AAATACCTGCCCTACAACCACCAGCATGAATACTTCTTCCT  877 
 
Query  1003  GATTGGCCCTCCGCTGCTCA-CCTTGGTGAACTTTGAAGTTGAAAATCTGGCGT-AC-AT  1059 
             ||| || || |||||||||| || |  || || ||  |||   | |||   | | || || 
Sbjct  878   GATCGGACCGCCGCTGCTCATCCCT-ATGTAC-TTCCAGTACCAGATC-ATCATGACAAT  934 
 
Query  1060  GCTGGTG-TGCATGCAGTGGACGGACTT-GCTGTGGGCTGCCAGTTTCTACTCCCGC-TT  1116 
             | |   |  ||| | | |||  |||||| ||| |||||   ||| | ||| |   || || 
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Sbjct  935   GAT-CAGCCGCAGGGACTGGGTGGACTTGGCT-TGGGCCATCAGCTACTA-T-ATGCGTT  990 
 
Query  1117  T-TTCTTGTCCTACTCTCCC-TTCTATGGTGCCA-C-TGGGA-CACT-G--CTCCTCTTT  1168 
             | ||||   |||||  |||| |||||  | | || | ||||| | || |   |||||    
Sbjct  991   TCTTCTACACCTAC-ATCCCTTTCTA-CG-G-CATCTTGGGAGCCCTGGTTTTCCTC-AA  1045 
 
Query  1169  GTTGCTGTCAGGGTGCTGGAGAGCCACTGGTTCGTGTGGATCACGCAGATGAACCACATC  1228 
              ||  | ||||| | ||||||||||||||||| |||||| |||| |||||||||||| |  
Sbjct  1046  CTT--TATCAGGTTCCTGGAGAGCCACTGGTTTGTGTGGGTCACACAGATGAACCACCTT  1103 
 
Query  1229  CCCAAGGAGATTGGCCATGAAAAGC-ATCGGGACTGG-GCAAGC-TCTCAGCTGGCAGCC  1285 
               || ||||||||  | |||  | | | |||||||||  | |||  | |||||||||||| 
Sbjct  1104  GTCATGGAGATTGATCTTGATCA-CTACCGGGACTGGTTC-AGCAGC-CAGCTGGCAGCC  1160 
 
Query  1286  ACCTGCAATGTGGAACCTTCGC-TCTTCATTGACTGGTTCAGCGGGCACCTCAATTTCCA  1344 
             |||||||||||||| |  || | |||||| |||||||||||||||||||||||||||||| 
Sbjct  1161  ACCTGCAATGTGGAGCAGTC-CTTCTTCAATGACTGGTTCAGCGGGCACCTCAATTTCCA  1219 
 
Query  1345  GATTGAGCACCACCTCTTCCCCACGATGCCAAGGCACAAC-TAC-CGGAGGGTGGCCCCC  1402 
             |||||||||||||||||||||||| |||||| | |||||| | | |  ||  || ||||  
Sbjct  1220  GATTGAGCACCACCTCTTCCCCACTATGCCACGTCACAACCTGCACA-AGATTG-CCCCA  1277 
 
Query  1403  CTGGTCAAGGCGT-TCTGCGCCAAGCACGGCCTACACTACGAGGTGAAGCCTTTCCTCAC  1461 
             ||||| ||| | | ||||||||||||| ||| |  | ||| ||| |||||| || || |  
Sbjct  1278  CTGGTGAAGTC-TCTCTGCGCCAAGCATGGCATTGAATACCAGGAGAAGCCGTTGCTGAG  1336 
 
Query  1462  CGCTCTGGTGGATATCATCGGGTCC-CTGAAGAAGTCTGGCGA-CATCTGGCTGGATGCA  1519 
              || ||| | || ||  | | || | |||||||||||||| || | | |||||||||||  
Sbjct  1337  GGCCCTGATCGACATTGT-GAGTTCACTGAAGAAGTCTGGGGAGC-TGTGGCTGGATGCT  1394 
 
Query  1520  TACCTCCATCAATGAAG  1536 
             ||||||||| ||||||| 
Sbjct  1395  TACCTCCATAAATGAAG  1411 
 
 
Mouse Fads3 consists of 449 aminoacids 
"MGGVGEPGGGPGPREGPAPLGAPLPIFRWEQIRQHDLPGDKWLV 
                     
IERRVYDISRWAQRHPGGSRLIGHHGAEDATDAFHAFHQDLHFVRKFLKPLLIGELAP 
                     
EEPSQDGAQNAQLIEDFRALRQAAEDMKLFEADTTFFALLLGHILAMELLAWLIIYLL 
                     
GPGWVSSILAALILAISQAQCWCLQHDLGHASIFTKSRWNHVAQQFVMGQLKGFSAHW 
                     
WNFRHFQHHAKPNIFHKDPDVTVAPVFLLGESSVEYGKKKRRYLPYNHQHLYFFLIGP 
                     
PLLTLVNFEVENLAYMLVCMQWTDLLWAASFYSRFFLSYSPFYGATGTLLLFVAVRVL 
                     
ESHWFVWITQMNHIPKEIGHEKHRDWASSQLAATCNVEPSLFIDWFSGHLNFQIEHHL 
                     
FPTMPRHNYRRVAPLVKAFCAKHGLHYEVKPFLTALVDIIGSLKKSGDIWLDAYLHQ" 
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Sequence confirmation of Fads3 clone in mammalian vector 
The following forward and reverse sequences using BigDye 3.1 and the ABI 3730XL 
capillary sequencer, confirmed that the correct sequence of the Fads3 clone (highlighted) was 
used for transfections. 
FAD3 m13F-21 Forward  
annnnaggcgaattgggcccgacgtcgcatgctcccggccgccatggcggccgcgggaat 
 X  X  G  E  L  G  P  T  S  H  A  P  G  R  H  G  G  R  G  N  
tcgattggatccatgggcggtgtcggggagcccggagggggacccgggccgcgggagggg 
 S  I  G  S  M  G  G  V  G  E  P  G  G  G  P  G  P  R  E  G  
cccgcaccgctgggggcgcccctacccatcttccgctgggagcagatccgccagcatgac 
 P  A  P  L  G  A  P  L  P  I  F  R  W  E  Q  I  R  Q  H  D  
ctaccaggcgacaagtggctggtcatcgagcgccgtgtctacgacatcagccgctgggca 
 L  P  G  D  K  W  L  V  I  E  R  R  V  Y  D  I  S  R  W  A  
cagcggcacccagggggtagccgcctcatcggccaccacggtgcggaggacgccacggat 
 Q  R  H  P  G  G  S  R  L  I  G  H  H  G  A  E  D  A  T  D  
gccttccacgccttccaccaagatctccattttgtgcgcaagttcctgaaacccctgttg 
 A  F  H  A  F  H  Q  D  L  H  F  V  R  K  F  L  K  P  L  L  
attggagagctagccccagaggaacccagccaggatggagctcagaatgcccagctgatc 
 I  G  E  L  A  P  E  E  P  S  Q  D  G  A  Q  N  A  Q  L  I  
gaggacttccgagccttgcgccaggcagctgaagacatgaagctgtttgaagctgatagc 
 E  D  F  R  A  L  R  Q  A  A  E  D  M  K  L  F  E  A  D  S  
actttctttgcactcctgctgggccacatcctggctatggagttgttggcctggcttatc 
 T  F  F  A  L  L  L  G  H  I  L  A  M  E  L  L  A  W  L  I  
atctacctcttgggccctggctgggtgtccagtatccttgctgccctgatcctggccatc 
 I  Y  L  L  G  P  G  W  V  S  S  I  L  A  A  L  I  L  A  I  
tctcaggcccagtgctggtgtctgcaacatgatctaggtcatgcttccatcttcactaag 
 S  Q  A  Q  C  W  C  L  Q  H  D  L  G  H  A  S  I  F  T  K  
tccaggtggaaccatgtggcccagcagttcgtgatggggcagttgaaaggcttttccgcc 
 S  R  W  N  H  V  A  Q  Q  F  V  M  G  Q  L  K  G  F  S  A  
cactggtggaatttccgccacttccagcaccatgccaaacccaacatcttccacaaagac 
 H  W  W  N  F  R  H  F  Q  H  H  A  K  P  N  I  F  H  K  D  
ccagatgtgactgtcgcacctgtcttcctcctgggggagtcatctgtggagtatggcaag 
 P  D  V  T  V  A  P  V  F  L  L  G  E  S  S  V  E  Y  G  K  
aagaaacgcagatacctgccctacaaccaccagcatctatacttcttcctgattggccct 
 K  K  R  R  Y  L  P  Y  N  H  Q  H  L  Y  F  F  L  I  G  P  
ccgctgctcaccttggtgaactttgaagttgaaaatctggcgtacatgctggtgtgcatg 
 P  L  L  T  L  V  N  F  E  V  E  N  L  A  Y  M  L  V  C  M  
cagtggacggacttgctgtgggctgccagtttctactccgctttttcttgtctactctcc 
 Q  W  T  D  L  L  W  A  A  S  F  Y  S  A  F  S  C  L  L  S  
cttnctatggtgccactggganactgctcctctttgttgctgtcagggtgctggaaancn 
 L  X  M  V  P  L  G  X  C  S  S  L  L  L  S  G  C  W  K  X  
actggtttcgtgtggatcacncaaatgaaccacatnccccaagnaaantggnccatgaaa 
 T  G  F  V  W  I  X  Q  M  N  H  X  P  Q  X  X  W  X  M  K  
aaacattngggactgggcaaanctttnanctggn 
 K  H  X  G  L  G  K  X  X  X  W  X 
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FAD3 m13R-48 Reverse 
nnantttcntgatnggggcagttgaaaanggntttttcccgccccnnctggnggaattttn 
  X  F  X  D  X  G  S  -  K  X  X  F  P  A  X  X  X  G  I  X  
ccgccatttnccaggcacccatgccaaaaccccaacntttttccacaaagaccccagatg 
 P  P  F  X  R  H  P  C  Q  N  P  N  X  F  P  Q  R  P  Q  M  
tgactgtcgcccctnttttnctncntggggggagttcatntgtggagtatggcnagnaga 
 -  L  S  P  X  F  X  X  X  G  G  V  H  X  W  S  M  X  X  R  
aaacgcagatacctgcccttacaaaccacccagcatttatacttttttcctgattggccc 
 K  R  R  Y  L  P  L  Q  T  T  Q  H  L  Y  F  F  P  D  W  P  
ntccgctgctcacctttggtgaactttgaagttgaaaatctggcgtacatgctggtgtgc 
 X  R  C  S  P  L  V  N  F  E  V  E  N  L  A  Y  M  L  V  C  
atgcagtggacggacttgctgtgggctgccagtttctactcccgctttttcttgtcctac 
 M  Q  W  T  D  L  L  W  A  A  S  F  Y  S  R  F  F  L  S  Y  
tctcccttctatggtgccactgggacactgctcctctttgttgctgtcagggtgctggag 
 S  P  F  Y  G  A  T  G  T  L  L  L  F  V  A  V  R  V  L  E  
agccactggttcgtgtggatcacgcagatgaaccacatccccaaggagattggccatgaa 
 S  H  W  F  V  W  I  T  Q  M  N  H  I  P  K  E  I  G  H  E  
aagcatcgggactgggcaagctctcagctggcagccacctgcaatgtggaaccttcgctc 
 K  H  R  D  W  A  S  S  Q  L  A  A  T  C  N  V  E  P  S  L  
ttcattgactggttcagcgggcacctcaatttccagattgagcaccacctcttccccacg 
 F  I  D  W  F  S  G  H  L  N  F  Q  I  E  H  H  L  F  P  T  
atgccaaggcacaactaccggagggtggcccccctggtcaaggcgttctgcgccaagcac 
 M  P  R  H  N  Y  R  R  V  A  P  L  V  K  A  F  C  A  K  H  
ggcctacactacgaggtgaagcctttcctcaccgctctggtggatatcatcgggtccctg 
 G  L  H  Y  E  V  K  P  F  L  T  A  L  V  D  I  I  G  S  L  
aagaagtctggcgacatctggctggatgcatacctccatcaatgaaggcagcacccttat 
 K  K  S  G  D  I  W  L  D  A  Y  L  H  Q  -  R  Q  H  P  Y  
gggtggtgaaggggtaagggtccagactccagcagtcaccgagtcactgggcaagattga 
 G  W  -  R  G  K  G  P  D  S  S  S  H  R  V  T  G  Q  D  -  
cagtcatcctcaccccctgctggggcagcctgtctgcccgcctggtcctgctggctttcc 
 Q  S  S  S  P  P  A  G  A  A  C  L  P  A  W  S  C  W  L  S  
tcagtcctcagcattttctggtcagcaatcctatggccatggcacatgtccaacaggacc 
 S  V  L  S  I  F  W  S  A  I  L  W  P  W  H  M  S  N  R  T  
agggtggagggaacatacttaaaatgacacggtgagcatagcatgttttcctagagcaag 
 R  V  E  G  T  Y  L  K  -  H  G  E  H  S  M  F  S  -  S  K  
aactggaaggaaaacttgttatttttatataaaaacaacccagacacctcgagaatcact 
 N  W  K  E  N  L  L  F  L  Y  K  N  N  P  D  T  S  R  I  T  
agtgaattcgcggccgcctgcaggtcgaccatatgggagagctcccaacgcgttggatgc 
 S  E  F  A  A  A  C  R  S  T  I  W  E  S  S  Q  R  V  G  C  
atagcttgagtattctatagtgtcacctaaatagctggcgnatnttcttt 
 I  A  -  V  F  Y  S  V  T  -  I  A  G  X  X  S  
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Fads3 gene expression of transfected cells 
Fads3 mRNA abundance was measured in HEK293 cells transfected at different ratios of 
Fads3 plasmid (μg) to lipofectamine (μl) to determine optimum experimental conditions for 
Fads3 expression.  A ratio of 1 to 5, DNA to lipofectamine, resulted in the highest Fads3 
expression overcoming any D6D expression present in the cell line (Table 3.1). 
Fads3 is not a D6D isozyme 
HEK293 cells transfected with an empty vector, a D6D plasmid, or a Fads3 plasmid were 
analyzed for total fatty acids (Figure 3.1).  Empty vector transfected HEK293 cells did not 
desaturate 18:2n6 as indicated by absence of D6D product 18:3n6.  Despite overexpression of 
Fads3, HEK293 cells transfected with Fads3 plasmid did not desaturate 18:2n6 as indicated by 
absence of 18:3n6, showing a fatty acid profile same as the empty vector trasfected cells.  
Transfection with D6D plasmid resulted in synthesis of 18:3n6, as well as a four time reduction 
in 18:2n6 substrate and a five time increase in 20:3n6 product when compared to Fads3 
transfected and empty vector transfected cells.     
Fads3 does not have D5D or D8D activity 
HEK293 cells transfected with an empty vector, a D5D plasmid, or a Fads3 plasmid were 
analyzed for total fatty acids (Figure 3.2).  Empty vector transfected HEK293 cells did not 
desaturate 20:2n6 as indicated by absence of desaturase product.  Despite overexpression of 
Fads3, HEK293 cells transfected with Fads3 plasmid did not desaturate 20:2n6 as indicated by 
no increase in desaturase products, either of D5D (20:3 n-5,11,14) or of D8D which would have 
made 20:4 n-6.  Fads3 transfected cell fatty acid profile was similar to that of empty vector 
transfected cells.  Transfection with D5D plasmid resulted in synthesis of 20:3 n-5,11,14, as well 
as a reduction in 20:2n6 substrate. 
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DISCUSSION 
Despite overexpression of Fads3 in HEK293 cells, incubation with the D6D substrate 
18:2n6 did not result in synthesis of the D6D product 18:3n6.  The lack of D6D activity 
demonstrates that Fads3 is not a D6D isozyme, at least for the first step in HUFA synthesis.  The 
lack of an isozyme in the D6D-/- mouse was further demonstrated in a separate study where [U- 
13 C] labeled 18:2n6 was given by oral gavage to D6D-/- mice in order to track its metabolism 
(3).  The -/- liver was analyzed and no radiolabeled D6D products were detected including 
arachiconic acid.  This demonstrates the lack of a D6D isozyme in the -/- as well as complete 
disruption of omega-6 HUFA synthesis.  The omega-3 metabolic pathway however was not 
evaluated. 
An alternative route for the synthesis of HUFA, 20:4n6, from 18:2n6 in absence of D6D, 
would require delta-8 desaturation.  18:2n6 would be elongated to 20:2n6 which would then be 
desaturated at carbon 8 to form 20:3 (n-8,11,14).  This would bypass the D6D step.  The D8D 
product, 20:3 (n-8,11,14), could then be desaturated by D5D to form the HUFA, 20:4n6.  In this 
study, we demonstrate that Fads3 does not function as a D8D at least for the omega-6 pathway.  
Recently, Fads2, which encodes for D6D was also shown to have D8D activity for the substrates 
20:2n6 and 20:3n3, with preference towards the omega-3 fatty acid substrate (5). 
The function of Fads3 may be as a desaturase for substrates other than omega-6 fatty 
acids.  In omega-3 HUFA synthesis, D6D participates in two steps: desaturation of 18:3n3, and 
desaturation of 24:5n3 which becomes 24:6n3 and then beta-oxidized to 22:6n3 or DHA (6,7).  
Fads3 may be specific to a fatty acid as in the case of a D5D isozyme in salmon that has 63% 
identity to D5D/FADS1 and specifically desaturates omega-3 fatty acids (8).  A similar situation 
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may occur with Fads3 and D6D which have 73% identity in mouse.  The function of Fads3 may 
also be specific to certain tissues.  Eight Fads3 alternative transcripts have been detected in 
baboon tissues showing differential expression (9). Certain transcripts had higher expression in 
immune tissues while other dominated in brain or heart suggesting potential tissue specific roles.  
The presence of several transcripts indicates more than one gene product for Fads3.  Three 
protein isoforms were confirmed in rat and mouse which were also differentially distributed in 
tissues (10).  Despite low Fads3 expression in rat liver when compared to D6D, a Fads3 isoform 
was abundant in liver supporting its potential role in lipid metabolism (10).  
Although the Fads3 gene function has not been determined, we can conclude it is not 
involved in synthesis of omega-6 HUFA. The residual AA and DHA in D6D-/- tissues at 5 
months of age are likely transferred from the mother to the pup during pregnancy until weaning. 
 
TABLES AND FIGURES 
Table 3.1 Fads3 mRNA abundance of Fads3 transfected HEK293 cells at different DNA to 
lipofectamine ratios (2^-∆Ct). 
DNA(ug)/                
Lipofectamine (ul) 
FADS3 mRNA D6D mRNA 
1 to 0.5 0.016 0.009 
1 to 2.5 0.030 0.008 
1 to 5 1.867 0.007 
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Figure 3.1 Total fatty acid analysis of 18:2n6 treated HEK293 cells transfected with plasmid 
Fads3 (pFADS3), plasmid delta-6 desaturase (pD6D), or an empty vector (pcDNA3.1); pooled 
from duplicates.  *Only pD6D transfected cells showed D6D activity as indicated by 18:3n6 
production. 
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Figure 3.2 Total fatty acid analysis of 20:2n6 treated HEK293 cells transfected with plasmid 
Fads3 (pFADS3), plasmid delta-5 desaturase (pD5D), or an empty vector (pcDNA3.1); pooled 
from duplicates.  *Only pD5D transfected cells showed desaturase activity as indicated by 
decrease in 20:2n6 substrate and increased production of 20:3(n-5,11,14). 
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CHAPTER 4 
 TIME COURSE PATHOLOGY                                                                         
OF DELTA-6 DESATURASE KNOCKOUT (D6D -/-) MOUSE 
ABSTRACT 
A D6D-/- mouse was created to study the physiological roles of highly unsaturated fatty 
acids (HUFA).  The D6D-/- mouse is unable to synthesize HUFA, therefore, any pathology 
present is due to HUFA deficiency.  Externally, pathology occurs around 5 months of age with 
ulcerative dermatitis.  Further histological evaluation at 5 months showed gastrointestinal (GI) 
ulcers, infertility, hepatomegaly, and altered immune system.  A time course characterization of 
the D6D-/- at 3, 6, 9,12, and 16 weeks of age was done in order to determine the sequence in 
which HUFA deficiency phenotype appears, as well as to measure HUFA levels in -/- at weaning 
since HUFA stores may explain the delay in appearance of dermatitis until 5 months of age. A 
total of 44 fully backcrossed C57/bl/6J male and female mice of +/+ and -/- genotype were 
distributed among the 5 time points.  At 3 weeks of age, the -/- mice have liver and testis HUFA 
levels comparable to wild type and no liver pathology.  Male infertility, hepatic lipidosis, and GI 
lesions are the first evidence of HUFA deficiency that appear at 6 weeks of age correlating with 
a significant decrease in testis and liver HUFA.  In conclusion, the D6D-/- mice present HUFA 
stores at weaning most likely provided prenatally in milk from the mother.  An increase in 
severity of HUFA deficiency phenotype occurs as the -/-mice age and are further depleted of 
arachidonic acid (AA) and docosahexaenoic acid (DHA). 
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INTRODUCTION 
Initial characterization of -/- at 5 months of age showed residual AA and DHA in tissues 
such as liver, brain, and testis.  The synthesis of these HUFA by a D6D isozyme, potentially 
Fads3, was hypothesized.  However, the presence of an isozyme was ruled out by an in vivo 
analysis with 13C-labeled 18:2 n-6 showing halted synthesis of 20:4 n-6 and by testing the 
activity of Fads3 (1).  I therefore hypothesized that HUFA are transferred from the mother to the 
pups at birth and are depleted as the mice age.  Pathology would appear as tissues become 
deficient in HUFA, and HUFA stores at birth could delay appearance of dermatitis in D6D-/- 
which occurs until 5 months of age.  In addition to dermatitis at 5 months of age, a histological 
evaluation of D6D-/- tissues shows gastrointestinal ulcers, disrupted spermatogenesis, liver 
lipidosis, and spleen myeloid hyperplasia (1), however the age and HUFA levels at which each 
deficiency phenotype occurs has not been established.  A time course study of D6D-/- pathology 
will help determine which tissues are first to be impaired by HUFA deficiency.  This information 
will help in the design of future experiments using the D6D-/- by providing time points of HUFA 
deficiency symptoms for different tissues.  
In this study we determined the order of appearance of the known D6D-/- pathology due 
to HUFA deficiency as well as quantify HUFA depletion in D6D-/- liver and testis at different 
time points, from weaning until 3 months of age.   
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METHODS 
Experimental design 
All animal work was approved by the University of Illinois Institutional Animal Care and 
Use Committee.  Mice used in the experiment were produced by breeding both wild type (+/+) 
and heterozygous (+/-) males and females of pure C57BL/6J strain fed a standard rodent chow.  
At weaning, a total of 17 male mice (8 +/+, 9 -/-) and 15 female mice (8+/+, 7 -/-) were 
distributed in groups of different euthanasia time points (3, 6, 9, and 12 weeks of age).  Groups 
consisted of 4 mice per genotype for each time point.  In a separate experiment, 6 +/+ and 6 -/- 
were euthanized at 16 weeks of age.  All mice received the AIN93G diet which is a purified, 
nutritionally adequate diet that contains sufficient linoleic acid and α-linolenic acid, but no D6D 
products (2).  Mice were single housed at weaning and received the diet until their corresponding 
time point for euthanasia.  All mice were injected with 100 μl of a T-cell dependant antigen 
(KLH) 8 days prior to euthanasia.   
Tissue collection and histology 
At each time point of euthanasia, mice were weighed, bled from the retro-orbital vein, 
and euthanized by carbon dioxide inhalation.  A portion of the blood collected (500 μl) was 
diluted in 50 μl of anticoagulant 0.5M EDTA and used for a complete blood count.  The other 
portion of blood collected was left at room temperature for sera collection. 
Tissues collected at euthanasia were liver, spleen, gastrointestinal tract, and testis.  Liver, 
spleen, testis were removed and weighed.  The entire gastrointestinal tract was cassetted for 
histological examination as a swiss roll preparation in order to allow evaluation of entire tract.  
Half the liver was frozen for fatty acid and RNA analysis while the other half was fixed in 10% 
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neutral buffered formalin.  Left testis was frozen for fatty acid and RNA analysis while right 
testis was fixed in Davidson’s fixative and transferred to 10% neutral buffered formalin after 24 
hours.  Tissues were trimmed, processed, and paraffin embedded.  Sections were cut at 3 microns 
and stained with hematoxylin and eosin for histological evaluation.  At 3 weeks, only liver was 
examined histologically.  In subsequent time points, all tissues were examined. 
Fatty acid and triglyceride (TG) analysis 
Total lipids were extracted from liver and testis using the Folch method (3). C17:0 
phosphatidylcholine and triacylglycerol were added as internal standards to liver while testis 
only received C17:0 phosphatidylcholine.  Liver lipid fractions of phospholipid and triglyceride 
were obtained by thin layer chromatography with a mixture of petroleum ether, ethyl ether, and 
acetic acid at 80:20:1.  Total lipids were analyzed in testis.  Liver and testis fatty acids were 
methylated with methanolic HCl (Supelco, Bellefonte, PA) at 75ºC for 90 minutes.  Fatty acid 
methyl esters were identified by HP5890 gas chromatography (Agilent Technologies, 
Wilmington, DE) using a 30 m x 0.25 mm Omegawax capillary column (Supelco) at 180ºC for 2 
minutes followed by a 3ºC gradient until a final temperature of 230ºC for 35 minutes. 
Gene expression 
RNA was analyzed with a slight modification of a method previously described (4).  
Testis was homogenized in TRIzol reagent (Invitrogen, Carlsbad, CA), and total RNA extracted. 
MultiScribe Reverse Transcriptase (Applied Biosystems, Foster City, CA), along with random 
hexamers, were used to synthesize cDNA.  Real-time quantitative PCR, using SYBR Green 
fluorescent dye (Applied Biosystems) was used to analyze RNA relative to a ribosomal RNA 
L7a.  Oligonucleotides used for real-time quantitative PCR were SCD-1-F, 
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GTCATCGTTTGTGGTCAGATACT, SCD1-R, GCCGGCATGATGATAGTCAGT, DGAT-2-
F, GTGGCTGCAGGTCGGGTTCC, DGAT-2-R, GACGGCACCTGTGGGACAGC, MTP-1-F, 
TGCCATGCAAAATAGCGGTCACA, MTP-1-R, TAGCCCACGCTGTCTTGCGG,  
D5D-F, CCAGCTTTGAACCCACCAA, D5D-R, CATGAGGCCCATTCGCTCTA, 
ELOVL2-F, GCTAATGGCATGACGGACAA , ELOVL-2-R, GTTCCCCGGCACTTCATTT.  
Antibody response to a T-cell dependant antigen 
Mice were challenged with one hundred μg of a soluble T-cell dependant antigen, 
keyhole limpet haemocyanin (KLH), injected intraperitoneally eight days before termination.  
Serum was collected and assayed for antibodies specific to KLH by ELISA on plates coated with 
antigen KLH.  
Peripheral blood neutrophil counts 
Blood was collected in EDTA and submitted to the University of Illinois Diagnostic 
Laboratory for neutrophil quantification.   
Statistical Analyses 
Significant differences between +/+ and -/- groups were determined by Student’s t-test. 
 
RESULTS  
Time course pathology of D6D-/-  
Delta-6 desaturase knockout (D6D-/-) tissues were evaluated at 3, 6, 9, and 12 weeks of 
age.  First signs of HUFA deficiency were observed at the 6 week time point, which included 
decreased spermatogenesis, mild hepatic lipidosis, and gastrointestinal erosions.  Only liver was 
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evaluated at the previous time point of 3 weeks and did not show lipidosis.   Histological 
evaluation of tissues at subsequent time points indicates D6D-/- pathology becomes more 
apparent as mice age (Table 4.1).  At 9 weeks of age, the -/- immune system is unable to produce 
antibody at the same level as +/+ when challenged with an antigen.  At 12 weeks of age, hepatic 
lipidosis is marked and gastrointestinal erosions become ulcers.  By 16 weeks of age, mild 
neutrophilia occurs before ulcerative dermatitis which appears between 18 and 20 weeks of age 
(1).  Despite pathology occurring by 6 weeks of age, body and tissue weights, as well as organ to 
body ratios, do not differ statistically as HUFA are depleted(Table 4.2 and 4.3).  It is until 16 
weeks of age, when liver weight is significantly higher in D6D-/- versus +/+. 
Hepatic lipidosis occurs by 6 weeks of age in D6D -/- 
Liver HUFA are depleted rapidly from 3 to 6 weeks of age.  D6D -/- liver AA and DHA 
levels are at 27.6% and 19% of +/+ (Figure 4.1).  This drop in hepatic HUFA molar percentage 
coincides with the appearance of mild hepatic lipidosis at 6 weeks of age.  Lipidosis was 
confirmed by measuring liver triglycerides.   An increase of TG from 5.45 to 22.53 µg/mg liver 
occurs at 6 weeks of age, parallel to the severe drop in liver HUFA levels (Figure 4.2).  By 12 
weeks of age, liver AA and DHA have decreased 88% when compared to +/+.  Liver TG are 
significantly higher in -/- at 27.51 µg/mg liver when compared to +/+ which only has 6.2 µg/mg 
liver.  According to histological evaluation, the lipidosis becomes more severe with age as 
HUFA are further depleted.  At 16 weeks of age, D6D-/- have severe hepatic lipidosis (Figure 
4.3).   
Liver gene expression also changes with HUFA depletion (Figure 4.4).  Elongase-2 and 
D5D gene expression increases in all -/- as early as 3 weeks of age and is maintained at high 
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expression in D6D-/- when compared to +/+.  SCD1 gene expression is significantly higher 
(p<0.05) only at 12 weeks of age. 
Disrupted spermatogenesis occurs by 6 weeks of age in D6D -/- 
In addition to hepatic lipidosis, impaired male fertility is also present by 6 weeks of age,  
The first time point examined shows testicular pathology of disrupted spermatogenesis.  Rate of 
HUFA depletion in testis is similar to liver.  Testis HUFA analysis at 6 weeks indicates AA is 
67% less than +/+ while the sum of DPAn6 and DHA are 62% less than +/+.  The depletion of 
these HUFA continues as the mice age and by 12 weeks, HUFA are 91% less than +/+ (Figure 
4.5).    
Gene expression of elongase-2 (ELOVL2) and delta-5 desaturase (D5D) was measured in 
testis with D5D increased expression, although not significant, in -/- testis.  ELOVL2 did not 
change in expression.  
Gastrointestinal (GI) lesions appear by 6 weeks of age in D6D -/- 
The third HUFA deficiency phenotype to appear by 6 weeks of age is the presence of 
erosions in the ileocolic region.  In more severe cases, inflammation extended through the 
intestinal wall into the mesentery.  As indicated by liver and testis HUFA analysis, the amount of 
AA depleted by 6 weeks of age is significant.  A threshold of AA deficiency in GI may have 
been reached compromising the GI protection provided by AA-derived prostaglandins.  As the 
mice age, AA is further depleted and the lesions progress to ulcers by 12 weeks of age. 
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Immune system deficiency in D6D -/- by 9 weeks of age 
The immune system was evaluated by challenging the mouse with a T-cell dependant 
antigen and measuring the amount of antibody produced and present in serum.  At 9 weeks, -/- 
mice had a significantly lower antibody response (p<0.05) compared to +/+.  The low antibody 
response persists as the mice age (Figure 4.6).  
Peripheral blood neutrophils increase in D6D -/- by 16 weeks age 
The majority of the -/- mice show mild neutrophilia (Figure 4.7) by 16 weeks of age, 
becoming severe once dermatitis appears at approximately 21 weeks of age.  The increase in 
number of neutrophils may be secondary to an inflammatory state caused by GI ulcers since 
neutrophilia does not occur before 16 weeks of age. 
 
DISCUSSION 
The D6D -/- mouse at 3 weeks of age has a considerable amount of HUFA in liver with 
11 times more AA and 8 times more DHA than -/- at 4 months of age.  This confirms the 
hypothesis that D6D -/- mice receive a certain amount of HUFA from the mother during 
pregnancy and before weaning delaying appearance of D6D-/- pathology tissue due to HUFA 
deficiency.  Interestingly, despite HUFA supply by the mother, 3 week old +/+ mice still had 
significantly more liver HUFA than -/- mice of the same age indicating active HUFA synthesis 
from +/+ pups as an important contributor to liver AA and DHA at that time point.  In -/-, HUFA 
are rapidly depleted once mice are separated from the mother at 3 weeks of age.  By 6 weeks of 
age, liver HUFA levels dropped significantly by more than half.  The period of 3 weeks to 6 
weeks of age is a period of growth in which mice nearly double their weight.  This growth period 
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may have contributed to the accelerated depletion of HUFA.    The accelerated rate of HUFA 
depletion by 6 weeks of age coincides with first signs of HUFA deficiency in liver, as well as in 
gastrointestinal tract and testis.  At this time point, HUFA deficiency phenotype consist of mild 
hepatic lipidosis with 3 times more TG than +/+ and early lesions in the gastrointestinal tract.   
Male D6D-/- mice are infertile due to disrupted spermatogenesis and inability to 
impregnate female as demonstrated in a separate study (5).  In this study, we show disrupted 
spermatogenesis occuring in D6D-/- as early as 6 weeks of age.  There are two important 22 
carbon length HUFA in testis, DHA (22:6n3) and DPA (22:5n6).  It is the depletion of the sum 
of DHA and DPA molar percentages which correlates with testis pathology.  In +/+, DPAn6 
represents 4.74% of total fatty acids in testis while DHA is 2.95%; combined these HUFA 
represent around 7.7% of fatty acids in testis. In 6 week old infertile -/-, DPAn6 is already 
depleted while DHA is present at 2.22%, a total percentage below the 7.7% observed in +/+.  A 
separate study showed DHA supplementation at 0.2% fully restoring spermatogenesis in -/- and 
raising the total percentage of 22 carbon length HUFA to 7.33%, all contributed by DHA since 
DPAn6 remained depleted (5).  This indicates that DHA and DPA are interchangeable for 
spermatogenesis.   Therefore, as long as total percentage of 22 carbon length HUFA is 
approximately 7%, mice should be fertile.  It is also worth noting HUFA are not completely 
depleted in D6D-/- testis by 2 months of age as suggested by Stoffel et al (6).  
It is long known that essential fatty acid deficiency results in hepatic lipidosis (7).  In the 
case of the D6D-/-, we can attribute hepatic lipidosis specifically to the lack of AA and DHA, 
since PUFA, LA and ALA, were provided in diet and present in liver.  LA and ALA alone were 
not sufficient to prevent accumulation of TG in D6D-/- liver.  The mechanism behind the 
essentiality of AA and DHA in maintaining liver lipid homeostasis has not been determined.  
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Increased expression of lipogenic genes was hypothesized, however, the SCD-1 gene in D6D-/- 
liver only shows a slight increase in expression until 12 weeks of age.  SCD-1 cannot explain 
lipidosis.  Measurements of other lipogenic genes involved in triglyceride synthesis is required to 
determine if increased lipogenesis is the underlying cause of lipidosis in D6D-/-. 
The initial observation of a possible altered immune system in the 21 week old D6D-/- 
consisted of thymic atrophy and splenomegaly accompanying severe dermatitis (1).  Thymic 
atrophy was not present in any of the time points in the current study when animals were 
terminated before manifestation of ulcerative dermatitis. Therefore, thymic atrophy is most likely 
secondary to development of severe dermatitis.  Splenic myeloid hyperplasia appears at around 
the same time as gastrointestinal ulceration, therefore spleen pathology may be secondary to 
intestinal inflammation.  Before 16 weeks of age, increase in neutrophil numbers are not 
observed, however, an impaired ability to produce antibody in response to a T-cell dependent 
antigen challenge occurs by 9 weeks of age.  We can conclude that HUFA deficiency interferes 
with the development of an adaptive immune response for antibody production independent of 
other D6D-/- pathologies. 
In summary, this study established that D6D-/- pathology appears as HUFA are depleted 
in tissues.  By 6 weeks of age, HUFA deficiency symptoms are already present in liver, testis, 
and intestine, while skin function is not impaired until approximately 21 weeks of age.  These 
deficiency symptoms are specific to AA and/or DHA and not their corresponding fatty acids 
precursors, LA and ALA.  HUFA supplementation studies of either AA or DHA will indicate if 
there is specific HUFA essentiality for each tissue function or if both HUFA are required to 
reverse D6D-/- pathology of hepatic lipidosis, gastrointestinal ulcers, male infertility, and 
dermatitis.  The mechanisms behind HUFA essentiality in these tissues is yet to be elucidated.  
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TABLES AND FIGURES 
Table 4.1 Time course of delta-6 desaturase knockout (D6D-/-) phenotype due to highly 
unsaturated fatty acid deficiency (male n=2-3; female n=2). 
Age (weeks) D6D -/- phenotype 
6 
 
Decreased spermatogenesis 
Hepatic lipidosis - mild (+)* 
GI erosions (+) 
 
9 
 
Low antibody response 
 
12 
 
Hepatic lipidosis - marked (++) 
GI erosion/ulceration at ileocolic junction (++) 
 
16 
 
Splenic myeloid hyperplasia-mild to moderate 
Neutrophilia-mild 
Initial signs of skin lesions 
 
18-20 
 
Ulcerative dermatitis 
 
                  *Lipidosis not present at 3 weeks. 
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Table 4.2 Body and tissue weights of -/- mice from 3 to 16 weeks of age. 
Age Body (g) Liver (g) Testis (mg) Spleen (mg) 
Weeks +/+ -/- +/+ -/- +/+ -/- +/+ -/- 
3 10.4±0.07 7.8±1.6 nd nd nd nd nd Nd 
6 17.8±4.3 17.6±1.5 1±0.002 0.86±0.05 73±14 86±13 53±2 47±7 
9 20±6.6 15.3±3.2 0.97±0.01 1.05±0.18 100±2 89±19 55±6 41±4 
12 20.2±5.9 18.1±3.4 0.93±0.09 0.92±0.12 106±2 83±32 69±1 75±6 
16 26.1±1 24.6±3.5 0.95±0.1 1.2±0.19* 102±6 91±10 72±8 75±18 
Mean ± SD. *statistically different by Student’s t-test ( p < 0.05), compared to +/+.  Male n=2-3; female n=2. 
nd=not determined 
 
Table 4.3 Tissue to body weight ratios of -/- mice from 6, 9, 12, and 16 weeks of age. 
Age  Liver  Testis  Spleen  
Weeks +/+ -/- +/+ -/- +/+ -/- 
6 4.1±1% 4.9±0.3% 0.35±0.01% 0.46±0.01% 0.3±0.05% 0.27±0.1% 
9 3.6±0.8% 4.9±0.6% 0.41±0.04% 0.5±0.1% 0.29±0.1% 0.26±0.1% 
12 3.4±0.8% 3.7±0.9% 0.43±0.02% 0.4±0.1% 0.37±0.08% 0.36±0.03% 
16 3.6±1% 4.87±1%* 0.4±0.03% 0.37±0.04% 0.27±0.03% 0.3±0.07% 
Mean ± SD. *statistically different by Student’s t-test ( p < 0.05), compared to +/+.  Male n=2-3; female n=2.  
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Figure 4.1 Liver HUFA depletion in D6D -/- mouse at 3, 6, 9, and 12 weeks of age.  Mean±SD.                            
Male n=2-3; female n=2.  * p<0.05, Student’s t-test, +/+ compared to -/- within age group. 
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Figure 4.2 Liver triglycerides accumulate in D6D-/- as HUFA are depleted.  Mean±SD.                            
Male n=2-3; female n=2.  * p<0.05, Student’s t-test, +/+ compared to -/- within age group. 
 
 
Figure 4.3 Liver histology (hematoxylin and eosin). Hepatic lipidosis in 16 week old -/- mouse 
with accumulated lipids as indicated by large vacuoles (macrovesicular lipidosis).  
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Figure 4.4 Liver gene expression for lipogenic genes. Mean±SD.  Male n=2-3; female n=2.               
* p<0.05, Student’s t-test, +/+ compared to -/- within age group. 
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Figure 4.5 Testis HUFA depletion. A) arachidonic acid (AA); B) docosahexaenoic acid (DHA); 
C) DHA+docosapentaenoic acid.  Mean±SD (n=2-3). * p<0.05, Student’s t-test. 
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Figure 4.6 Antibody response to a T-cell dependant antigen, KLH, at 6, 9 and 16 weeks of age.  
Mean±SD.  n=2-3 males, n=2 females for 6 and 9 weeks, n=6 males for 16 weeks.                                           
* p<0.05, Student’s t-test, +/+ compared to -/-. 
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Figure 4.7 Peripheral blood neutrophils in D6D -/-. Mean±SD.  n=2-3 males, n=2 females for 6 
and 9 weeks, n=6 males for 16 weeks.  * p<0.05, Student’s t-test, +/+ compared to -/-. 
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CHAPTER 5 
DIETARY ARACHIDONIC ACID AND DOCOSAHEXAENOIC ACID PREVENT 
HEPATIC LIPIDOSIS IN DELTA-6 DESATURASE KNOCKOUT (D6D -/-) MOUSE 
 
ABSTRACT 
The D6D-/- mouse presents highly unsaturated fatty acid (HUFA) deficiency symptoms 
in liver by 6 weeks of age.  Disrupted HUFA synthesis results in hepatic lipidosis which is 
characterized by large lipids vacuoles in cytoplasm of hepatocytes.  The severity of liver 
pathology increases as the D6D-/- ages and becomes more depleted of HUFA.  Liver triglyceride 
(TG) levels increase with HUFA depletion.  To determine which HUFA is essential for liver 
lipid homeostasis, a diet supplemented with either 0.2% (w/w) arachidonic acid (AA) or 
docosahexaenoic acid (DHA) was fed to wild type (+/+) and -/- males at weaning until 16 weeks 
of age (n=3-5).  Both dietary AA and DHA supplementation are capable of preventing hepatic 
lipidosis, maintaining liver triglycerides at +/+ levels.  Accumulation of liver TG cannot be 
explained by changes in gene expression of lipogenic enzymes.  In conclusion, HUFA are 
essential in liver lipid homeostasis.  Future studies are required to determine a potential role of 
HUFA in lipid secretion for hepatic TG homeostasis.  
 
 
 
 
 
 77
INTRODUCTION 
Hepatic lipidosis is characterized by accumulation of lipids in cytoplasm of hepatocytes.  
Increased lipogenesis is one of many factors which can contribute to lipidosis (1).  PUFA of the 
omega-3 and omega-6 family are known to downregulate expression of lipogenic genes while 
saturated and monounsaturated fatty acids are not capable of inhibiting fatty acid synthesis (2).  
Reversal of hepatic steatosis can be achieved with PUFA supplementation.  The leptin deficient 
ob/ob mouse, for example, develops hepatic lipidosis which can be ameliorated through dietary 
supplementation of fish oil (3).  Downregulation of genes involved in de novo fatty acid 
synthesis, such as fatty acid synthase (FAS) and stearoyl coenzyme-A desaturase (SCD-1), was 
observed in PUFA-supplemented ob/ob mice when compared to their non-supplemented 
counterparts.  In a separate study, rats fed menhaden fish oil also showed suppressed lipogenesis 
with reduced expression of FAS, when compared to rats fed saturated tripalmitin (4).  PUFA also 
suppress the lipogenic genes involved in HUFA synthesis: D6D and delta-5 desaturase (D5D) 
(5,6).  Both omega-6 and omega-3 PUFA achieve lipogenic suppression by decreasing nuclear 
content of transcription factor SREBP1c (7,8) which targets lipogenic genes such as  SCD1 and 
FAS for upregulation (9). 
 Deficiency of essential fatty acids, LA and ALA, leads to hepatic lipidosis (10).  
However, liver triglyceride (TG) accumulation occurs in a specific HUFA deficient state with the 
D6D-/- mouse (11), indicating a requirement for HUFA and not the precursors LA and ALA in 
modulating TG levels in liver.  It is not clear if both HUFA are needed to maintain liver function 
or if either AA or DHA alone can specifically prevent lipidosis.  These HUFA may have a role in 
maintaining liver lipid homeostasis through regulation of lipogenic genes.   
 78
The objective of this study is to compare dietary supplementation of AA and DHA in 
reversing liver pathology and TG accumulation, as well as measure changes in lipogenic gene 
expression. 
 
METHODS 
Animal study 
All animal work was approved by the University of Illinois Institutional Animal Care and 
Use Committee.  Mice used in the experiment were produced by breeding heterozygous males 
and females of mixed strain (129S6/SvEvTac/C57BL/6J) fed a standard rodent chow.  At 
weaning, a total of 30 male mice, 9 wild type (+/+), 9 heterozygote (+/-), and 12 D6D null (-/-) 
were distributed to receive one of the following diets: control diet (AIN93G), AIN93G 
supplemented with 0.2 w/w % AA, or AIN93G with 0.2 w/w % DHA.  The AIN93G diet is a 
purified, nutritionally adequate diet that contains sufficient linoleic acid and α-linolenic acid, but 
no D6D products (12).  DHASCO and ARASCO oils (Martek Biosciences, Columbia, MD) were 
used for supplementation of DHA and AA, respectively. All dietary groups consisted of 3 mice 
with exception of the AA supplemented -/- (n=4) and DHA supplemented -/- (n=5).  Mice were 
single housed at weaning and received the diet until four months of age.   
Tissue collection and histology 
Animals were euthanized by carbon dioxide inhalation at 4 months of age.  Liver was 
removed and weighed; half the liver was then frozen for fatty acid and RNA analysis while the 
other half was fixed in 10% neutral buffered formalin.  Fixed liver was trimmed, processed, and 
paraffin embedded.  Sections were cut at 3 microns and stained with hematoxylin and eosin for 
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histological evaluation.  Frozen sections were prepared from formalin fixed liver and stained 
with oil-red-O for evaluation of lipid. 
Gene expression 
RNA was analyzed with a slight modification of a method previously described (13). 
Liver was homogenized in TRIzol reagent (Invitrogen, Carlsbad, CA), and total RNA extracted. 
MultiScribe Reverse Transcriptase (Applied Biosystems, Foster City, CA), along with random 
hexamers, were used to synthesize cDNA. Real-time quantitative PCR, using SYBR Green 
fluorescent dye (Applied Biosystems) was used to analyze RNA relative to a ribosomal RNA 
L7a.  Oligonucleotides used for real-time quantitative PCR were: SCD-1-F, 
GTCATCGTTTGTGGTCAGATACT, SCD1-R, GCCGGCATGATGATAGTCAGT, DGAT-2-
F, GTGGCTGCAGGTCGGGTTCC, DGAT-2-R, GACGGCACCTGTGGGACAGC, MTP-1-F, 
TGCCATGCAAAATAGCGGTCACA, MTP-1-R, TAGCCCACGCTGTCTTGCGG, D5D-F, 
CCAGCTTTGAACCCACCAA, D5D-R, CATGAGGCCCATTCGCTCTA, ELOVL2-F, 
GCTAATGGCATGACGGACAA , ELOVL-2-R, GTTCCCCGGCACTTCATTT.  
Fatty acid extraction and analysis 
Total lipids were extracted from liver using the Folch method (14).  C17:0 
phosphatidylcholine and triacylglycerol were added as internal standards to liver.  Liver lipid 
fractions of phospholipid and triglyceride were obtained by thin layer chromatography with a 
mixture of petroleum ether, ethyl ether, and acetic acid at 80:20:1.  Total lipids were analyzed in 
testis.  Liver and testis fatty acids were methylated with methanolic HCl (Supelco, Bellefonte, 
PA) at 75ºC for 90 minutes.  Fatty acid methyl esters of phospholipids and triacyglycerols were 
identified by HP5890 gas chromatography (Agilent Technologies, Wilmington, DE) using a 30 
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m x 0.25 mm Omegawax capillary column (Supelco) at 180ºC for 2 minutes followed by a 3ºC 
gradient until a final temperature of 230ºC for 35 minutes. 
Statistical analysis 
Statistical analysis with Statview version 5.01 for Windows was conducted using one-
way ANOVA with Fisher’s PLSD post test and Student’s t-test.  Data were presented as mean ± 
SD; p < 0.05 was considered as statistically significant. 
 
RESULTS 
Both dietary AA and DHA can prevent hepatic lipidosis in D6D -/- 
Liver absolute weight and liver to body weight ratios were increased only in the non-
supplemented -/- AIN mice, while HUFA supplemented -/- had liver weights similar to +/+ 
(Table 5.1).  Macrovesicular hepatic lipidosis occured only in -/- without HUFA 
supplementation, consisting of large vacuoles of accumulated lipids in cytoplasm of hepatocytes 
(Figure 5.1A).   Individual supplementation of either AA or DHA at 0.2% (w/w) of diet 
prevented hepatic lipidosis in -/-, restorting hepatocyte morphology to +/+ (Figure 5.1A).  Oil 
red stain confirmed the presence of accumulated neutral lipids in vacuoles of D6D-/- hepatocytes 
(Figure 5.1B). 
Hepatic HUFA phospholipids restored with supplementation 
Fatty acids in liver phosphoslipids of -/- with or without HUFA supplementation were 
compared (Figure 5.2).  In non-supplemented -/-, oleic acid and LA were significantly higher 
when compared to +/+ while AA and DHA were nearly depleted; a D5D product unique to -/-, 
20:3 (n7, 11, 14), increased in amount.   
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Dietary AA reduced LA in -/- to +/+ levels while dietary DHA was not as effective in 
doing this.  AA supplementation restored hepatic phospholipid AA in -/- to 23% of fatty acids, 
significantly above the 15% of AA in +/+.  DHA supplementation in -/- raised phospholipid 
DHA to 12.7% of total fatty acids compared to 7.8% in +/+.  The  20:3 (n7, 11, 14) fatty acid, 
unique to -/- mice, was present in non-supplemented -/- at 7.7%, while HUFA supplementation 
significantly decreased this fatty acid to 0.7% in the AA supplemented -/-, and to 1.2% in DHA 
supplemented -/-. 
Liver TG levels maintained at +/+ level 
Non-supplemented -/- mice showed significantly increased TG amounts in liver (p<0.05) 
at 79.5 µg/mg while +/+ only had 12.1 µg/mg.  Dietary HUFA supplementation was capable of 
maintaining TG levels closer to +/+ level at 18.8 µg/mg for AA supplemented -/- and at 19.1 
µg/mg for DHA supplemented -/-.  There was no significant difference in liver TG amounts 
between HUFA supplemented -/- and +/+ mice. 
Liver gene expression of lipogenic enzymes are not all increased with HUFA deficiency 
Gene expression of lipogenic enzymes (Table 5.2) significantly increased (p<0.05) for 
D5D (2.5x) and ELOVL2 (1.8x) in non-supplemented -/- compared to +/+.  AA supplemented -/- 
maintained high gene expression for D5D (2.2x) and ELOVL2 (2.1x), while DHA 
supplementation decreased D5D and ELOVL2 expression to +/+ levels.  SCD-1 did not reach 
significant difference, however average gene expression in -/- was slightly higher.  Genes 
involved in TG synthesis, MTP-1 and DGAT-2, were not significantly different in non-
supplemented -/-.      
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DISCUSSION 
HUFA deficiency results in hepatic lipidosis as demonstrated previously in the initial 
characterization of the D6D-/- (11), as well as in the D6D-/- pathology time course study 
(Chapter 4) where HUFA depletion parallels severity of hepatic lipidosis.  The present study 
demonstrates the ability of dietary HUFA in preventing hepatic accumulation of TG.  Both AA 
and DHA supplementation successfully prevented formation of large lipid droplets of TG in 
D6D-/- liver and restored respective HUFA levels of AA and DHA.   
Hepatic lipidosis in D6D-/- could not be explained by changes in lipogenic gene 
expression.  The diacylglycerol acyltransferase-2 (DGAT2) enzyme participates in TG synthesis 
by esterifying fatty acids into TG.  Overexpression of liver DGAT-2 results in steatosis (15) 
while suppression of DGAT-2 reverses diet-induced lipidosis in rats (16).  Increased DGAT-2 
gene expression was not observed in D6D-/- liver.  SCD-1 synthesizes the main 
monounsaturated fatty acid, oleic acid, providing substrate for esterification into TG and its 
expression also did not significantly increase in D6D-/- liver.  Microsomal triglyceride transfer 
protein (MTP) participates in TG packaging into VLDL for secretion (20).  Gene expression for 
this protein was not changed with HUFA deficiency.   
Delta-5 desaturase (D5D) and elongase-2 (ELOVL-2) participate in fatty acid 
desaturation and elongation (17) of PUFA for HUFA synthesis.  D5D synthesizes AA from 
20:3n6; or eicosapentaenoic acid (EPA; 20:5n3) from 20:4n3.  ELOVL2 substrates are most 
likely the 20 carbon PUFA, AA (20:4n6) and EPA (20:5n3) (18), which are precursors to other 
HUFA, docosapentaenoic acid (DPA; 22:5ω6) and DHA, respectively.  Both D5D and ELOVL2 
had increased expression in D6D-/- liver; most likely as a compensatory mechanism to lack of 
HUFA in tissue.  Increased hepatic expression of these genes has been previously demonstrated 
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in an omega-3 PUFA deficient state in rat (19).  In D6D-/-, increased expression of D5D and 
ELOVL2 does not explain hepatic lipidosis since AA supplementation was not able to 
downregulate these genes yet was effective in preventing liver pathology.  Only DHA 
supplementation was capable of decreasing D5D and ELOVL2 expression back to +/+ level.  
Although not related to hepatic lipidosis, this data provides new insight on gene expression 
regulation of D5D and ELOVL2.  Little is known about the regulation of ELOVL2.  Failed 
downregulation of D5D and ELOVL2 genes in AA supplemented -/- may indicate specific 
regulatory function of DHA (22:6n3), omega-6 DPA (22:5n6), or their corresponding 24 carbon 
products, which are near depletion in AA supplemented -/-.  DPAn6 is structurally similar to 
DHA and therefore may participate in feedback regulation of D5D and ELOVL2 in absence of 
DHA.    
The underlying cause of D6D-/- hepatic lipidosis could not be explained by changes in 
lipogenic gene expression.  An alternative mechanism involves altered lipoprotein secretion.  
Microsomal triglyceride transfer protein (MTP) is a critical protein for TG packaging into VLDL 
(20).  MTP is present in endoplasmic reticulum where VLDL is assembled.  VLDL is then 
transported through Golgi.  MTP is also present within the trans-Golgi network where it 
colocalizes with SNARE protein (21).  SNARE proteins are involved in fusion of transport 
vesicles and target membranes.  The SNARE components syntaxin-5, SNAP23 and VAMP4 
have also been identified in liver cytosolic lipid droplets (22).    HUFA are required for SNARE 
complex formation (23).  HUFA deficiency in D6D-/- therefore may disrupt SNARE complex 
formation within the VLDL formation process which could eventually interfere with TG 
secretion from liver favoring hepatic steatosis.   
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In summary, the role of HUFA in maintaining lipid homeostasis is yet to be elucidated.  
Further research is needed to elucidate the mechanism behind the essentiality of HUFA in TG 
homeostasis. 
 
TABLES AND FIGURES 
Table 5.1 Liver absolute and relative weights of +/+ and -/- groups fed HUFA supplemented 
and non-HUFA supplemented diets.   
Liver Genotype AIN AA DHA 
+/+ 0.95±0.1 1.01±0.1 1.1±0.2 Absolute weight 
(grams) -/- 1.2±0.2 1.03±0.19 1.03±0.15 
+/+ 3.65±0.4% 3.9±0.4% 4.1±0.03% Relative to body 
weight -/- 4.86±0.2%* 3.94±0.5% 4.24±0.5% 
Mean ± SD. n=3-5. *p<0.05, compared to +/+ with Student’s t-test. AIN, AIN93G diet without HUFA 
supplementation.  AA, 0.2% arachidonic acid supplemented AIN93G diet. DHA, 0.2% docosahexaenoic acid 
supplemented AIN93G diet. 
 
Table 5.2 Liver lipogenic gene expression of +/+ and -/-. 
Gene +/+ AIN -/- AIN -/- AA -/- DHA 
d5d 1±0.6 2.5±1 * 2.2±1  1.5±0.5 
elovl2 1±0.5 1.8±0.01* 2.1±0.6* 1.4±0.3 
scd-1 1±0.6 1.4±0.5 1.5±1.5 1.2±0.9 
dgat-2 1±0.1 0.7±0.3 0.67±0.4 1.31±0.2 
mtp-1 1±0.1 1±0.4 0.7±0.05 1.12±0.3 
Mean ± SD. n=3-5. *p<0.05, compared to +/+ with Student’s t-test. AIN, AIN93G diet without HUFA 
supplementation.  AA, 0.2% arachidonic acid supplemented AIN93G diet. DHA, 0.2% docosahexaenoic acid 
supplemented AIN93G diet. 
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Figure 5.1 A)  Liver histology (hematoxylin and eosin).  16 week old wild type mice (+/+) show 
normal hepatocyte morphology while -/- hepatocytes have large vacuoles containing due to lipid 
accumulation (macrovesicular lipidosis).  AA and DHA supplementation prevent lipidosis in -/- 
showing similar hepatocyte morphology to +/+. B) Oil red O stain confirms accumulation of 
neutral lipids in D6D-/- liver. 
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Figure 5.2   Molar percentage of fatty acids in liver phospholipids of +/+ and -/- mice.  AIN, 
AIN93G diet without HUFA supplementation.  AA, 0.2% arachidonic acid supplemented 
AIN93G diet. DHA, 0.2% docosahexaenoic acid supplemented AIN93G diet.  Mean±SD.  n=3-5. 
Groups with different letters are significantly different (p<0.05) by one-way ANOVA followed by 
Fisher’s PLSD.  
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Figure 5.3   Triglyceride quantification of +/+ and -/- liver.  AIN, AIN93G diet without HUFA 
supplementation.  AA, 0.2% arachidonic acid supplemented AIN93G diet. DHA, 0.2% 
docosahexaenoic acid supplemented AIN93G diet.  Mean±SD.  n=3-5. Groups with different 
letters are significantly different (p<0.05) by one-way ANOVA with Fisher’s PLSD. 
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CHAPTER 6 
AA SUPPLEMENTATION, BUT NOT DHA, PREVENTS                                     
ULCERATIVE DERMATITIS AND GASTROINTESTINAL ULCERS IN                                     
DELTA-6 DESATURASE KNOCKOUT MOUSE1 
ABSTRACT 
In order to study arachidonic acid (AA) functions without depleting precursor linoleic 
acid (LA), a delta-6 desaturase knockout (D6D-/-) mouse was produced.  Previous studies have 
shown that the main D6D-/- pathology is severe ulcerative dermatitis manifested  in 100% of -/- 
mice around 5 months of age despite abundant LA in tissues, a fatty acid essential for skin 
barrier function.  In addition to skin pathology, gastrointestinal (GI) ulcers are also observed in -
/- possibly due to AA deficiency.  The main purpose of this study was to evaluate the prevention 
of skin and gastrointestinal HUFA deficiency symptoms by AA supplementation.  Wild type 
(+/+) and -/- received either a non-supplemented AIN93G diet (AIN), an AA supplemented AIN 
diet at 0.2% or 0.4% (n=3 per group), or a 0.2% (w/w) DHA supplemented AIN diet.    AA 
supplemented -/- groups at both doses did not develop dermatitis or GI ulcers, even at 8 months 
of age, while 50% of the DHA -/- group developed skin lesions and 100% developed GI ulcers at 
4 months of age.  Total skin lipid extracts showed significantly lower AA in non-supplemented -
/- fed AIN, whereas skin AA was restored in AA supplemented -/- to 129.5% of +/+ levels.  Skin 
prostaglandin (PG) D2, a modulator of skin reaction to irritants, was decreased to 11.6% of +/+ 
(p<0.05) in the non-supplemented -/-.  AA supplementation partially restored -/- skin PGD2 to 
40.5% of +/+.  In conclusion, dietary AA but not DHA was able to prevent dermatitis and 
                                                            
1 Part of this study has been published in: Stroud et al, 2009, J. Lipid Res. 50: 1870-80 (7).  
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gastrointestinal ulcers which demonstrates AA essentiality in skin and GI function possibly 
through production of prostaglandins. 
INTRODUCTION 
The role of PUFA in skin physiology has been attributed mainly to omega-6 linoleic acid 
(LA), a dietary essential fatty acid which cannot be synthesized de novo by mammals.  Common 
skin essential fatty acid deficiency symptoms are excessive skin water loss and dermatitis (1).  
Skin pathology due to an essential fatty acid deficient diet is a result of an inefficient epidermal 
water barrier (2).  LA supplementation prevents this pathology as an essential component of skin 
barrier ceramides.  Ceramides are required for lipid lamellar layer formation of the stratum 
corneum, the upper most layer of the skin, essential for moisture retention. 
Despite the presence of LA in the diet, the D6D-/- mouse still develops a skin disorder 
characterized by ulcerative dermatitis with excessive scratching behavior.  This would indicate 
that AA may have an essential role for skin function, possibly as a precursor to prostaglandins.  
Prostaglandins (PG) are signaling molecules that can modulate a localized tissue response at low 
concentrations.  Prostaglandin D2 (PGD2), for example, is required for skin repair and has been 
shown to have an antipruritic effect on mice with acrodermatitis, reducing scratching behavior to 
allow skin recovery from a lesion (3).   Therefore, PGD2 is a molecule of interest in studying the 
etiology of skin D6D-/- pathology.   
Prostaglandin (PG) are also essential in maintaining gastrointestinal integrity as 
demonstrated through use of NSAID, which block PG synthesis resulting in gastric and intestinal 
ulceration (4).  AA deficiency in D6D-/- would decrease levels of PG required for GI function 
explaining the appearance of gastrointestinal lesions as early as 6 weeks of age (Chapter 4).  
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The essentiality of DHA in GI function is less clear.    The objective of this study is to determine 
the essentiality of AA and DHA in preventing dermatitis and gastrointestinal ulcers through 
dietary supplementation and creation of specific deficiencies of each HUFA. 
 
METHODS 
Animals 
All animal work was approved by the University of Illinois Institutional Animal Care and 
Use Committee. C57BL/6J-129S6/SvEvTac mixed strain male and female mice of +/+ and -/- 
genotype were used. 
AA supplementation at 0.4% (w/w) of diet 
21-day old +/+ and -/- females (n=3) were fed ad libitum AIN93G diet with and without 
supplementation of 0.4% (w/w) AA (ARASCO, Martek Biosciences, Columbia, MD). Water 
was given ad libitum. Body weight was measured every 2 days.  Animals without HUFA 
supplementation were euthanized at 4 months of age while the AA supplemented mice were 
euthanized at 8 months of age by CO2 inhalation. Skin samples from both time points were 
obtained for PGD2 measurement and for histological evaluation. Skin samples were also 
collected for fatty acid analysis.  The entire gastrointestinal tract was cassetted for histological 
examination as a swiss roll preparation in order to allow evaluation of entire tract.   
AA or DHA supplementation at 0.2% (w/w) of diet 
21-day old +/+ and -/- males (n=3) were fed ad libitum AIN93G diet with and without 
supplementation of 0.2% (w/w) DHA (DHASCO, Martek Biosciences, Columbia, MD) or 0.2% 
AA (ARASCO, Martek Biosciences, Columbia, MD). Water was given ad libitum.  Animals 
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were euthanized at 4 months of age by CO2 inhalation. Skin samples and gastrointestinal tract 
were obtained for histological evaluation.  
Fatty acid analysis 
Total lipids were extracted from spleen using the Folch method (5). C17:0 
phosphatidylcholine was added as an internal standard.  Fatty acids extracts were methylated 
with methanolic HCl (Supelco, Bellefonte, PA) at 75ºC for 90 minutes.  Fatty acid methyl esters 
were identified by HP5890 gas chromatography (Agilent Technologies, Wilmington, DE) using 
a 30 m x 0.25 mm Omegawax capillary column (Supelco) at 180ºC for 2 minutes followed by a 
3ºC gradient until a final temperature of 230ºC for 35 minutes. 
Skin PGD2 assay 
Prostaglandin extraction from skin was based on the method by Sugimoto et al (6).  A 
skin sample was removed from the back of the mouse (intrascapular region), weighed, and 
minced on ice.  Tissue was then homogenized in ice-cold phosphate buffered saline, containing 
10μM indomethacin.  An equal volume of acetone was added to the sample, mixed, and 
incubated on ice for 5 minutes.  Precipitate was removed by centrifugation at 2000 g for 10 
minutes at 4°C. Supernatants containing prostaglandin were blown down with nitrogen and 
resuspended in enzyme immunoassay buffer.  Methoximation of samples was performed and 
PGD2 was measured using the PGD2-Mox EIA kit (Cayman Chemical, Ann Arbor, MI). 
Statistical Analyses 
Significant differences between +/+ and -/- groups were determined by Student’s t-test. 
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RESULTS 
Dietary AA, but not DHA, prevents ulcerative dermatitis in D6D-/- 
A 0.4% AA supplementation study was done to evaluate prevention of dermatitis in 
D6D-/-.  In this study, non-supplemented D6D-/- body weight plateaus by 60 days (Figure 6.1) 
on diet.  In contrast to non-supplemented -/-, AA supplemented -/- body weight does not plateau 
nor does ulcerative dermatitis develop 60 days beyond the usual time point of skin lesion 
appearance in non-supplemented -/-.  A second HUFA supplementation study confirmed dietary 
AA prevention of dermatitis in 100% -/- at a lower dose of 0.2%.  In order to determine if the 
omega-3 DHA can also prevent dermatitis in -/-, a 0.2% DHA supplemented -/- group was also 
included.  However, dietary DHA did not prevent dermatitis successfully as skin lesions 
appeared in 50% of the mice by 4 months of age similar to non-supplemented -/- mice.  
Skin PGD2 levels in -/- partially restored with dietary AA supplementation 
Skin PGD2 in non-supplemented -/- mice was significantly lower (p<0.05) with only 
11.6% of wild type (Figure 6.2).  AA supplementation partially restored levels of -/- skin PGD2 
to 53.8% of AA supplemented +/+ and 40.5% of non-supplemented +/+.  This increase was 
significantly different versus non-supplemented -/- (p<0.05). 
   Skin AA levels restored in -/- with dietary AA supplementation 
Skin AA (20:4 n6) was significantly lower in non-supplemented -/- mice (p<0.05), while 
supplementation increased AA levels to 129% of +/+ (Figure 6.3).  The skin fatty acid profile 
(Figure 6.4) of non-supplemented -/- mice unexpectedly showed lower levels of linoleic acid 
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(18:2 n6), a major component of skin ceramides.  Supplementation was able to restore the -/- 
skin fatty acid profile of linoleic acid and arachidonic acid to +/+ levels.      
Dietary AA but not DHA prevents gastrointestinal ulcers in -/- 
Histological evaluation of gastrointestinal tract (Figure 6.5) indicated presence of ulcers 
with loss of mucosa and infiltration of inflammatory cells primarily in ileocolic junction and 
sometimes in duodenum of non-supplemented -/- mice.   When supplemented with AA, GI 
pathology was not observed.  DHA supplementation however was not capable of preventing GI 
pathology showing ulceration similar to non-supplemented -/-. 
 
DISCUSSION 
Dietary supplementation of AA, but not of DHA, is capable of preventing ulcerative 
dermatitis in 100% of -/- mice.  Both dose levels of 0.2% and 0.4% AA supplemented AIN93G 
diets (w/w) were successful in maintaining skin physiology in D6D-/-.  Based on previous 
studies (7), it is approximately at 120 days of age when D6D-/- mice fed a HUFA deficient diet 
develop initial signs of skin pathology.  AA supplemented -/- mice showed no signs of skin 
lesions throughout the 200 days on the diet.  HUFA analysis indicates skin AA levels were 
significantly higher in supplemented -/- when compared to +/+ suggesting availability of AA for 
PG production required for proper skin physiology.  PGD2 is one of the main PG synthesized 
from AA in human and mouse skin (8).  PGD2 exerts its function through binding to a 
prostanoid receptor.  PGD2 bindng to DP1 receptor decreases scratching behavior in the Nc/Nga 
mouse model of acrodermatitis (9).  Similar to the D6D-/-, Nc/Nga mice present excessive 
scratching behavior that leads to skin ulceration.  Therefore, PGD2 is of particular interest in 
studying D6D-/- skin pathology due to its antipuritic effect and potential involvement in skin 
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repair.  Skin PGD2 levels were increased in AA supplemented D6D-/- and no characteristic 
scratching behavior was observed.  Despite skin PGD2 being only partially recovered in 
comparison to +/+, the amount restored was enough to prevent skin pathology.  Both AA and 
PGD2 are effective in treating skin pathology in Nc/Nga mice. Topically applied AA and PGD2 
to Nc/Nga mice reduced scratching behavior allowing skin recovery from a lesion (10).  
Silencing of the cyclooxygenase-1 gene in skin by RNA interference resulted in increased 
scratching behavior of the Nc/Nga mice, further demonstrating the importance of AA-derived 
PG in skin physiology (11).  PG production was also most likely restored in GI since AA 
supplemented -/- did not develop ulcers.  PG are important for maintaining GI epithelial 
integrity.  PGE2 for example stimulates mucosal bicarbonate secretion to protect the GI against 
acidic conditions (12).   
In -/- tissues, such as liver and testis, fatty acid substrates to D6D accumulate 
significantly above +/+ levels.  LA increases up two times that of +/+ in liver (7).  The skin fatty 
acid profile of non-supplemented -/- mice unexpectedly showed significantly lower levels of LA 
(18:2 n6), a major component of skin ceramides.  Low levels of LA in skin may indicate altered 
ceramide composition within the skin barrier.  AA supplementation successfully restores LA 
back to +/+ levels in the D6D-/-.  A possible mechanism of AA in contributing to proper skin 
structure formation may be as a ligand to transcription factor PPARγ.  Keratinocytes differentiate 
to corneocytes which are the main cell type in the stratum corneum. PPARγ activation favors 
keratinocyte differentiation and lamellar body formation which are important processes for 
stratum corneum or skin barrier formation (13).   
Lamellar bodies are formed within keratinocytes and are then secreted providing lipids 
and enzymes required for lamellar layer formation characteristic of the skin barrier (14).  
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Lamellar bodies are vesicles derived from Golgi and their proper secretion and formation relies 
on a SNARE complex (15).  HUFA have been shown to be required for SNARE complex 
formation (16) suggesting another possible role for AA in skin function through proper lamellar 
granule formation which is essential in delivering components for skin barrier function. 
DHA supplementation was not able to prevent skin pathology or GI ulcers in D6D-/- 
further demonstrating the essentiality of AA in these tissues.  AA-derived PG are essential in 
maintaining gastrointestinal integrity as demonstrated through use of NSAIDS, which block PG 
synthesis resulting in gastrointestinal ulceration (4).  AA deficiency in D6D-/- would decrease 
levels of PG required for GI function possibly explaining the appearance of gastrointestinal 
lesions as early as 6 weeks of age (Chapter 4).  DHA supplementation may accelerate depletion 
of AA in skin and GI, similar to AA depletion of liver where HUFA analysis indicates higher 
depletion of hepatic AA in DHA supplemented -/- when compared to non-supplemented -/- mice 
(Chapter 5).  Accelerated depletion of AA may have an impact on the appearance phenotype 
specific to AA deficiency. 
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FIGURES
 
 
Figure 6.1 Average body weigh of mice fed AIN93G diet with and without 0.4% AA 
supplementation for 200 and 112 days respectively, n=3.  Previous studies show skin lesions in   
-/- by 120 days on a diet deficient of HUFA.  No dermatitis was present in AA-supplemented -/- 
at 200 days. 
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Figure 6.2 Skin prostaglandin (PG) D2 levels relative to wild type (+/+) mouse. Non-
supplemented (AIN93G) -/- have a 90% decrease in PGD2.  AA supplemented -/- skin has 
partially restored PGD2 levels. Mean±SD.  n=3. * p < 0.05, ** p < 0.001 by Student’s t-test. 
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Figure 6.3  Skin arachidonic acid (AA) molar percentages of wild type and D6D -/- mice; 
Mean±SD.  n=3.  *p<0.05, Student’s t-test, +/+ compared to -/-.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 102
**
*
0%
5%
10%
15%
20%
25%
30%
35%
40%
45%
50%
16:0 16:1 18:0 18:1 n9 18:2 n6 18:3 n3
nm
ol
 %
+/+
-/-
+/+ fed AA
-/- fed AA
 
Figure 6.4 Skin fatty acid molar percentages of wild type and D6D -/- mice on 0.4% AA 
supplemented and non-supplemented diets. Mean±SD.  n=3. * p<0.05, Student’s t-test.                     
+/+ compared to -/-. 
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Figure 6.5 Ileocolic junction (hematoxylin and eosin).  Wild type mice (+/+) present normal 
celluar morphology of mucosa and serosa.  D6D-/- mice present loss of mucosa with 
inflammatory cells in serosa (arrow, inset).  AA supplemented -/- do not present ulceration, 
unlike DHA supplemented -/- which has similar pathology to non-supplemented D6D-/- (arrow). 
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CHAPTER 7 
DHA SUPPLEMENTATION, BUT NOT AA, FULLY RESTORES                                     
MALE FERTILITY AND SPERMIOGENESIS IN D6D -/-1 
ABSTRACT 
Delta-6 desaturase knockout mice (-/-) are unable to synthesize highly unsaturated fatty 
acids (HUFA): arachidonic acid (AA), docosahexaenoic acid (DHA), and docosapentaenoic acid 
(DPAn6).  The -/- males exhibit infertility and arrest of spermatogenesis at late spermiogenesis.  
To determine which HUFA is essential for spermiogenesis, a diet supplemented with either 0.2% 
(w/w) AA or DHA was fed to wild type (+/+) and -/- males at weaning until 16 weeks of age 
(n=3-5).  A breeding success rate of DHA-supplemented -/- was comparable to +/+.  DHA-fed -/- 
showed normal sperm counts and spermiogenesis.  Dietary AA was less effective in restoring 
fertility, sperm count and spermiogenesis than DHA. Testis fatty acid analysis showed restored 
DHA in DHA-fed -/-, but DPAn6 remained depleted.   In AA-fed -/-, AA was restored at the +/+ 
level, and 22:4n6, an AA elongated product, accumulated in testis.  Cholesta-3,5-diene was 
present in testis of +/+ and DHA-fed -/-, whereas it diminished in -/- and AA-fed -/-, suggesting 
impaired sterol metabolism in these groups.  Expression of spermiogenesis marker genes was 
largely normal in all groups.  In conclusion, DHA was capable of restoring all observed 
impairment in male reproduction, whereas 22:4n6 formed from dietary AA may act as an inferior 
substitute for DHA.  
 
1This study has been published: Roqueta-Rivera et al., 2010, J. Lipid Res. 51: 360-7 
 
INTRODUCTION 
Delta-6-desaturase (D6D) is the first and rate limiting enzyme for highly unsaturated fatty 
acid (HUFA) synthesis that consists of a series of elongation and desaturation reactions (1).  The 
dietary essential fatty acids 18:2n-6 (linoleic acid) and 18:3n-3 (α-linolenic acid) are substrates 
for D6D and precursors of physiologically important HUFA such as 20:4n-6 (arachidonic acid, 
AA), 22:5n6 (docosapentaenoic acid, DPAn6), and 22:6n3 (docosahexaenoic acid, DHA).  D6D 
is also required for the final desaturation step for the synthesis of DPAn6 and DHA.    
These HUFA are present in high concentration in testes and sperm of mammals.  DPAn6, 
a HUFA derived from AA, dramatically increases in rat testes during the sexual maturation stage 
(2).   In mice, AA, DPAn6, and DHA are abundant in membrane phospholipids of round 
spermatids (3) and mature mouse spermatozoa (4), suggesting an important role for these fats for 
proper spermatogenesis.  In humans, DHA is the main HUFA in sperm (5).  DHA is specifically 
high in the sperm tail when compared to the sperm head in monkeys (6), implying a role of DHA 
in sperm tail function.  AA may also have a role in male fertility as a precursor to eicosanoids.  
Prostaglandin E2, for example, has been shown to increase sperm motility (7), while inhibition 
of cycloxygenase-2 in mouse vas deferens results in a decrease of sperm motility and fertility (8).   
 In addition to the presence of HUFA in mammalian testis and spermatozoa, there are 
also very long chain polyunsaturated fatty acids (VLCPUFA) that contain C26-C38 hydrocarbon 
chains (9-11).  These VLCPUFA are elongation products of the C20 and C22 chain HUFA (12).  
These VLCPUFA are incorporated mainly into sphingomyelin and ceramides in the sperm head 
(9,10).  These sphingolipids are suggested to be involved with capacitation of sperm (13,14). 
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In the study reporting discovery of essential fatty acids, testicular degeneration and a low 
breeding success rate were among the deficiency symptoms in rats fed a fat free diet (15).  A 
later study reported that rats receiving a diet deficient in all essential fatty acids had a lower 
epididymal sperm concentration (16).  However, these previous studies were unable to 
demonstrate the essentiality of HUFA for male fertility because these animals also had severe 
growth retardation and dermatitis.  In order to deplete tissue HUFA in these studies, D6D 
enzyme substrates, linoleic acid and α-linolenic acid, were eliminated as well as all products 
from the diet.  However, linoleic acid is required for skin water barrier function (17).  Thus, 
deficiency of linoleic acid resulted in severe growth retardation and dermatitis, confounding the 
study into the physiological roles of HUFA, including male fertility (15,18).   
To overcome this confounding problem, we and others created mice with the D6D gene 
disabled (19,20).  The D6D knockout (-/-) mouse is unable to synthesize HUFA, thus allowing us 
to specifically create AA deficiency without depleting tissue linoleic acid, or to create DPAn6 
and DHA deficiency without depleting tissue AA.  The D6D-null mouse developed intestinal 
ulcers and severe dermatitis by 5 months of age despite an adequate supply of linoleic acid and 
α-linolenic acid from diet (19).  Moreover, the male -/- mouse became infertile before 
manifestation of dermatitis.  Histology of the D6D -/- mouse revealed disrupted spermiogenesis, 
the last stage of spermatogenesis in which spermatids develop to spermatozoa (19,20).  Although 
the essentiality of HUFA in spermiogenesis and male fertility has been demonstrated by these 
studies, the specific role of each HUFA for spermatogenesis has not been elucidated.  Thus, the 
objective of this study was to determine if dietary AA and DHA can restore spermatogenesis in 
the D6D-null mouse, and to elucidate the role of these HUFA in spermiogenesis.   
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METHODS 
Animal study 
All animal work was approved by the University of Illinois Institutional Animal Care and 
Use Committee.  Mice used in the experiment were produced by breeding heterozygous males 
and females of mixed strain (129S6/SvEvTac/C57BL/6J) fed a standard rodent chow.  At 
weaning, a total of 30 male mice, 9 wild type (+/+), 9 heterozygote (+/-), and 12 D6D null (-/-) 
were distributed to receive one of the following diets: control diet (AIN93G), AIN93G 
supplemented with 0.2 w/w % AA, or AIN93G with 0.2 w/w % DHA.  The AIN93G diet is a 
purified, nutritionally adequate diet that contains sufficient linoleic acid and α-linolenic acid, but 
no D6D products (21).  DHASCO and ARASCO oils (Martek Biosciences, Columbia, MD) were 
used for supplementation of DHA and AA, respectively. All dietary groups consisted of 3 mice 
with exception of the AA supplemented -/- (n=4) and DHA supplemented -/- (n=5).  Mice were 
single housed at weaning and received the diet until four months of age.   
Male fertility 
Fertility was evaluated by breeding single housed males with either a +/+ or +/- female 
for 4 days at four different time points: 6, 9, 12 and 15 weeks of age; different females were used 
at each time point; at least 12 mating attempts were done per dietary group for each genotype. 
Copulatory behavior was confirmed in all mice.  The percentage of successful matings as 
indicated by pregnant females and viable litters was noted.  
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Tissue collection and histology 
Animals were euthanized by carbon dioxide inhalation at 4 months of age.  Left testis and 
left epididymis were removed and weighed; left testis was then frozen for HUFA and RNA 
analysis while left epididymis was used for sperm collection from cauda.  Right testis and 
epididymis were fixed in Davidson’s fixative and transferred to 10% neutral buffered formalin 
after 24 hours.  Tissues were trimmed for paraffin embedding.  Sections were cut at 3 microns 
and stained with hematoxylin and eosin for histological evaluation. 
Sperm count and motility 
The cauda epididymis was cut with a surgical blade, minced with small scissors and 
placed in 2 ml of dmKBRT buffer at 37°C for 15 minutes.  The dmKBRT buffer contained 120 
mM NaCl, 2 mM KCl, 2 mM CaCl2, 10 mM NaHCO3, 0.36 mM NaH2 PO4 H2O, 1.2 mM MgSO4, 
5.6 mM glucose, 1.1 mM Na pyruvate, 25 mM TAPSO, 18.5 mM sucrose, and 6 mg/ml BSA.   
The sperm cell suspensions were then observed using an inverted microscope to record sperm 
motility.  Epididymal sperm counts were done by hemocytometer from epididymal sperm in 2 ml 
of dmKBRT buffer. 
Gene expression 
RNA was analyzed with a slight modification of a method previously described (22). 
Testis was homogenized in TRIzol reagent (Invitrogen, Carlsbad, CA), and total RNA extracted. 
MultiScribe Reverse Transcriptase (Applied Biosystems, Foster City, CA), along with random 
hexamers, were used to synthesize cDNA. Real-time quantitative PCR, using SYBR Green 
fluorescent dye (Applied Biosystems) was used to analyze RNA relative to a ribosomal RNA 
L7a.  Oligonucleotides used for real-time quantitative PCR were: mTISP69-F, 
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5’CGGACGCTCAGGTTAACTTGA 3’, mTISP69-R, 5’CCACAGGAACCCCAAGCA 3’, 
mTISP50-F, 5’ACCTTTGGCATCAAGCATTC 3’, mTISP50-R, 
5’GCACATTTCTGTGGGAGGAT 3’, mAkap3-F, 5’CGCAAAGACCTGGAGAAAAG 3’, 
mAkap3-R, 5’-ACCTTTTCGTTGGTCCACTG-3’, mCttn-F, 5’AGGTGCCATCTGCCTATCA 
3’, mCttn-R, 5’TCTCGGCTTCTGCCTTCC 3’, mTnp1-F, 5’ATGTCGACCAGCCGCAAGC 
3’, mTnp-R, 5’CCACTCTGATAGGATCTTTGG 3’, mSfap-F, 
5’AGAAGGGAAGCTCAGATCCA 3’, mSfap-R, 5’AGAAGGGAAGCTCAGATCCA 3’ 
Fatty acid extraction and GC-MS analysis 
Total lipids were extracted from frozen testis according to the method of Folch et al (23).  
VLCPUFA methyl esters were prepared with a slight modification of a method previously 
described (12).  A mixture of pentadecanoic acid (15:0), heptadecanoic acid (17:0), 
heneicosanoic acid (21:0), pentacosanoic acid (25:0), and heptacosanoic acid (27:0) was added 
as an internal standard to the lipid extracts from the testis.  The extracts were derivatized to fatty 
acid methyl esters (FAME) with HCl in methanol at 85°C overnight.  After extracting with 
hexane, FAME were separated on thin layer chromatography plates with hexane:ether (80:20) to 
remove cholesterol.  Absolute ethanol was added to the scraped bands, which was then sonicated 
for 10 min.  FAME were extracted with hexanes after adding water.  Gas chromatography-mass 
spectrometry (GC-MS) analysis was performed as previously described (12). 
Statistical analysis 
Statistical analysis with Statview version 5.01 for Windows was conducted using one-
way ANOVA with Fisher’s PLSD post test (Table 7.1 and Fig. 7.1B) and the Wilcoxon sum 
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rank test (Figure 7.1A).  Data were presented as mean ± SD; p < 0.05 was considered as 
statistically significant. 
 
RESULTS 
Fertility, sperm counts and motility were restored by dietary DHA 
One of three non-supplemented -/- males was able to impregnate a female at the first time 
point of 6 weeks of age.  Beyond six weeks of age, all non-supplemented -/- males (AIN) failed 
to impregnate females of +/+ or +/- genotype.  The rate of successful matings (Figure 7.1A) for 
non-supplemented -/- (8%) was significantly lower (p<0.05) when compared to non-
supplemented +/+ (67%) and +/- (50%).  Both dietary AA and DHA supplemented -/- had 
significantly higher success rates, 38% and 61% , respectively (p<0.05) than the non- 
supplemented -/- (Figure 7.1A).   
Wild type (+/+) and heterozygote (+/-) mice from all dietary groups presented normal 
total sperm numbers stored in epididymis (Figure 7.1B).  On the other hand, non-supplemented  
-/- animals showed a drastic decrease in sperm count (18% of +/+).  Spermatozoa in non-
supplemented -/- had abnormal morphology with a condensed rounded head (globozoospermia, 
Figure 7.3B inset).  DHA supplementation to -/- males fully restored sperm count (11.62 ± 3.0 x 
106) to wild type levels, while AA supplementation only partially restored sperm counts (2.62 ± 
1.2 x 106) (Figure 7.1B).  Epididymal sperm was motile in all AA and DHA supplemented -/- 
animals, while sperm in -/- animals fed the control diet completely lacked motility.   
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DHA was required for sperm head elongation and flagellum formation 
  Testis and epididymis weights did not differ among groups in either absolute weight or 
in % weight relative to body weight.  Testis histology showed all stages of spermatogenesis in 
+/+ and +/- genotypes regardless of the dietary treatments (Figure 7.2A).  Consistent with our 
previous study (19), all animals of non-supplemented -/- had disrupted spermatogenesis 
specifically at Step 9 of spermiogenesis where round spermatids are elongated.  Spermatogonia, 
spermatocytes, and round spermatids were present, while elongated spermatids and spermatozoa 
were absent (Figure 7.2B).  AA supplementation partially restored spermatogenesis (Figure 
7.2C), while DHA supplemented -/- show all stages of spermatogenesis from spermatogonia to 
spermatozoa (Figure 7.2D). 
All +/+ mice had spermatozoa in the lumen of the epididymis (Figure 7.3A).  Non-
supplemented -/- epididymis contained mostly sloughed round spermatids and spermatocytes, 
cells from an earlier stage of spermatogenesis than spermatozoa (Figure 7.3B).  A closer 
examination revealed that the few spermatozoa present in the epididymis of -/- exhibited 
globozoospermia (Figure 7.3B, inset).  Partial restoration of spermatogenesis by AA 
supplementation is indicated by a mix of mature spermatozoa, spermatocytes and round 
spermatids present in the epididymal lumen (Figure 7.3C).  DHA supplemented -/- group 
presented only spermatozoa in epididymal lumen (Figure 7.3D), the same as in the +/+ (Figure 
7.3A). 
Expression of genes analyzed were largely unchanged in -/-   
Spermatogenesis did not proceed successfully beyond the round spermatid phase (Step 9 
of spermiogenesis) in -/- males, therefore, we measured gene expression of late spermiogenesis 
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markers in testis (Table 7.1).  There was a 45% decrease in sperizin (Znrf4, TISP69) RNA in -/- 
males of all dietary groups.  Two other genes that encode sperm flagellar proteins, Shippo1 
(Odf3, TISP50) and A-kinase anchoring protein (Akap3), had a mild (20%) but statistically 
significant decrease in RNA expression in -/- fed the non-supplemented diet.  Other 
spermiogenesis markers analyzed were transition protein 1 (Tnp1), cortactin (Cttn), and sperm 
flagellum associated protein (Sfap1), all of which were normally expressed in -/- with the non-
supplemented diet.  These results suggest that a gene expression sequence still proceeds to the 
spermiogenesis stage in the -/- . 
Testis DHA and cholesta-3,5-diene were restored by dietary DHA 
Testis fatty acid analysis (Table 7.2) shows significant changes due to genotype and 
dietary treatments.  As shown in the previous study (19), non-supplemented -/- presented low 
levels of DHA (35% of +/+), AA (8% of +/+), near depletion of DPAn6, and accumulation of 
20:3Δ7,11,14, a product of linoleic acid desaturated by delta-5 desaturase and elongated to 20 
carbons (Table 7.2).  As expected, AA supplementation to -/- males restored AA to the level of 
+/+ animals, but not DHA and DPAn6, whereas 22:4n6 and 24:4n6, elongation products of AA, 
accumulated in the AA supplemented -/- group.  Testis DHA was restored in -/- receiving DHA 
supplementation, while AA in testis was low, similar to non-supplemented -/-.  DPAn6 was 
nearly depleted in -/- (Table 7.2), indicating that DPAn6 is dispensable for spermatogenesis and 
male fertility in presence of sufficient DHA.   
The very long chain polyunsaturated fatty acids (VLCPUFA, C ≥ 26) in testis of all +/+ 
groups were elongation products of DPAn6 (26:5n6, 28:5n6, 30:5n6), and a possible elongation 
product of DHA (30:6n3), all of which were quantitatively minor (Figure 7.4A).  In non-
supplemented -/-, these VLPUFAs became undetectable, except for 30:6n3, while an AA- 
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elongated product, 26:4n6, appeared.  AA supplemented -/- had AA-elongation products 28:4n6 
and 30:4n6, but did not present the common DPAn6-elongated VLPUFAs found in +/+.  The 
DHA supplemented -/- lacked n6 VLPUFAs, however, 28:5n3, 28:6n3 and 30:6n3 were present.  
VLPUFA analysis revealed presence of a large peak at 49 min in +/+ and DHA supplemented -/- 
(Figure 7.4A).  The peak diminished in non-supplemented and AA supplemented -/-.  The major 
species in the peak was identified as cholesta-3,5-diene (CD, Figure 7.4B), a dehydration 
product of the alcohol group at the 3 position of cholesterol. 
 
DISCUSSION 
In this study, we determined the effects of dietary AA and DHA on the fertility and 
spermatogenesis of the D6D-null males.  Supplementing 0.2% DHA alone was able to fully 
restore male fertility, spermiogenesis, sperm morphology, and sperm count in -/- males.  This 
restoration occurred despite very low AA and near depletion of DPAn6, the major HUFA present 
in +/+ males.  Considering the variable ratios of DPAn6 and DHA among species (24), DPAn6 
and DHA may be interchangeable for sperm function, and therefore DPAn6 is dispensable for 
sperm function in mice as long as sufficient DHA is present.  It was a little unexpected that DHA 
supplementation alone can fully restore male reproduction and spermiogenesis because of 
proposed roles of AA as eicosanoid precursor in male reproductive function (7,8).  Although the 
underlying mechanism is yet to be elucidated, there could be a functional redundancy that might 
compensate for the lack of eicosanoids.  Alternatively, the residual AA present in the DHA 
supplemented group might be sufficient as a precursor of eicosanoids for male reproduction. 
In AA supplemented -/- mice, sperm counts and a breeding success rate were partially 
restored even though the testis DHA and DPAn6 were as low as the non-supplemented -/-.  This 
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partial rescue is unlikely to be due to the restoration of testis AA in the AA supplemented -/- 
considering DHA supplemented -/- had full recovery with AA levels similar to non-
supplemented -/-.  On the other hand, there was an accumulation of the AA elongated products 
22:4n6 and 24:4n6 in testis of AA supplemented -/-.  Thus, 22:4n6 or 24:4n6 may have acted as a 
substitute for DHA and DPAn6 although these AA-elongated fatty acids do not seem as effective 
as DPAn6 or DHA in restoring fertility.   
Yet to be elucidated is the mechanism underlying the loss of spermatogenesis in the -/- 
and the remarkable restoration by dietary DHA.  In monkey sperm, 99% of DHA is present in 
flagella (6).  Thus, the failure of spermatogenesis at a late stage of spermiogenesis may be at 
least in part due to lack of DHA and DPAn6 for structural components of the flagellar membrane 
phospholipids.  However, the impairment of spermatogenesis is not limited to tail formation.  It 
extends to globozoospermia and possible impairment of sterol metabolism.  Globozoospermia is 
a rare form of infertility in humans, characterized by a rounded sperm head (25).  The Jackson 
Laboratory lists 39 mutant mouse strains under globozoospermia (http://www.jax.org), 
suggesting multiple causes of this abnormality.  Mammalian sperm heads contain ceramides and 
sphingomyelins with high percentages of VLPUFAs (9,10).  Loss of VLPUFA in non-
supplemented -/- may play a role in the impaired sperm head function and structure.   
Another important finding of this study is decreased cholesta-3,5-diene (CD) in the lipid 
extract of non-supplemented and AA-supplemented -/-, and restoration by dietary DHA.  
Because of the paucity of literature on CD, it is unclear if CD is present in testis, or if it is 
derived from sterols during sample processing, although presence of CD in cornea has been 
reported (26). Whichever the case, our data indicate an impairment of sterol metabolism in -/- 
that was restored by DHA supplementation.  Desmosterol (24-dehydrocholesterol), an 
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intermediate metabolite of the last step of cholesterol synthesis, is not present in large quantity in 
most tissues.  However, free desmosterol is the major sterol present in flagella of monkey sperm 
followed by free cholesterol and cholesteryl esters (6,27).  Furthermore, the major impairment in 
the hormone sensitive lipase-null mouse is a complete loss of spermatogenesis (28), similar to 
our D6D-null mice.  Because hormone sensitive lipase is the only esterase that can hydrolyze 
cholesteryl ester, a loss of the enzyme resulted in accumulation of cholesteryl ester in Sertoli 
cells and loss of spermatogenesis (28), indicating essentiality of cholesterol in spermatogenesis.   
Sperizin is a protein highly expressed in spermatids and may act as ubiquitin ligase 
(29,30).  A study reported complete abolition of sperizin RNA in the testis of D6D-null mice, 
and suggested an arrest of the gene expression sequence at the spermiogenesis stage (20).  
However, in our study, sperizin showed only a mild decrease in the -/- animals of all three 
dietary groups, which displayed a drastic difference in spermiogenesis, excluding sperizin as the 
cause of impaired spermatogenesis.  Moreover, several other markers specific to spermiogenesis 
showed largely normal expression in -/- animals fed different diets including genes that encode 
proteins in sperm flagella such as Shippo1 (31), Akap3 (32), and Sfap1(33).  Thus, our RNA 
analysis suggests that there is no general arrest of gene expression sequence at the 
spermiogenesis stage although it is possible that expression of specific genes may be affected by 
DHA deficiency.   
In conclusion, this study demonstrated that DHA supplementation to D6D-null male mice 
restored spermatogenesis and fertility in the absence of DPAn6 and low AA in testis, while 
dietary AA was much less effective.   The accumulation of 22:4n6 in the AA supplemented -/- 
testis suggests that 22:4n6 may act as a lesser substitute for DPAn6 or DHA in spermiogenesis. 
Cholesta-3,5-diene was detected in testis lipid extract from +/+ and DHA-supplemented -/-, 
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whereas it greatly decreased in non-supplemented and AA-supplemented -/-, suggesting 
impairment of sterol metabolism in the latter groups.  The expression of spermiogenesis marker 
genes in -/- animals was largely normal.  The mechanism underlying the loss of spermatogenesis 
in the -/- and the rescue by dietary DHA is yet to be elucidated.  
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TABLES AND FIGURES 
Table 7.1 Spermiogenesis-specific gene expression markers in testis at 16 weeks of age.  
  relative mRNA expression 
Name Description/function +/- AIN -/- AIN -/- AA -/- DHA 
Shippo1                 
(Odf3, TISP50) 
Flagellum structural 
component 
1 ±0.06a 0.81 ±0.06b 0.96 ±0.14ab 1.01 ±0.1a 
Sperizin                 
(Znrf4, TISP69) 
Proteasome-mediated 
degradation of 
spermatid proteins ? 
1 ±0.03a 0.55 ±0.11b 0.63 ±0.19b 0.63 ±0.02b 
A-kinase anchoring 
protein (Akap3) 
Flagellum component 1 ±0.11a 0.80 ±0.12b 0.84 ±0.07b 0.88 ±0.03ab 
Cortactin (Cttn) 
Spermatid-Sertoli cell 
interaction 
1 ±0.06 1.25 ±0.20 1.08 ±0.16 1.06 ±0.09 
Transition protein-1 
(Tnp1) 
Compaction of sperm 
head 
1 ±0.16 0.93 ±0.28 0.93 ±0.17 1.10 ±0.15 
Sperm flagellum 
associated protein 
(Sfap1) 
Flagellum structural 
component 
1 ±0.11 1.03 ±0.04 nd nd 
 
Mean ± SD.  Groups without a common letter differ by Fisher’s PLSD after one-way ANOVA, p<0.05; nd=not 
determined. +/+ AIN, wild type fed AIN93G diet; -/- AIN, knockout fed AIN93G; -/- AA, knockout with 0.2% AA 
supplementation; -/- DHA, knockout with 0.2% DHA supplementation. 
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Table 7.2 Total fatty acid analysis of testis from 16 week old delta-6-desaturase knockout mice 
with and without HUFA supplementation. 
 Relative molar percentage 
HUFA +/+ AIN -/- AIN -/- AA -/- DHA 
20:3(∆7,11,14) nd 6.59 0.83 0.35 
20:4n6 8.55 ±3.65 0.68 10.45 0.79 ±0.53 
22:4n6 1.07 ±0.43 0.31 6.33 0.1 ±0.07 
22:5n6 8.49 ±3.88 0.06 0.05 0.01 ±0.01 
22:6n3 5.49 ±2.52 1.91 1.43 7.33 ±4.58 
24:4n6 0.35 ±0.16 1.306 13.61 0.29 ±0.19 
 
Mean ± SD. Groups without SD were pooled.   +/+ AIN, wild type fed AIN93G diet; -/- AIN, knockout fed 
AIN93G; -/- AA, knockout with 0.2% AA supplementation; -/- DHA, knockout with 0.2% DHA supplementation; 
nd=not detected.  
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 Figure 7.1 (A) Fertility of +/+, +/-, and -/- male mice fed AIN93G diet (black), 0.2% AA 
supplemented (gray), or 0.2% DHA supplemented (white) to the AIN93G diet (n=3-5) . Fertility 
is expressed as frequency of matings resulting in impregnated females and a viable litter; 12 to 
18 attempts per group.  * p<0.05 by Wilcoxon rank sum test.  (B) Total mature sperm count of 
epididymis from 16 week-old male mice.  Mean ± SD.  Groups without a common letter are 
statistically different by Fisher’s PLSD after one-way ANOVA (p<0.05).  
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Figure 7.2  Testis histology of +/+ and -/- male mice fed AIN93G diet with or without 0.2% AA, 
or 0.2% DHA supplementation from weaning until 16 weeks of age. A. Seminiferous tubule in 
testis of +/+ without supplementation showing stage VII of spermatogenesis with normal 
elongated spermatids.  B. Seminiferous tubule from non-supplemented -/- shows impairment of 
spermiogenesis, with abnormal elongation of spermatid head.  C. AA supplementation to -/- 
partially restores spermatogenesis.  D. DHA supplementation to -/- completely restores 
spermatogenesis showing no difference when compared to +/+.  H & E stain.  S, spermatocytes. 
Rs, round spermatids. Es, elongated spermatids. Es(ab), abnormal elongated spermatids. 
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Figure 7.3   Epididymis histology of +/+ and -/- male mice fed AIN93G diet with or without 
0.2% AA, or 0.2% DHA supplementation from weaning until 16 weeks of age.  A. Epididymis of 
+/+ without supplementation contains viable, mature spermatozoa (Sp), with normal heads and 
tails. Inset: sperm showing normal morphology.  B. Epididymis of non-supplemented -/- contains 
sloughed round spermatids (Rs) and spermatocytes (S) and abnormal rounded head sperm (Ab). 
Inset: globozoospermia (rounded head sperm), C. AA supplemented -/- epididymis shows a 
combination of sloughed round spermatids (Rs), some abnormal rounded head sperm (Ab), as 
well as spermatozoa (Sp), with normal morphology.  D. DHA supplemented -/- epididymis has 
only spermatozoa (Sp) and shows no difference compared to +/+. H & E stain.  
 Figure 7.4 A. Very long chain polyunsaturated fatty acid (VLPUFA) analysis of testis at 16 
weeks of age by gas chromatography-mass spectrometry. +/+ AIN, wild type fed AIN93G diet; 
+/+ AA, wild type with 0.2% AA supplementation; +/+ DHA, wild type with 0.2% DHA 
supplementation; -/- AIN, knockout fed AIN93G; -/- AA, knockout with 0.2% AA 
supplementation; -/- DHA, knockout with 0.2% DHA supplementation; IME, isocholesteryl 
methyl ether (normalizer); CD, cholesta-3,5-diene. B. Mass spectra of the peak at 48.9 minutes 
of +/+ testis sample matches reference spectra (NIST Mass Spectral Library, Agilent 
Technologies) of cholesta-3,5-diene (chemical structure shown at the right).  
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CHAPTER 8 
 HIGHLY UNSATURATED FATTY ACIDS ARE REQUIRED FOR                
ACROSOME BIOGENESIS IN SPERMATOGENESIS 
ABSTRACT 
The delta-6 desaturase knockout (D6D-/-) male mice are unable to synthesize highly 
unsaturated fatty acid (HUFA) and become infertile as result of disrupted spermiogenesis, the 
final stage in sperm formation where round spermatids become spermatozoa.  Dietary HUFA 
prevents infertility in D6D-/- with DHA fully restoring spermiogenesis while AA 
supplementation is less effective.  To elucidate the mechanism underlying the essential role of 
HUFA in spermiogenesis, acrosome biogenesis in D6D-/- mice was examined by histological 
comparison of testis from wild type (+/+) and D6D-/- mice fed HUFA deficient diet.  Acrosome 
was absent in non-supplemented -/- round spermatids as indicated by periodic acid-Schiff stain 
while HUFA supplementation of either AA or DHA restored periodic acid-Schiff stain.  
Immunofluorescence using an acrosomal marker, acrosin, showed the characteristic cap-like 
acrosome structure in +/+, while D6D-/- presented acrosin as a dot-like pattern suggesting 
impaired vesicle fusion which is required for acrosome biogenesis.  DHA supplementation 
restored cap-like staining of acrosin while fragmented acrosome was observed with dietary AA.  
Electron microscopy confirmed formation of Golgi-derived proacrosomal vesicles in D6D-/- 
which never fuse to develop acrosome, further supporting immunohistochemistry data.  In 
conclusion, DHA restores D6D-/- fertility as an essential component of acrosome biogenesis, 
most likely providing an adequate lipid environment for proacrosomal vesicle fusion. 
 
 129
INTRODUCTION 
The highly unsaturated fatty acids (HUFA), arachidonic acid (AA) and docosahexaenoic 
acid (DHA), are physiologically essential for the proper function of many tissues, however, the 
mechanisms behind their essentiality are not fully understood.  A delta-6-desaturase knockout 
(D6D-/-) mouse was created to study HUFA function and underlying mechanisms behind HUFA 
deficiency symptoms (1).  The D6D-/- lacks the enzyme to synthesize HUFA, allowing for 
HUFA deficiency without depletion of essential fatty acid precursors.  One of the main HUFA 
deficiency symptoms in male D6D-/- mice is infertility (1).  In testis, DHA is in high 
concentrations, but its exact role for fertility has not been established.   
The D6D-/- males display arrest of spermatogenesis at the spermiogenesis stage, resulting 
in infertility. During spermiogenesis, round spermatids acquire structural components and go 
through morphological changes in order to develop into spermatozoa with an elongated head and 
motile tail.  This process is interrupted with HUFA deficiency as indicated in the D6D-/- male 
which develops abnormal round head sperm morphology (2), a condition known as 
globozoospermia (3).  Dietary supplementation of omega-3 DHA is able to prevent infertility and 
globozoospermia in D6D-/-, restoring normal breeding success rates and sperm counts (2).  AA 
supplementation, however, only partially restores fertility parameters, suggesting a specific role 
for DHA in proper sperm formation (2).   
Similar to the D6D-/- mouse, there are other mouse models which are infertile due to 
globozoospermia, such as the Hrb (4) and GOPC (5) deficient mice.  Globozoospermia in these 
mice is accompanied by a complete loss of acrosome.  The acrosome is a vesicle formed on the 
nuclear envelope of round spermatids during spermiogenesis.  Absence of an acrosome results in 
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round headed sperm (6).  Impaired acrosome biogenesis is therefore hypothesized to occur in the 
D6D-/- due to HUFA deficiency.   
The objective of this study is to elucidate the mechanism underlying an essential role of 
HUFA in spermiogenesis by examining acrosome biogenesis in D6D-/- mice. 
METHODS 
Animals and diets 
All animal work was approved by the University of Illinois Institutional Animal Care and 
Use Committee.  Mice used in the experiment were produced by breeding heterozygous males 
and females fed a standard rodent chow.  Mice were mixed strain (129S6/SvEvTac/C57BL/6J) 
for immunohistochemistry and pure strain (C57BL/6J) for electron microscopy.   At weaning, 
wild type (+/+) and D6D null (-/-) mice were distributed to receive one of the following diets: 
control diet (AIN93G), AIN93G supplemented with 0.2 w/w % AA, or AIN93G with 0.2 w/w % 
DHA.  The AIN93G diet is a purified, nutritionally adequate diet that contains sufficient linoleic 
acid and α-linolenic acid, but no AA or DHA (7).  DHASCO and ARASCO oils (Martek 
Biosciences, Columbia, MD) were used for supplementation of DHA and AA, respectively.  
Dietary groups consisted of 3-5 mice.  Mice were single housed at weaning and received the diet 
until four months of age.   
Histology 
Testis were excised and fixed in Davidson’s fixative and transferred to 10% neutral 
buffered formalin after 24 hours.  The testes were trimmed and embedded in paraffin.  Sections 
were cut at 3 microns and stained with hematoxylin/eosin and with periodic acid Schiff (PAS).   
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Immunohistochemistry 
Paraffin sections at 5 microns were deparaffinized and rehydrated.  Antigen retrieval was 
carried out with 10mM citrate buffer in water bath at 95ºC for 40 minutes.  Samples were then 
permeabilized in 1% Triton-X, blocked with Image iT FX Signal Enhancer (Invitrogen #I36933), 
and incubated with 2% primary antibody overnight at room temperature. After washing, sections 
were incubated with 1% secondary fluorescent antibodies for three hours at room temperature.  
Finally, samples were treated with 0.5 μg/ml of Hoescht 33342 (Invitrogen # H21492) for 
nuclear staining during 5 minutes at room temperature.  Imaging was done with a Zeiss LSM 710 
Confocal Microscope.  Three dimensional rendering of deconvoluted immunohistochemistry 
images was done using Imarisx64 version 7 (Saint Paul, MN), with background subtraction 
based on fluorescence intensity threshold. 
The following antibodies were used: rabbit polyclonal anti-acrosin (Santa Cruz 
Biotechnology, Inc.; sc-67151), mouse monoclonal anti-actin (Abcam Inc.; ab40864), and Golgi 
marker mouse monoclonal antibody to 58k Golgi protein (Abcam Inc.; ab27043).   Secondary 
fluorescent antibodies used were anti-rabbit Alexa 488 (Invitrogen # A11008) and anti-mouse 
Alexa 647 (Invitrogen #A21235). 
Electron microscopy   
Adult male mice (C57BL/6J) of +/+ and -/- genotype fed AIN93G diet until 16 weeks of 
age were injected intraperitoneallly with heparin (125 IU/kg body weight) 15 minutes prior to 
euthanasia, then anesthetized with pentobarbital (30μg/g body weight),  perfused with PBS, and 
fixed with 5% glutaraldehyde in 0.05M sodium cacodylate buffer (pH 7.2-7.4) through the left 
ventricle.  Testes were diced into small pieces, postfixed in osmium tetroxide/potassium 
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ferrocyanide, dehydrated, and embedded in epoxy-resin. One-micrometer sections were cut and 
stained with toluidine blue for high resolution light microscopy examination of spermiogenesis.  
Ultramicrotome sections at 70nm were prepared and stained for electron microscopy.  Imaging 
was done with a Hitachi H600 electron microscope. 
 
RESULTS 
HUFA deficiency results in disrupted acrosome formation 
HUFA deficient D6D-/- mice have disrupted spermiogenesis at stage of acrosome 
biogenesis.  In +/+ mice, acrosome was detected by PAS stain as a purple-magenta color (Figure 
8.1 arrows) on nuclear envelope of round spermatids as well as around the elongated sperm head  
(Figure 8.1A-B).  PAS stain was absent in non-supplemented D6D-/- mice (Figure 8.1C-D) 
therefore lacking acrosome as well as developed elongated sperm head.  Both AA (Figure 8.1E-
F) and DHA supplemented -/- mice (Figure 8.1G-H) present PAS stain, indication of restored 
acrosome. 
Spermiogenesis disrupted at Golgi phase due to HUFA deficiency 
Spermiogenesis can be divided into four phases: Golgi, cap, acrosomal, and maturation 
(8).  Acrosome biogenesis occurs during the Golgi and cap phases.  The initial Golgi phase 
consists of sorting and packaging of acrosomal components into vesicles known as proacrosomal 
granules.  These granules are transported from Golgi to the nuclear envelope of round spermatids 
where several proacrosomal vesicles and granules then fuse to form a single acrosomal granule 
(9,10).  Subsequently the acrosome continues to grow in size as Golgi-derived granules continue 
to provide acrosomal components such as the protease acrosin (11,12).  Acrosome biogenesis 
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proceeds with a cap phase in which the acrosomal granule is flattened over half the nucleus 
forming a cap-like structure.  Differentiation of round spermatid into elongated spermatid and 
spermatozoa occurs during the acrosomal and maturation phase.   
Nuclear stain shows all stages of spermatogenesis from spermatogonia to elongated heads 
of spermatozoa in +/+ (Figure 8.2).  Immunohistochemistry shows acrosin, a protein contained 
within acrosomal vesicles, specifically in the spermiogenesis stage of round spermatids (Figure 
8.2).  Acrosin staining forms the characteristic acrosome cap-like structure attached to nuclear 
envelope of round spermatids.  Golgi stain can be seen above the acrosomal structure.   
Nuclear stain for non-supplemented D6D-/- show stages of spermatogenesis up to round 
spermatid but lack elongated spermatids confirming globozoospermia (Figure 8.2).  Acrosin is 
present as several small vesicles near nuclear envelope and within cytosol, failing to form the 
acrosomal cap-like structure (Figure 8.2).  DHA supplementation restored normal localization of 
acrosin in D6D-/- as indicated by the characteristic cap-like structure on round spermatids; 
elongated sperm heads are also observed (Figure 8.2).   
Actin is associated to the acrosomal structure (13) and involved in trafficking of 
proacrosomal vesicles to the docking site on nucleus, also known as the acroplaxome (14).  Actin 
is also a component of Sertoli cell ectoplasmic specializations which interact with round 
spermatid during acrosome biogenesis (14).  This was indicated with actin immunofluorescence 
showing Sertoli cell specializations in a crescent shape above round spermatids in +/+ and all 
D6D-/- mice (Figure 8.3).  Thus, HUFA deficiency does not disrupt the Sertoli-round spermatid 
interaction.  The acrosin cap-like structure is present below the actin stain in +/+ and HUFA 
supplemented -/- (Figure 8.3).  HUFA deficient D6D-/- however lack this acrosin cap-like 
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structure and only show a dot-like pattern near nucleus and in cytosol, representative of vesicles.  
Three dimensional rendering of images seen in Figure 8.3 were obtained for acrosin and actin 
staining.  In +/+, acrosomal caps are observed as a continous acrosin stain while -/- mice present 
scattered acrosin which do not form a cap (Figure 8.4).  AA supplemented -/- presents an arc-
like acrosin stain from a top view; however a side view indicates a fragmented acrosomal cap 
(Figure 8.5).  DHA supplementation was more effective presenting a continous acrosomal cap 
similar to +/+ (Figure 8.5).  Disrupted acrosome biogenesis in D6D-/- cannot be attributed to 
altered Sertoli cell interactions with round spermatids since actin is not mislocalized in non-
supplemented -/-.  Impaired proacrosomal vesicle fusion is a more likely explanation as indicated 
by electron microscopy. 
Golgi-derived proacrosmal vesicles do not fuse or form an acrosomal granule attached to 
nucleus in HUFA deficient mice 
Electron microscopy evaluation of round spermatids confirmed lack of acrosome 
formation in D6D-/- mice.  Golgi-derived proacrosomal vesicles and granules are formed in both 
+/+ (Figure 8.6B) and -/- (Figure 8.7B) but only +/+ forms a single acrosomal granule (Figure 
8.6C-D) attached to the nuclear envelope.  This acrosomal granule flattens over the nuclear 
envelope forming a cap-like structure (Figure 8.6E-F) which eventually becomes the acrosome 
(Figure 8.6G-H).  Proacrosomal vesicles and granules are present in D6D-/- and can be seen 
between Golgi and nuclear envelope (Figure 8.7A-B), but do not fuse to form a single acrosomal 
structure confirming immunohistochemistry data and indicating disruption of spermiogenesis at 
step 2 of the initial Golgi phase.  In a later step of spermiogenesis, the -/- spermatid nuclear 
envelope is flattened (Figure 8.7C-D) but does not have the single acrosomal granule attached as 
in +/+.  The acroplaxome, docking site of proacrosomal vesicles, can be identified as a darkened 
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region on the nuclear envelope (Figure 8.7E-F) and is present in both +/+ and -/-; however, 
acrosome is not attached in D6D-/-.  Several fragmented small vesicles are present on top of 
D6D-/- nucleus where acrosome should be present (Figure 8.7F).  In addition to lack of 
acrosome, the -/- spermatid also presents abnormal nuclear indentations (Figure 8.7G). 
 
DISCUSSION 
Globozoospermia is a type of male infertility characterized by round headed sperm 
lacking acrosome (3,6).  The acrosome is a vesicle on the nuclear envelope of round spermatids 
which forms prior to a series of morphological changes which include elongation of spermatid 
head and formation of tail (8).  Disruption of acrosome formation is therefore associated with 
failed sperm head elongation which leads to globozoospermia.  In this study, we demonstrate 
HUFA essentiality for acrosome development, as HUFA deficient D6D-/- completely lack 
acrosome.  The mechanisms underlying disrupted acrosome formation have been studied in mice 
deficient in proteins that participate in acrosome biogenesis.  These proteins include GOPC, Hrb, 
and PICK1 which are involved in the trafficking of proacrosomal vesicles from Golgi to nuclear 
envelope and their subsequent fusion for acrosome biogenesis.  GOPC encodes for the Golgi 
associated PDZ and coiled-coil motif containing protein which is present in the trans-Golgi 
network and participates in vesicle trafficking of granules from Golgi to nucleus (5).  PICK1 
encodes for protein interacting with C kinase 1 and associates with GOPC favoring vesicle 
budding from Golgi as well as participating in vesicle trafficking (15).  Hrb encodes for HIV1-
Rev binding protein which is present in the cytosolic surface of proacrosomal vesicles (4).  Hrb, 
GOPC, or PICK1 deficiency results in impaired proacrosomal vesicle fusion.   
The HUFA deficient D6D-/- mice present similar acrosomal alterations to those seen in 
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Hrb, GOPC, and PICK1-/- mice with disrupted acrosome biogenesis in step 2 of spermiogenesis 
during the initial Golgi phase.  Electron microscopy of D6D-/- round spermatids confirms the 
presence of proacrosomal vesicles and granules between Golgi and nucleus.  The docking site for 
proacrosomal vesicles on the nuclear envelope, known as acroplaxome (14), is present in the 
D6D-/- round spermatid, however, docking and fusion to form the single acrosomal granule does 
not occur.  This further supports the hypothesis of impaired vesicle fusion suggested by acrosin 
immunofluorescence in D6D-/-, represented by dot-like pattern in cytosol and near nucleus, but 
lacking an acrosomal cap-like structure.  These spermiogenic defects, also observed in GOPC, 
Hrb, and PICK1-/-mice, suggest a potential mechanism of HUFA requirement for vesicle fusion 
in acrosome formation. 
Vesicle fusion relies on the formation of a soluble NSF-attachment receptor (SNARE) 
complex consisting of a four helical structure that drives the union of opposing membranes (16).  
HUFA have been shown to interact with components of the SNARE complex vesicle fusion in 
neuroendocrine cells and retina, which similar to testis are also rich in DHA.  In brain, DHA 
favors hippocampus neuronal development and synaptic function (17), which relies on neurite 
outgrowth and the SNARE complex (18).  In retina, DHA optimizes the visual transduction 
system (19) and modulates vesicle fusion for rhodopsin delivery to retinal outer segments (20).  
SNARE proteins have also been identified in testis (21) however their interaction with HUFA for 
acrosome formation has not been elucidated.   
This SNARE complex consists of proteins such as, syntaxin and synaptobrevin, which 
are on opposing membranes and interact to achieve vesicle fusion.  Syntaxin exists in an inactive 
and closed conformation and requires activation into an open conformation for SNARE assembly 
(22).  AA activates syntaxin (23) allowing SNARE complex formation consisting of syntaxin-3, 
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SNAP25, and synaptobrevin interactions and favoring neurite outgrowth (18).  DHA was shown 
to efficiently substitute for AA for SNARE assembly in vitro (18).  In retina, rhodopsin delivery 
by Golgi-derived vesicles requires SNARE components which are regulated by DHA (20).   
Syntaxin, synaptobrevin, and SNAP have also been identified in mouse testis in acrosome 
biogenesis (21), however the role of HUFA in regulating SNARE components in male fertility 
has not been demonstrated.  SNARE complex formation is most likely required for fusion of 
proacrosomal vesicles during acrosome formation.  Similar to neuroendocrine cells, free HUFA 
may be required to activate syntaxin to favor SNARE assembly.  DHA supplementation was 
more effective than AA in restoring acrosome, which could suggest a specific role for this HUFA 
in SNARE complex assembly for acrosome biogenesis.  
In conclusion, we demonstrated essentiality of HUFA for acrosome biogenesis in 
restoring D6D-/- fertility.  The most likely mechanism behind impaired acrosomal biogenesis in 
HUFA deficiency is impaired proacrosomal vesicle fusion as seen in Hrb, GOPC, and PICK1-
null mouse models of globozoospermia, which are disrupted at the same spermiogenesis stage as 
D6D-/-.  Further research into the interaction of HUFA with acrosomal SNARE components may 
have implications in developing treatments for certain cases of male infertility. 
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FIGURES 
 
Figure 8.1 Histology of testis stained with periodic acid-Schiff (PAS) to detect acrosome in wild 
type (+/+) and delta-6 desaturase knockout (-/-).  Only HUFA supplemented -/- mice fed either 
arachidonic acid (-/-AA) or docosahexaenoic acid (-/-DHA) present positive PAS staining.  
Arrows indicate acrosome staining absent in HUFA deficient D6D-/-.   
 
 
 
-/- +/+ 
-/- AA -/- DHA 
 tids to 
n 
n of Es. 
 
 
 
 
 
 
 
 
Figure 8.2  Immunohistochemistry of acrosin (red), Golgi (green), nuclei (blue). +/+ mouse 
presents acrosin as cap-like structure on nuclear envelope of round spermatids (Rs)  with Golgi 
above acrosin;  elongated spermatids (S) are present. D6D-/- presents acrosin as dot-like 
pattern, but does not form cap-like structure indicating failed acrosome formation; sperma
not develop elongated head and are abnormal (Es(ab)).  DHA supplementation restores acrosi
cap-like staining as well as formatio
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Figure 8.3 Immunohistochemistry of nuclei (blue), Golgi (green), acrosin (red). The acrosomal 
marker acrosin stains as a cap-like structure on nuclear envelope of round spermatids in +/+ 
and DHA supplemented -/- mice (DHA-/-); D6D-/- lacks acrosomal structure with acrosin 
dispersed near nucleus; AA supplementation restores acrosomal cap-like structure although in 
fewer cells and in some cases seems fragmented.  Actin is not disturbed by HUFA deficiency. 
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Figure 8.4 Immunohistochemistry. Three dimensional rendering of acrosin (red) and actin 
(green) stain of wild-type (+/+) and knockout (-/-) round spermatids.  Left column shows a top 
view with acrosin as arc-like structure in +/+, while dispersed acrosin is in non-supplemented    
-/-.  Right column is a side view of acrosomal cap structures in +/+ which are not formed in -/-. 
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Figure 8.5 Immunohistochemistry. Three dimensional rendering of acrosin (red) and actin 
(green) stain of round spematids from knockout (-/-) mice supplemented with AA or DHA.  Left 
column shows a top view with acrosin as arc-like structures in both AA and DHA -/-.  Right 
column is a side view of acrosomal cap structures which are fragmented with AA 
supplementation while DHA supplementation fully restores cap. 
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Figure 8.6 
Figure 8.6 Electron microscopy images of acrosome formation in +/+ testis. (A) Golgi phase 
round spermatid. (B) Higher magnification view of boxed region in A showing Golgi-derived 
proacrosomal vesicles and granules (*) before attaching to nuclear envelope. (C) Round 
spermatid with single acrosomal vesicle attached to nuclear envelope. (D) Higher magnification 
of boxed region in C showing attached vesicle (*). (E) Cap phase round spermatid with flattened 
acrosomal vesicle on darkened nuclear envelope or acroplaxome. (F) Higher magnification of 
boxed region in E showing vesicles (*) between Golgi and acrosomal cap. (G) Acrosome formed 
on +/+ round spermatid. (H) Higher magnification of G boxed region. n=nucleus, ne=nuclear 
envelope, g=Golgi, ac=acrosome. 
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Figure 8.7 Electron microscopy images of failed acrosome biogenesis in D6D-/- testis. (A) Golgi 
phase round spermatid. (B) Higher magnification view of boxed region in A with Golgi-derived 
proacrosomal vesicles and granules (*) before attaching to nuclear envelope. (C) Round 
spermatid with flattened region of nuclear envelope without acrosomal vesicle indicating 
disruption at Golgi phase. (D) Higher magnification of boxed region in C. (E) Round spermatid 
with darkened nuclear envelope acroplaxome but no attached acrosome. (F) Higher 
magnification of boxed region in E. (G) Round spermatid without acrosome and with nuclear 
indentation (black arrow). n=nucleus, ne=nuclear envelope, g=Golgi. 
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CHAPTER 9  
PRELIMINARY IMMUNE SYSTEM CHARACTERIZATION OF                                   
DELTA-6 DESATURASE KNOCKOUT (D6D -/-) MOUSE 
ABSTRACT 
Highly unsaturated fatty acids (HUFA) are important components of membrane 
phospholipids of immune cells and are also precursors to signaling molecules which modulate 
immune function.  The D6D-/- is unable to synthesize HUFA providing a model to further 
characterize the physiological roles of arachidonic acid (AA) and docosahexaenoic acid (DHA) 
in the immune system.  Certain immune parameters of D6D-/- mice were characterized including 
an in vivo antibody response and cytokine production of splenocytes and macrophages.  HUFA 
deficiency results in decreased antibody production (p<0.05).  Splenocytes and macrophages are 
involved in the process leading to antibody formation and were therefore quantified and 
characterized by flow cytometry as well as in culture.  Although, D6D-/- splenocyte counts, as 
well as CD3+, CD4+, and CD8+ T-cell subpopulations did not differ from +/+,  a decrease in 
IL2 production was observed in HUFA deficient males.  D6D-/- preliminary data suggests a 
decrease in F4/80+ peritoneal macrophage and increase for CD11b+ peritoneal cells 4 days after 
an inflammatory challenge with thioglycollate.  In summary, the D6D-/- indicates HUFA 
essentiality for immune function, specifically antibody production, which cannot be prevented by 
the presence of the HUFA precursors LA and ALA. More work is required to elucidate the 
mechanism behind the requirement of HUFA in establishing an adequate immune response. 
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INTRODUCTION 
The main highly unsaturated fatty acids (HUFA) present in tissues are arachidonic acid 
(AA) and docosahexaenoic acid (DHA) (1).  AA and DHA can be found in membrane 
phospholipids of immune cells and are known to modulate immune function (2).  AA 
participates in regulating immunity as a precursor to a variety of prostaglandins and leukotrienes, 
which are synthesized by immune cells such as monocytes, macrophages, mast cells, and 
neutrophils (3).  Prostaglandin E2 (PGE2) is a major player in inflammation after tissue injury, 
increasing vasodilation and vascular permeability as well as participating in resolving 
inflammation.  Leukotrienes participate in the inflammatory process favoring leukocyte 
chemotaxis and modulating neutrophil activity (4).  DHA on the other hand is considered anti-
inflammatory, decreasing inflammatory cytokine production (5) and driving resolution of 
inflammation as a precursor to docosanoids (6).  Immune cell functionality is sensitive to 
membrane HUFA levels which can be modified based on the composition of fatty acids 
consumed in the diet (7).  It is therefore important to further elucidate the role of HUFA in 
immune function.   
The D6D-/- mouse is an experimental model of HUFA deficiency which can be used to 
determine what aspects of the immune system have an absolute requirement for AA and DHA.  
The D6D-/- is unable to synthesize HUFA becoming AA and DHA deficient which leads to 
ulcerative dermatitis at 21 weeks of age (8).  The immune system plays an active role in the 
initial inflammatory condition of skin lesions and its subsequent repair.  HUFA derived signaling 
molecules participate in this process recruiting immune cells to the site of injury and resolving 
inflammation to achieve a return to tissue homeostasis.  As mentioned previously, AA and DHA 
are known to modulate immunity and inflammation.  A state of HUFA deficiency in D6D-/- may 
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therefore disrupt a proper inflammatory response and subsequent tissue repair, allowing skin 
lesions to persist.  In addition to skin pathology, atrophy of thymus and enlargement of spleen 
was observed in D6D-/- mice with dermatitis (8).  Spleen and thymus are important organs of the 
immune system; therefore, an impaired immune system due to HUFA deficiency was 
hypothesized.  It was important to take into account the presence of ulcerative dermatitis and its 
possible contribution to spleen and thymus D6D-/- pathology.  Thus, in order to establish if the 
D6D-/- immune system is altered due to HUFA deficiency, immune function parameters needed 
to be tested before the development of dermatitis in D6D-/-.   
In this study, immune function of D6D-/- was evaluated by measuring the ability of the 
mouse to develop antibody in response to a T-cell dependant antigen as well as attempting to 
characterize splenocytes, thymocytes, and macrophage.  Both spleen and thymus are sites in 
which several types of immune cells interact to develop an adequate antibody response.  
Macrophages and dendritic cells participate as antigen presenting cells interacting with T-cells.  
T-cells then differentiate into helper T-cells which are needed for activation of B-cells to drive 
antibody production.  Several steps involving different types of immune cells are required to 
produce antibody.   
The essentiality of HUFA in the immune system was confirmed in the D6D-/- mice 
which all present impaired antibody production (Chapter 4).  The mechanism behind the HUFA 
requirement for adaptive immune response is yet to be determined.  Impairment of functionality 
may occur in any cell involved in the process leading up to antibody production, which include 
lymphocytes and macrophages.  In order to determine the role of HUFA in antibody production, 
D6D-/- T-cell populations were characterized by flow cytometry and interleukin-2 (IL-2) 
production of cultured splenocytes was quantified.  Peritoneal macrophages were also attempted 
 152
to be characterized by flow cytometry and functionality was evaluated in culture by measuring 
tumor necrosis factor alpha (TNFα) production upon stimulation with lipopolysaccharide (LPS).  
Preliminary data indicates a requirement for HUFA in maintaining an adequate immune 
response, specifically antibody production; however more studies are required to establish the 
underlying mechanism behind this essentiality. 
 
METHODS 
Animal studies 
All animal work was approved by the University of Illinois Institutional Animal Care and 
Use Committee. C57BL/6J-129S6/SvEvTac mixed strain male and female mice of +/+ and -/- 
genotype were used for all assays except peritoneal macrophage studies, which used pure strain 
C57BL/6J. 
Diets 
At weaning, +/+ and -/- females (n=3) and males (n=3-6) were given AIN93G diet and 
water ad libitum..  Animals were euthanized at 4 months of age.  A HUFA supplemented group 
(n=3) of female +/+ and -/- were fed AIN93G diet with 0.4% (w/w) AA (ARASCO, Martek 
Biosciences, Columbia, MD) from weaning until 8 months of age.   
Tissue collection and histology 
At euthanasia, mice were weighed, bled from the retro-orbital vein and then euthanized 
by carbon dioxide inhalation.  Blood collected was left at room temperature to allow clotting and 
subsequently refrigerated for clot shrinking in order to collect sera used for the antibody response 
assay.  Sera was frozen until needed. 
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Tissues collected at euthanasia were spleen and thymus, which were removed and 
weighed.  Splenocytes and thymocytes were collected from male and female mice.  Briefly, 
spleen and thymus were teased with forceps in Petri dish with one milliliter RPMI1640 medium, 
complete with 10% fetal bovine serum, which was then transferred to 9ml of RPMI1640 to 
obtain cell suspensions which were spun down, washed, and resuspended to a final concentration 
of 2x107 cells per milliliter of RPMI1640.  These cell suspensions were used for thymocyte and 
splenocyte counts by hemacytometer, for splenocyte cytokine production assay, and for 
splenocyte flow cytometry.  
In a separate study, half the spleen was frozen for HUFA analysis while the other half 
was fixed in 10% neutral buffered formalin for histological evaluation.    Tissues were trimmed 
for paraffin embedding.  Sections were cut at 3 microns and stained with hematoxylin and eosin 
for histological evaluation.  Bone marrow was collected from femur with phosphate buffered 
saline using a syringe.  A cytospin slide was prepared from the bone marrow cell suspension and 
evaluated for myeloid and erythroid precursors.   
Spleen HUFA analysis 
Total lipids were extracted from spleen using the Folch method (9). C17:0 
phosphatidylcholine was added as an internal standard.  Fatty acids extracts were methylated 
with methanolic HCl (Supelco, Bellefonte, PA) at 75ºC for 90 minutes.  Fatty acid methyl esters 
were identified by HP5890 gas chromatography (Agilent Technologies, Wilmington, DE) using 
a 30 m x 0.25 mm Omegawax capillary column (Supelco, Bellefonte, PA) at 180ºC for 2 minutes 
followed by a 3ºC gradient until a final temperature of 230ºC for 35 minutes. 
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Antibody response to a T-cell dependant antigen 
Mice were challenged with 100 micrograms of a soluble T-cell dependant antigen, 
keyhole limpet haemocyanin (KLH), injected intraperitoneally eight days before termination. 
Serum was collected at euthanasia and assayed for antibodies specific to KLH by ELISA, as 
described previously with slight modifications (10).  Briefly, 96 well Immulon 2HB microtiter 
assay plates (Thermo scientific #3455, Pittsburgh, PA) were coated with KLH 
(10microgram/milliliter solution in coating buffer), 50 microliters per well.  Plates were 
incubated overnight at 4ºC.  Wells were blocked the next morning for 1 hour at room 
temperature with 100 microliters of PBS with 0.5% bovine serum albumin and tween20.  Wells 
are washed three times with PBS tween.  Serial dilution of +/+ and D6D-/- sera samples were 
distributed in wells and incubated for 2 hours at room temperature.  Wells were then washed five 
times and incubated for 1 hour with enzyme horseradish peroxidase conjugated to goat anti-
mouse (H+L) at a dilution of 1:4000.  Wells were then washed seven times.  The developing 
reagent, 100 microliters of substrate ABTS (2,2'-Azinobis [3-ethylbenzothiazoline-6-sulfonic 
acid]- diammonium salt) was added to each well.  Color development was measured with 
spectrophotomer at 450nm.  Serum titer was defined as the dilution of sample giving a 
measurement equal to 25% of a maximum reponse to KLH obtained from a positive control. 
Splenocytes 
a) Flow cytometry 
Splenocytes (1x106 cells) were stained with anti-mouse fluorescent antibodies: APC-
hamster anti-mouse CD3-epsilon (clone 145-2c11; BD bioscience, San Jose, CA), FITC 
conjugated anti-mouse CD4 (clone YTS191.1; Immunotech), and PE conjugated anti-mouse 
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CD8α (clone KT15; Beckman Coulter; Miami, FL) in order to evaluate T-cell populations.  
Staining was done as described previously with slight modifications (11).  Briefly, cell 
suspensions of 50 microliters (1x106 splenocytes) were washed with one milliliter PBS azide in 
10% fetal bovine serum.  Cells were spun down (1500rpm for 5 minutes) and supernatant 
removed.  Ten microliters of each labeled antibody were added to cells, incubated for 30 
minutes, and then washed twice with 1ml of PBS azide10% fetal bovine serum.   Cells were 
resuspended with 450 microliters of PBS azide, fixed with 50 microliters of 1% 
paraformaldehyde, and kept on ice until evaluation with flow cytometry was done on a BD 
Biosciences LSR II flow cytometer.  
b) Cytokine production  
Splenocytes (2x106 per milliliter) in complete RPMI1640 are distributed in a 24-well 
plate (BD falcon tissue-culture treated polystyrene, flat-bottom #353047, San Jose, CA) at 0.4 
milliliter per well; and stimulated with 0.4 milliliter concavalin-A (2.5μg/ml).  Supernatants were 
collected after 48 hours of incubation at 37ºC and assayed by ELISA to quantify cytokine 
production of IL-2 according to instructions of BD OptEIA Set Mouse IL-2 kit (BD Biosciences, 
#2614kI San Jose, CA).   
Peritoneal macrophage 
a) Flow cytometry 
Peritoneal lavage cell suspensions (2x106 per milliliter), from mice challenged with 
thioglycollate four days prior to euthanasia, were treated with lysis buffer to remove red blood 
cells.  1x106 cells were stained with Alexa Fluor 488 conjugated anti-mouse F4/80 macrophage 
pan marker (ebioscience clone BM8, San Diego, CA) and PE conjugated anti-mouse CD11b 
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(ebioscience clone M1/70, San Diego, CA).  Briefly, cells were washed with PBS, incubated 
with 2 microliters of blocking antibody CD16/32 for 5 minutes on ice, and then incubated with 2 
microliters of fluorescent antibody for 30 minutes in the dark on ice.  Cells were washed twice 
and resuspended in 500 microliters of PBS and transferred to 5 milliliter polystyrene round 
bottom tubes with cell strainer cap (BD Falcon #352235, San Jose, CA) to eliminate potential 
clumps.  Flow cytometry was done on an iCyt flow cytometer. 
b) Macrophage cytokine and nitric oxide production  
From +/+ and -/- cell suspensions at 2x106cells/ml, peritoneal macrophages were 
distributed in a 96 well plate at 1x105cells/well.  Cells were incubated overnight at 37ºC.  The 
following day, cells were treated by triplicate either with medium, interferon-gamma (IFNγ), 
LPS, or a combination of IFNγ and LPS.  After 48 hour incubation with treatment, supernatants 
were collected and assayed for nitric oxide and TNFα production (Mouse Ready-SET-Go ELISA 
Kit, ebioscience #887324, San Diego, CA).  Nitric oxide assay is based on the Griesse reaction in 
which nitrite is quantified by color development at absorbance of 550nm. Cells attached to plate 
were measured by Cyquant cell proliferation assay (Invitrogen add #C7026, Carlsbad, CA). 
Statistical Analyses 
Significant differences between groups were determined by Student’s t-test. 
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RESULTS  
Spleen histology indicates myeloid hyperplasia in D6D-/- mouse before dermatitis 
HUFA deficiency in D6D-/- results in ulcerative dermatitis at 21 weeks of age and is 
accompanied by splenomegaly and thymic atrophy (8).  Since the severe dermatitis may 
exacerbate spleen and thymus pathology, D6D-/- mice immune parameters were evaluated 
before development of dermatitis at 16 weeks of age.  D6D-/- spleen and thymus weights as well 
as cell counts were not significantly different from +/+ in both males and females (Tables 9.1 
and 9.2).  However, histology of D6D-/- spleen showed myeloid hyperplasia, an increase in red 
pulp (Figure 9.1), and significantly higher (p<0.05) number of neutrophils (Table 9.3).  This 
data fits with bone marrow evaluation of myeloid precursors where a significant increase 
(p<0.05) of the myeloid to erythroid ratio was observed in D6D-/- (Table 9.3).  Splenic myeloid 
hyperplasia is prevented with AA supplementation at 0.4% (Figure 9.1). 
Spleen of D6D-/- is depleted of HUFA which can be restored with supplementation 
AA (20:4 n-6) represents an important molar percentage in the +/+ spleen at 17% (Figure 
9.2A).  Non-supplemented D6D-/- spleen AA (20:4 n6) was depleted and non detectable (Figure 
9.2A), while supplementation restored AA to 20.31% (Figure 9.2B).  Spleen LA (18:2 n6) 
accumulated in the non-supplemented D6D-/- due to the absence of D6D enzyme.  LA 
accumulation in D6D-/- was 177% of +/+.  With AA supplementation, LA no longer 
accumulates in D6D-/- and is restored to +/+ levels.  OA (18:1n9) also accumulated in D6D-/- at 
173% of +/+; with AA supplementation OA was restored to +/+ levels.  DHA depletion occurred 
in D6D-/- spleen with and without AA supplementation. 
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Antibody response is impaired in D6D-/- mouse 
Antibody response, to the T-cell dependent antigen keyhole limpet hemocyanin (KLH), 
was compromised in 100% of 16 week old D6D-/- mice; both male and female (Figure 9.3).  
Titer of male +/+ was at 75.41±10.82 while D6D-/- was significantly lower (p<0.05) at 
18.87±7.08.  Female +/+ titer was at 58.56±32.87 while D6D-/- was at 15.37±5.14. 
Spleen T-cell population and cytokine production is normal in D6D-/- 
Spleen T-cells were characterized due to impaired T-cell dependant antibody response.  
T-cell CD3, CD4, and CD8 positive cell populations were characterized in spleen by flow 
cytometry (Figure 9.4).  T-cells positive for CD3, a pan marker for subset of T-cells, was used to 
gate a population and determine percentages of CD3+CD4+ and CD3+CD8+ cells.  Two well 
defined populations were observed in spleen.  No significant differences were observed between 
cell percentages of +/+ and D6D-/-.  T-cell functionality was tested by measuring cytokine 
production after a mitogen challenge in culture.  The IL-2 cytokine is produced by T-cells for 
lymphocyte differentiation.  Significant differences (p<0.05) were observed in IL-2 cytokine 
production in male mice, with +/+ producing 42.6 pg/ml versus 20.6 in D6D-/-; female mice 
however did not present a significant difference (Table 9.4).  
Preliminary macrophage characterization of D6D-/- indicates differences in phenotype. 
D6D-/- mice were submitted to an inflammatory challenge with a thioglycollate 
intraperitoneal injection 4 days prior to euthanasia (n=3).  Peritoneal cells were collected and 
characterized.  No significant differences were observed in number of peritoneal cells collected 
between +/+ and D6D-/-; 1.3x107 ± 0.64 cells from +/+ and 1.1x107±0.26 from -/-.  Flow 
cytometry evaluation of peritoneal cells from +/+ and -/- (n=2 respectively) by forward and side 
scatter showed a defined macrophage population in +/+; in -/-, this population was less defined 
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and with a higher forward scatter, indication of larger cell morphology (Figure 9.5).  Population 
of cells containing macrophage was gated (circled region) based on F4/80 macrophage pan 
marker.  Staining with the mature macrophage marker of F4/80 indicated a lower percentage of 
mature macrophage cells in D6D-/- (Figure 9.6 and 9.8).  F4/80+ cells in +/+ were 
87.18±1.45% while D6D-/- was at 75.72±3.18% of gated cells.  The CD11b marker, a 
component of the complement receptor was higher in D6D-/- (Figure 9.7 and 9.8). CD11b+ 
cells were at 28.56±3.86% while D6D-/- was at 53.44±16.79% of gated cells. 
 Peritoneal cells from +/+ and -/- mice (n=3) were cultured and adhered macrophage were 
characterized for nitric oxide and TNFα production after stimulation with IFNγ and LPS, or a 
combination of both (Figure 9.9).  Adherence was significantly lower in D6D-/- macrophage 
stimulated with LPS.  Nitric oxide production was similar between +/+ and -/-.  TNFα 
production was statistically higher (p<0.05) in D6D-/- when stimulated with IFNγ and LPS.  
TNFα production of +/+ was 1.1±0.1 ng/1000cells while D6D-/- produced 1.5±0.1 ng/1000cells. 
 
DISCUSSION 
This study characterized some of the immune parameters of D6D-/- at 16 weeks of age 
prior to the appearance of any skin pathology.  The objective was to determine if the immune 
system is altered due to HUFA deficiency before development of dermatitis.  D6D-/- mice with 
dermatitis at 21 weeks of age present splenomegaly and thymic atrophy (8). Before dermatitis, 
16 week old D6D-/- mouse spleen and thymus weights, as well as splenocyte and thymocyte 
counts, were not significantly different from +/+ (Table 9.1 and 9.2) which suggests 
splenomegaly and thymic atrophy are most likely secondary to ulcerative dermatitis.   
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Although splenomegaly was not observed, closer histological evaluation of D6D-/- 
spleen indicated an increase in red pulp due to myeloid hyperplasia.  The spleen is a lymphoid 
tissue composed of defined regions of red and white pulp.  Neutrophils and red blood cells 
accumulate in the red pulp while lymphocytes predominate in the white pulp.  The increase in 
red pulp in D6D-/- spleen correlates with increased neutrophil counts and bone marrow myeloid 
precursor cells (Table 9.3).  A possible explanation behind the increase of neutrophils may be 
related to D6D-/- pathology within the gastrointestinal tract (GI).  GI lesions appear in D6D-/- by 
6 weeks of age (Chapter 4).  The severity of these lesions increased as the mice age and as the 
D6D-/- mice become further depleted of HUFA.  Recruitment of inflammatory cells occurs in 
response to the presence of these lesions.  Therefore an increased demand of neturophil 
production would occur to compensate for the persistent inflammatory condition in the intestine.  
HUFA may therefore be required for neutrophil homeostasis as well as resolving inflammation.  
The main HUFA in spleen is AA, at ~20% of total fatty acids.  AA becomes depleted in D6D-/- 
spleen of 16 week old mice.  Dietary AA restores this HUFA in D6D-/- spleen and prevents 
myeloid hyperplasia, demonstrating the importance of this fatty acid for spleen function.  AA 
supplementation also prevents gastrointestinal ulcers (Chapter 5) further indicating a 
physiological role for AA in neutrophil homeostasis and tissue repair.  The functional role of AA 
in this case is most likely as a precursor to signaling molecules such as prostaglandins and 
leukotrienes which have both been shown to modulate neutrophil chemotaxis (12), which is a 
critical process for inflammation and its resolution. 
The observed pathology in spleen may impact its other functions within the immune 
system such as antibody production.  Successful antibody production involves several immune 
cell types.  Foreign proteins must first be ingested by cells of the innate immune system such as 
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macrophage and dendritic cells.  The foreign protein or antigen is processed and then presented 
to T-cells as an MHC class II complex.  T-cells recognize the MHC complex and then 
differentiate into CD4+ T-helper cells which activate B-cells to drive their transformation into 
plasma cells for antibody production.  The white pulp of spleen is the site of B and T cell 
interactions required to develop this adaptive immune response (13).  A decrease in white pulp in 
D6D-/- may therefore result in impaired antibody production.  
We quantified antibody produced in response to a foreign soluble protein antigen, 
keyhole limpet hemocyanin (KLH) in D6D-/-.  This antigen induced a T-cell dependant antibody 
response which was significantly decreased in 100% of HUFA deficient D6D-/- mice (Figure 
9.3).  This suggests an impaired immune system which may result from inefficient lymphocyte 
function.  Splenocyte functionality was therefore assessed by measuring IL-2 cytokine 
production.  IL-2 plays an important role in T-cell proliferation and differentiation into T-helper 
cells.  Cytokine production of IL-2 was only significantly different in male D6D-/- (Table 9.4).  
The average amount of IL2 produced in female D6D-/- was lower compared to +/+, although did 
not reach significant difference.  An increase in sample size may be required to reach a statistical 
difference for female mice.  A decrease in IL-2 production may explain an impaired antibody 
response since this could disrupt T-cell differentiation into CD4+ T-helper cells which 
participate in the process leading up to antibody production.  The T-cell and antigen presenting 
cell immunological synapse which leads to T-cell activation relies on membrane interaction and 
proper localization of proteins within lipid rafts.  Fatty acid composition of lipid rafts as well as 
recruitment of signal transduction proteins can be modified by PUFA feeding in rodents (14,15).  
Specific HUFA deficiency may result in inadequate localization of signaling proteins within lipid 
rafts which then interferes with proper T-cell activation and IL-2 production. 
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Further splenocyte cytokine production quantification is required to obtain a better idea 
on how HUFA deficiency is altering T-cell functionality.  The IL-4 cytokine would be an ideal 
end point since it is secreted by T-cells for B-cell activation.   
In order to determine if HUFA deficiency modified T-cell subpopulations as a result of 
lower IL-2 production, flow cytometry was used to quantify CD3, CD4, CD8 receptors on 
splenocytes.  CD3 is a marker for mature T-cell lymphocytes.  CD4 is present on T-helper cells 
which activate B-cells to drive antibody production.  CD8 is a marker for cytotoxic T-cells.  
Flow cytometry quantification of these populations resulted in the same scattergram profile 
(Figure 9.4) and population percentages between +/+ and D6D-/- spleen.  Therefore, impaired 
antibody response in D6D-/- cannot be explained by altered expression of T-cell population 
markers in spleen. 
Another immune cell which participates in the process leading up to antibody production 
is the macrophage.  The macrophage plays an important role in antibody production through 
phagocytosis of foreign proteins and contributes as an antigen presenting cell.  The macrophage 
is also involved in neutrophil homeostasis, which may be altered in D6D-/- as indicated by 
increased spleen neutrophils, peripheral blood neutrophil counts, and myeloid precursors in bone 
marrow.  Macrophage is critical for neutrophil clearance by phagocytosis of apoptotic 
neutrophils resulting in a cascade of events leading up to neutrophil homeostasis (16).  
Macrophage phagocytosis of apoptotic neutrophils inhibits interleukin-23 (IL-23) production 
which signals bone marrow to stop myeloid precursor cell production and release into circulation 
(17).   Impaired macrophage functionality may therefore lead to D6D-/- pathology of increased 
neutrophil counts and impaired antibody response.    
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Due to the potential role of macrophage in the development of D6D-/- pathology, 
preliminary data was gathered characterizing this immune cell.  Peritoneal lavage cell 
suspensions containing macrophage after an inflammatory challenge of thioglycollate, were 
characterized by flow cytometry.  Differences in forward and side scatter, which denote size and 
complexity of the cell, were observed in the D6D-/-.  A less defined macrophage population was 
present in D6D-/- (Figure 9.5).  The marker for macrophages F4/80 was decreased in D6D-/- 
(Figure 9.6), while the marker for CD11b (Figure 9.7) was increased.  CD11b, together with 
CD18, form the complement receptor which participates in both chemotaxis and phagocytosis.  
These flow cytometry results may indicate a different stage of macrophage differentiation within 
the D6D-/-, 4 days post-inflammatory challenge.  A time course study evaluating immune cell 
populations would help determine if HUFA deficiency alters the differentiation process of the 
macrophage, as well as the appearance of immune cell populations after an inflammatory 
challenge. 
Peritoneal macrophages were cultured to evaluate their functionality.  Macrophage 
adherence to plate was lower (p<0.05) in D6D-/- when cells were challenged with a 48 hour 
treatment of LPS.  An AA requirement for adherence has been previously demonstrated (18). 
Macrophage cytokine production of TNFα was significantly increased (p<0.05) in D6D-/- when 
cells were treated with a combination of IFNγ and LPS.  TNFα is an inflammatory cytokine 
produced mainly by macrophage and is involved in NFKb activation, stimulation of 
phagocytosis, and chemoattraction of neutrophils.   The increase in TNFα production in D6D-/- 
parallels the increase in CD11b marker in the -/- which is also involved in chemotaxis and 
phagocytosis.  DHA downregulates TNFα production (19), therefore, the lack of HUFA may 
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result in dysregulated inflammatory cytokine production by immune cells which could also 
partially explain increased neutrophil counts and altered macrophage phenotype.   
Macrophage phagocytosis is a key function in the innate immune system; however, it also 
plays an important role in antibody production and neutrophil homeostasis.  The role of PUFA in 
modulating phagocytosis has been previously shown in cultured macrophage treated with PUFA 
resulting in increased phagocytosis of unopsinized zymosan particles when compared to 
saturated fatty acid treatments (20)(21).  Phospholipase A2, involved in the release of AA from 
membrane, is required for phagocytosis (22).  The mechanism behind the requirement of AA in 
phagocytosis was proposed to be in membrane fusion of vesicles for pseudopod formation.  
Macrophage pseudopods consist of membrane projections that engulf the target particles prior to 
endocytosis.  With phospholipase A2 inhibition, intracellular accumulation of vesicles occurs 
possibly due to lack of fusion with the forming pseudopod, resulting in lower phagocytic 
acitivity; AA treatment was shown to override phospholipase A2 inhibition reducing the number 
of intracellular vesicles (22).  This mechanism is similar to the AA requirement in neurite 
outgrowth within neuroendocrine cells, which also relies on membrane fusion and extension 
(23).   Interestingly, preliminary work with D6D-/- suggests only slight differences in peritoneal 
macrophage phagocytosis of opsonized zymosan and sheep red blood cells when compared to 
+/+.  It is important to note a limitation of using cell culture for immune function 
characterization.  Fetal calf serum added to cell culture medium contains 10% AA; the presence 
of this fatty acid in the medium may change the cell fatty acid profile of HUFA deficiency 
achieved in vivo, allowing lymphocytes to regain function. A cell culture system with serum free 
media may be preferable to evaluate immune function ex vivo.   
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Despite the limitation of arachidonic acid in fetal bovine serum used in cell culture, the 
impact of HUFA deficiency on macrophage lipid metabolism was demonstrated using the D6D-
/- (24).  Macrophage cholesterol biosynthesis is increased while antioxidant paraoxynase activity 
is decreased in peritoneal macrophages collected from D6D-/-; both parameters can be restored 
to +/+ levels with AA supplementation (24).  An alteration in macrophage lipid metabolism by 
HUFA deficiency may therefore also contribute to alteration in immune functionality. 
In summary, HUFA deficiency results in impaired antibody response which is indicative 
of an altered adaptive immune system.  Spleen histology indicates a decrease in white pulp 
which may explain impaired antibody production.  Although spleen cell counts were not 
different between +/+ and D6D-/-, we did not quantify individual immune cell populations such 
as B-cells.  Increased spleen red pulp consisting mainly of higher counts of neutrophils, as well 
as increased myeloid precursors in bone marrow may be secondary to inflammation within GI or 
a result of altered neutrophil homeostasis.  The macrophage is involved in both antibody 
production and neutrophil homeostasis through phagocytosis; therefore further characterization 
of D6D-/- macrophage functionality is necessary.  This preliminary immune system 
characterization of the D6D-/- will help develop future studies to give insight on specific roles of 
AA and DHA for proper immune function. 
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TABLES AND FIGURES 
Table 9.1 Male spleen and thymus weights and cell counts of 16 week old mice.  
Spleen Thymus 
Males 
+/+ -/- +/+ -/- 
Absolute weight (mg) 69±6 142±42 19±4 27±8 
Cells (x108) 1.22±0.16 1.58±0.46 0.39±0.2 0.4±0.13 
                     Mean ± SD. n=4-6. 
 
Table 9.2 Female spleen and thymus weights and cell counts of 16 week old mice.  
Spleen Thymus 
Females 
+/+ -/- +/+ -/- 
Absolute weight (mg) 91±28 125±43 22±5 25±6 
Cells (x108) 1.27±0.18 1.46±.77 0.83±0.1 0.58±0.52 
                    Mean ± SD. n=3. 
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Table 9.3   Spleen neutrophil count and bone marrow myeloid to erythroid (M:E) ratio in 16 
week old D6D -/- mice.  The spleen neutrophil count is an average counted in 10 fields using 
high power magnification.  
 Spleen Neutrophils (average/HPF 100x) Bone Marrow M:E ratio 
 +/+ -/- +/+ -/- 
Male  2.8±1 7.9±2.6* 1.9±0.4 3.1±0.5* 
Female 2.5±1 11.9±5.5* 1.3±0.4 2.2±0.3* 
Mean ± SD. *statistically different by Student’s t-test ( p < 0.05), compared to +/+.  Male n=2-3; female n=2 
 
Table 9.4 Spleen lymphocyte IL-2 cytokine production (picograms per ml) when stimulated with 
concavalin-A.   
 IL2 (pg/ml) 
 +/+ -/- 
Males 
 
42.6±8 20.6±10.5* 
Females 
 
27.5±4.4 21.9±9.7 
Mean ± SD. *Statistically different by Student’s t-test ( p < 0.05), compared to +/+.  Male n=4-6; female n=2. 
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Figure 9.1 Spleen histology (hematoxylin and eosin).  Wild type mouse (+/+) shows normal 
distribution of red pulp and white pulp (arrows).  D6D-/- has decreased white pulp (arrows).  AA 
supplemented -/- shows normal distribution of white pulp similar to +/+. 
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Figure 9.2 D6D-/- spleen fatty acid analyses of female +/+ and -/- mice (n=3) with and without 
0.4% (w/w) AA supplementation. Values represented as mean ± SD. n=3. *=p<0.05 as 
determined by Student’s t-test, comparing +/+ versus -/-. 
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Figure 9.3 Antibody response to a T-cell dependant antigen of KLH in (A) male (n=4-6) and (B) 
female (n=3) 16 week old mice.  Mean ± SD. *= p<0.05 as determined by Student’s T-test. 
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Figure 9.4 A typical scattergram of spleen CD3 positive cells gated for CD4 and CD8 T-cell 
populations in +/+ and D6D-/- (n=3).  
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Figure 9.5 Flow cytometry scattergram of +/+ and D6D-/- peritoneal cells 4 days post-injection 
with thioglycollate (n=2).  Macrophage population is contained in encircled region.  Population 
not defined in -/-. 
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Figure 9.6 Flow cytometry scattergram of +/+ and D6D-/- peritoneal cells positive for mature 
macrophage marker F4/80 (n=2).  F4/80+ cells in D6D-/- have a less defined population and 
higher forward scatter, indication of larger size. 
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Figure 9.7 Flow cytometry scattergram of +/+ and -/- (n=2) peritoneal cells positive for Cd11b, 
component of the complement receptor present of macrophage.  Cd11b positive cells are in a 
higher percentage in D6D-/-.  
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Figure 9.8 Preliminary flow cytometry percentages of +/+ and -/- peritoneal cells positive for 
F4/80 or Cd11b.   Mean±SD. n=2. *=p<0.05 statistically different according to Student’s t-test. 
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Figure 9.9 Adherence, nitric oxide and TNFα production of cultured +/+ and -/- peritoneal 
macrophage (n=3) after a 48 hour treatment of either 10% FBS, IFNγ, LPS, or a combination of 
IFNγ and LPS (both). Mean±SD. *=p<0.05 statistically different according to Student’s t-test. 
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CHAPTER 10 
SUMMARY AND FUTURE RESEARCH 
The general objective of this research was to elucidate specific physiological roles of AA 
and DHA and their underlying mechanisms.  In order to achieve this objective, the research was 
divided into three parts: a) establishing a time course of D6D-/- pathology, b) determining 
specific HUFA physiological functions through dietary prevention of D6D-/- pathology, c) and 
elucidating the mechanism behind HUFA requirement for male fertility.   
In chapter 4, a time course study of D6D-/- pathology was done to explain the delay in 
appearance of HUFA deficiency phenotype, specifically ulcerative dermatitis which occurs by 21 
weeks of age.   This study demonstrates the presence of HUFA stores in D6D-/- at weaning or 3 
weeks of age, indicating HUFA is provided by the mother.  These HUFA stores are rapidly 
depleted after weaning up to 6 weeks of age at which point the rate of depletion slows down.  
The period of accelerated depletion coincides with the first observed HUFA deficiency 
phenotype of hepatic lipidosis and disrupted spermatogenesis.  In future studies, avoiding these 
HUFA stores in D6D-/- before weaning could help in accelerating HUFA depletion in tissue 
such as brain, which is abundant in HUFA and still at approximately 85% of +/+ at 5 months of 
age.  This has been an important limitation in researching the physiological role of HUFA in 
brain function.   
Specific functions for each HUFA were determined by preventing D6D-/- phenotype 
through dietary supplementation of either arachidonic acid (AA) or docosahexaenoic acid (DHA) 
(Table 10.1).  In chapter 5, the dietary essential fatty acids linoleic and α-linolenic acid alone 
could not modulate liver lipid homeostasis resulting in hepatic lipidosis in D6D-/-.  In this case, 
either AA or DHA supplementation was sufficient to prevent liver pathology.  Therefore, 
essentiality in liver does not seem to be specific to either HUFA.  The mechanism behind HUFA 
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requirement in preventing accumulation of liver triglyceride is yet to be elucidated.  This study 
indicates increased lipogenesis does not seem to play a role in this pathology.  Future studies 
could focus on inefficient lipid secretion due to HUFA deficiency considering the presence of 
SNARE components during the VLDL secretion process and recent evidence of HUFA 
interactions with SNARE complex. 
In chapter 6, an essential requirement for AA in skin function was demonstrated through 
prevention of D6D-/- ulcerative dermatitis by AA supplementation but not dietary DHA.  
Previously, linoleic acid was considered the main polyunsaturated fatty acid required for skin 
physiology; however, its presence did not prevent D6D-/- skin pathology.  Prevention of 
gastrointestinal ulceration was also specific to AA.  The role of AA in skin and gastrointestinal 
tract is most likely related to prostaglandin production.  Further research is required to determine 
which prostaglandins maintain epithelial integrity and how this is achieved.  The trigger for 
excessive scratching behavior in D6D-/- prior to ulcerative dermatitis is yet to be elucidated.   
In chapter 7, a specific role for DHA was determined for male fertility.  The role for 
HUFA in male reproduction was previously only inferred, however, specific HUFA deficiency in 
the D6D-/- mouse allowed attribution of requirement for DHA in spermatogenesis since AA was 
not as successful in restoring all fertility parameters.  Chapter 8 demonstrates a novel role for 
DHA in acrosome biogenesis, an important process in sperm cell maturation.  Acrosome 
formation relies on vesicle fusion.  Future research will consist in identifying vesicle fusion 
SNARE proteins which participate in the development of the acrosome and determine if DHA 
drives the formation of SNARE complex during spermiogenesis.  It is also important to elucidate 
why AA fails to completely restore fertility parameters, as well as to identify specific steps that 
were rescued by its supplementation. 
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Several studies have demonstrated a role for HUFA in modulating the immune system 
through diet.  Chapter 10 shows that HUFA not only modulate immune function but are essential 
in the immune system, specifically in the development of an antibody response to a T-cell 
dependant antigen.  The underlying mechanism behind impaired antibody response due to HUFA 
deficiency is yet to be elucidated.  Decreased white pulp of D6D-/- spleen may be a focus area of 
future research since this is the site of immune cell interactions in the development of antibody.  
Challenging the mouse with a T-cell independent antigen would also help elucidate which 
immune cells are compromised by HUFA deficiency.  Macrophage from D6D-/- were shown to 
have altered metabolism with increased cholesterol synthesis and decreased paraoxynase 
activity.  Further macrophage characterization, specifically in relation to phagocytosis, would be 
important to elucidate a role for HUFA in immune function.   Preliminary work suggests 
impaired phagocytosis.  This process relies on SNARE components for pseudopod formation and 
would most likely require HUFA.  Neutrophil homeostasis would be another area of research to 
study HUFA function, considering the observed spleen myeloid hyperplasia, neutrophilia, and 
increase in bone marrow myeloid precursors, although this may be secondary to gastrointestinal 
ulceration. 
In all, the two key findings in this research were AA essentiality in skin and a specific 
requirement for DHA in male fertility, specifically in acrosome biogenesis through vesicle 
fusion.  Future research with the D6D-/- model will help elucidate the mechanism behind HUFA 
essentiality in testis as wells as other tissues, such as liver, skin, and the immune system.  Further 
comprehension of the role of HUFA would help in the development of treatments for diseases 
that result from altered HUFA metabolism. 
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SUMMARY TABLE 
 
Table 10.1 Summary of delta-6 desaturase knockout (D6D-/-) phenotype reversed by highly 
unsaturated fatty acid (HUFA) supplementation. 
 
 
 
 Supplementation 
D6D-/- phenotype AA (20:4n6) DHA (22:6n3) 
Dermatitis Prevented Not prevented 
Gastrointestinal ulcers Prevented Not prevented 
Hepatic lipidosis Prevented Prevented 
Male infertility Partially restored Fully restored 
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